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ABSTRACT 
 
Cell fate restriction in Caenorhabditis elegans is orchestrated by precise chromatin 
organization and transcription factor activity 
Tulsi Patel 
 
The plasticity of cells in a multicellular organism is progressively lost during 
differentiation. This loss is reflected in studies involving the ectopic misexpression of fate-
specifying or terminal selector transcription factors (TFs). These TFs can efficiently activate 
target genes in undifferentiated cells, but lose this ability as cells differentiate. While this 
phenomenon of cell fate restriction is widely observed, the mechanisms orchestrating it are 
poorly understood. In this thesis, I have used the ubiquitous overexpression of Zn-finger-TF 
CHE-1 as a tool to understand the mechanisms that restrict cell fate in Caenorhabditis elegans. 
When CHE-1 is ubiquitously expressed at embryonic stages, it activates target gene expression 
in many cell types, while in adults it can only act in a few neurons. To uncover factors that 
inhibit plasticity of all other adult cells, I first performed an RNAi screen against chromatin-
associated factors. Using this approach I found that the removal of either the PRC2 complex, 
which deposits the H3K27me3 mark, or loss of proteins that indirectly regulate domains of 
H3K27me3, allows CHE-1 and two other terminal selector TFs to activate target genes in the 
germline. These data show that the correct distribution of H3K27me3 is crucial for the restriction 
of germ cell fate. I next took a candidate approach to identify genes that regulate fate restriction 
in other cell types. We hypothesized that terminal selector TFs themselves, in addition to 
specifying cellular identity by controlling large gene sets, may also act to inhibit plasticity. To 
test this, I first assayed the activity of CHE-1 in mutants of COE-TF unc-3, the terminal selector 
for a subset of cholinergic motor neurons (MNs). I found that in contrast to wildtype MNs, unc-3 
mutant MNs remain plastic as CHE-1 can induce expression of target genes in these cells even at 
the adult stage. This phenotype is also observed in four of six additional terminal selector 
mutants tested. I further found that the removal of met-2, a protein required for H3K9 
methylation, or mes-2, a PRC2 component, also makes differentiated cholinergic MNs amenable 
to the activity of CHE-1. Preliminary evidence suggests that met-2 may act in the same pathway 
as unc-3. These results raise the exciting possibility that selector TFs play a role in restricting 
cell fate by organizing the heterochromatin domains in differentiated cells. Overall, in this work I 
provide functional evidence to show that specific chromatin-modifying enzymes restrict the fate 
of germ cells and that both fate-specifying TFs and chromatin-modifying enzymes are required 
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CHAPTER I: Introduction  
 
The acquisition of differentiated cell fates in a multi-cellular organism is accompanied by 
the loss of developmental plasticity (a detailed definition of the term differentiation as it pertains 
to this work is presented in Appendix A). Pluripotent cells have the potential to activate diverse 
categories of genes; however, once cells differentiate and acquire a fate-specific transcriptional 
program, they become less amenable to the activation of other fate-specific genes. Additionally, 
the acquisition of cell-type-specific transcriptional programs in differentiated cells is 
accompanied by changes in chromatin organization, suggesting a mechanistic link between 
chromatin organization and fate restriction. While decades of study have uncovered factors that 
play an important role in activating fate-specific genes, we are just beginning to understand the 
mechanisms that regulate plasticity. Studying the later phenomenon is important as it both 
advances our knowledge of development and aids in the production of biologically relevant cell 
types in vitro, which have become increasing useful in recent years for studying disease 
mechanisms and carry great potential for cell replacement therapies. The work in my thesis is 
therefore aimed at further understanding the molecules and mechanisms that coordinate the gain 
of a specific fate with the loss of plasticity using C. elegans as a model system.  
In this chapter, I first provide a brief historic overview of some of the seminal 
experiments that defined our understanding of cellular plasticity. I then discuss how transcription 
factor (TF) overexpression assays can be used to understand developmental fate restriction. And 
lastly, I provide an overview of our current understanding of the differences in chromatin 
structure found in a pluripotent vs. differentiated cells and outline the experimental approach 
used in my thesis to investigate the mechanisms of fate restriction. 
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I. Brief historic overview of the study of plasticity in differentiating cells 
Single zygotic cells contain the potential to divide and differentiate into the multitude of 
cell types that make a complex organism.  In his metaphorical epigenetic landscape, Waddington 
portrays such a potent cell as being on top of a hill (Figure 1-1). As development progresses, this 
cell rolls down the hill and is directed into ridges by the action of genes that instruct its 
differentiation, landing finally at the bottom of a valley that represents its terminal fate 
(Waddington, 1957).  Inherent to this metaphor is the idea that differentiation goes hand in hand 
with a loss of developmental plasticity, that the terminal fate is stable and that once a cell attains 
it, there is a barrier in its ability to choose alternative fates. The question of how cells change as 
they differentiate has interested embryologists for decades and the following section is an 








Figure 1-1: Waddington’s Epigenetic Landscape 
In this metaphor, Waddington portrays developing cells as balls rolling down a hill, coming to rest at the 
lowest points which represent various cell fates (left image). The movement of the balls is guided by a 
network of genes that are depicted underneath this hill (right image) (Waddington, 1957) 
 
 
Somatic nuclear transplant assays 
In the early 1900s, the embryologist Hans Spemann constricted a 16-cell salamander 
embryo to separate a single nucleus from the remaining 15. This resulted in the development of 
two viable animals from the same embryo—showing that developing nuclei remain totipotent. 
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Much of his work queried the principles of embryonic development, and at the end of his career 
he proposed that it would be a “fantastic” experiment to replace the nucleus of an egg with the 
nucleus of a differentiated cell to study if a completely developed nucleus retained the potential 
to make an entire organism (Sander, 1985). Briggs and King performed the first such somatic 
nuclear transplant experiment using frogs in the 1950s. They transplanted endoderm nuclei from 
dividing blastula, early gastrula, and late gastrula stage Rana pipiens embryos into enucleated 
eggs and monitored the development of these experimental zygotes. While 35% of the 
transplanted early gastrula nuclei formed tadpoles, only 7.5% of late gastrula nuclei were 
successful. They concluded that this showed the “intrinsic restriction in potentiality” of 
differentiating nuclei as embryogenesis progresses (Briggs and King, 1952; King and Briggs, 
1955). These experiments, however, did not test the developmental potential or plasticity of 
differentiated cells.  
John Gurdon repeated similar nuclear transplant experiments in Xenopus laevis. He and 
his colleagues transplanted endodermal nuclei from eight progressive developmental stages, 
starting with blastula embryos to differentiated intestine cells of feeding tadpoles, into enucleated 
eggs. They also saw that the percent of normal feeding tadpoles derived from these transplants 
decreased as the age of the host nucleus increased—21% and 24% of blastula and gastrula 
derived embryos formed tadpoles, while only 1.5% of embryos derived from differentiated 
intestinal cells did (Gurdon, 1960, 1962). The tadpoles derived from intestinal cell nuclei, 
however, did form adults that were fertile (Gurdon and Uehlinger, 1966). These experiments 
elegantly confirmed that nuclei progressively lose their developmental potential as they 
differentiate. They also established that differentiated cells retain all of the information required 
to make a complete organism.  
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These and many nuclear transplant experiments that have followed, show that cells retain 
genetic information as they differentiate, but this information becomes more difficult to access as 
differentiation progresses (reviewed in Gurdon and Wilmut, 2011). This phenomenon has been 
referred to as a loss of pluripotency, loss of developmental potential, loss of plasticity, or cell 
fate restriction. I will use these terms interchangeably. These nuclear transplant experiments also 
showed that factors found in the egg cytoplasm are sufficient to re-activate the parts of the 
genome that are necessary to make a whole organism. Experiments performed with cell fusions, 
or heterokaryons, as discussed in the next section, extended these findings by demonstrating that 
differentiated cells also contain factors that are sufficient to access inactive genetic material.  
 
Heterokaryons 
In the 1970s and 1980s, experiments with heterokaryons became instructive in 
understanding the stability of a differentiated fate. Work done by Helen Blau’s lab showed that 
when human amniocytes are fused to mouse muscle cells, the human amniotic nucleus starts to 
produce muscle proteins (Blau et al., 1983). Activation of the human muscle markers is stable, 
and similar results were seen when heterokaryons were formed by fusing human keratinocytes 
and hepatocytes with mouse muscle cells (Blau et al., 1985). This showed that differentiated 
cells could activate the expression of normally repressed genes in response to trans-acting factors 
from other differentiated cells. Additionally, for all these heterokaryons, the activation of muscle 
genes in the non-muscle human cell was dependent on the relative ratios of the different nuclei 
present in the heterokaryon, suggesting that a competition between activators and repressors 
determines the ultimate gene expression profile. Previous work with heterokaryons had resulted 
in only transient activation of silent genes because these hybrids continued to divide, which often 
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resulted in the loss of chromosomes that encoded the relevant trans-acting factors, or because the 
hybrids were made with only the cytoplasm of one of the cells resulting in a dilution of trans-
acting factors over time. These data cumulatively suggested that positive and negative regulators 
actively maintain the differentiated state. Genes that are repressed in a differentiated cell do not 
just passively stay repressed; their repressed state has to be maintained and can be challenged by 
an activator and vice a versa (Blau and Baltimore, 1991). Experiments done with temperature 
sensitive mutants and somatic mosaics in C. elegans and Drosophila melanogaster, respectively, 
also support the idea that an active maintenance of differentiated fates is required (Blau and 
Baltimore, 1991). These insightful conclusions continue to hold true, especially in the era of TF-
driven cell fate conversions as discussed extensively below. 
 
Ectopic overexpression of MyoD 
Just a few years after Helen Blau’s heterokaryon experiments, Weintraub and colleagues 
showed that the over-expression of a single cDNA, encoding for the helix-loop-helix TF MyoD, 
is sufficient to convert fibroblasts into muscle-like cells (Davis et al., 1987).  Expression of 
MyoD in fibroblast cell lines, primary rat, or primary human fibroblasts results in the activation 
of muscle genes in about 50% of transfected cells. An elongated and multinucleated muscle-like 
morphology is also seen in many of these cells. Transfection of MyoD in other cell lines shows 
mixed results. Neuroblasts and melanoma cells activate muscle markers in response to MyoD but 
also retain characteristics of the original fate, including the original cell morphology. Human 
hepatocytes and monkey kidney cells, in contrast, fail to express any muscle markers after 
induction of MyoD (Weintraub et al., 1989). These experiments were seminal in showing that 
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certain TFs can be sufficient for activating multiple facets of a differentiated fate and for 
establishing the importance of cellular context for TF activity.  
The ability of MyoD to convert the molecular and morphological identity of fibroblasts, 
but no other cell type, suggests that this cell type provides a unique context in which MyoD can 
activate many of its target genes. It is possible that the lineage relationship between muscles and 
host cells plays an important role in dictating how amenable a host cell is to MyoD. As many of 
the cell types tested are immortalized and these experiments are done in vitro, it is difficult to 
make concrete conclusions about the reasons for the activity of MyoD. In fact, while some 
fibroblast cell lines are very receptive to MyoD activity, not all fibroblast cell lines tested 
behaved the same way (Davis et al., 1987), highlighting the unpredictable effects of cultured 
cells on the phenomenon of differentiation.  
These early somatic nuclear transplant, heterokaryon, and MyoD overexpression 
experiments established some of the principles that govern the study of cellular differentiation 
and plasticity. The earliest embryology experiments showed that differentiated cells retain all 
genetic information but that this material is less accessible as cells differentiate and activate cell-
type-specific transcription. Then, heterokaryon and MyoD overexpression experiments showed 
that although unexpressed genetic material gets increasingly inaccessible in differentiated cells, 
certain trans-activating factors, and even single TFs, could still activate target expression in the 
right cellular context. These data cumulatively bolster the ideas that a differentiated state is 
actively maintained, that repressed genes can be re-activated, and that activated genes can be 
repressed by diverse manipulations.  
A few decades after these seminal experiments, our current understanding of 
transcriptional regulation and higher order chromatin structure shows that extensive and complex 
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regulation is required for the acquisition, restriction, and maintenance of unique cell fates. 
Despite the inherent complexity in the system, most differentiated cells are very stable under 
normal developmental conditions. Exceptions do exist: specific kinds of cells change their 
identity and function during the course of development (Jarriault et al., 2008; Sammut et al., 
2015), adult stem cells retain the potential to become various kinds of cells within the same 
lineage (reviewed in Wagers and Weissman, 2004), and cells switch fate in response to injuries 
(Tsonis et al., 2004). However, the loss of cellular identity or fate restriction in most 
differentiated cells is often pathological, leading to degenerative disorders or cancerous tissues 
(Ben-Porath et al., 2008; Holmberg et al., 2011; Piunti and Pasini, 2011). The work in this thesis 
is aimed at better understanding the mechanisms that ensure that differentiated cells acquire a 
restricted state. TF overexpression experiments, such as those pioneered by Weintraub and 
colleagues, are powerful tools for dissecting these mechanisms. The next section is an overview 
of such studies and their potential uses in understanding fate restriction.  
 
II. Study of cell fate plasticity with the overexpression of TFs 
Cell fates are restricted as differentiating cells make unrequired genetic content less 
accessible, such that only the genes expressed in a particular cell is readily available for 
activation. Experimentally, one way to test the state of accessibility of genes is to ectopically 
express TFs and ask whether their target genes can be activated. These kinds of experiments 
provide a window for understanding the developmental potential of a cell, and can be used to 




Response to an ectopically expressed TF is a reflection of the developmental potential of a 
cell 
 Experiments performed using hlh-1, the C. elegans homolog of MyoD, elegantly 
demonstrate that the cellular response to an ectopically expressed TF is indicative of its 
developmental potential.  In order to understand the myogenic potential of hlh-1, Krause and 
colleagues ubiquitously expressed the TF in developing C. elegans embryos and monitored the 
expression of several terminal muscle genes using reporters and immunostaining for muscle 
proteins (Fukushige and Krause, 2005). They found that when hlh-1 expression was induced in 
12-112 cell embryos, most, if not all, somatic cells activated various muscle genes. This ability 
of hlh-1 to activate target genes declines in ~300 cell embryos and continues to decline over the 
next few hours of development such that post mitotic cells are completely unresponsive 
(Fukushige and Krause, 2005).  
 These experiments show that the competence to respond to hlh-1 is lost as differentiation 
progresses. Similar experiments were done with GATA TF end-1, an endoderm regulator that is 
required for the development of the C. elegans intestine (Zhu et al., 1997). Ubiquitous expression 
of end-1 in early embryonic stages results in broad activation of various gut markers in almost all 
cells of the embryo. Induction of end-1 later in embryonic development has no ectopic effects 
(Zhu et al., 1998). The window of accessibility of embryonic cells in response to these TFs, 
however, seems to vary. In the case of end-1, cells stop responding after the 51-86 cell stage; 
whereas refraction to hlh-1 overexpression occurs around the 300 cell stage. The general trend 
still suggests that various types of genes are accessible only in the early embryo while cells are 
pluripotent.  
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 An alternative hypothesis is that hlh-1 and end-1 act only early in development because 
of the presence of a transient co-activator, or the transient absence of a repressor. In this case, the 
ability to activate target genes may not reflect their accessibility. In regard to this point, it is 
important to note that other TFs in C. elegans, like homeodomain TF pal-1 (Fukushige and 
Krause, 2005), another endodermal GATA TF elt-7 (Zhu et al., 1998), ectoderm regulating 
GATA TFs elt-1 and elt-3 (Gilleard and Mcghee, 2001; Gilleard et al., 1999; Page et al., 1997), 
pharyngeal FoxA TF pha-4 (Horner et al., 1998), and neuronal Zn-finger TF che-1 (Uchida, 
2003; this study), show a similar decrease in activity as development progresses. It is unlikely 
therefore, that the regulation is completely TF-specific. The generality of the phenomenon rather 
suggests that a broad mechanism, which affects the accessibility of many genes, is in play. 
Within the context of this broad phenomenon, some TF-specific mechanisms are also relevant, as 
the window of activity varies for different TFs. These TF-specific mechanisms are discussed 
later.  
 In addition to these studies in C. elegans, there are also indications in other systems that 
the developmental state of a host cell is correlated to its ability to respond to ectopically 
expressed TFs. After the pivotal discovery by Yamanaka and colleagues that the overexpression 
of c-Myc, Klf4, Sox2, and Oct4 can convert fibroblasts into induced pluripotent stem cells 
(iPSCs) (Takahashi and Yamanaka, 2006), the activity of these “Yamanaka factors” has been 
tested in numerous other cell types (Hochedlinger and Plath, 2009; Li et al., 2014). The 
efficiency of these TFs is also dependent on the host cell context, and this context can be partly 
explained by the state of differentiation of the host cells. The most convincing example of this is 
seen when the Yamanaka factors are overexpressed in B lymphocytes (Hanna et al., 2008). 
Expression of c-Myc, Klf4, Sox2, and Oct4 in non-terminally differentiated Pro-B cells leads to 
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the formation of iPSCs. Expression of these factors in terminally differentiated B lymphocytes 
does not produce iPSCs, suggesting again a loss of developmental potential with the progression 
of differentiation. If, however, Pax5 mutant B lymphocytes are used as host cells, iPSCs can be 
derived after the induction of c-Myc, Klf4, Sox2, and Oct4 (Hanna et al., 2008). It has been 
shown that in the absence of Pax5, B cells lose their lineage commitment and de-differentiate 
into a multipotent state (Nutt et al., 1999) thus reinforcing the idea that the state of differentiation 
predicts whether B cells are receptive to the Yamanaka factors. In a less convincing example, 
human keratinocytes convert into iPSCs faster and with higher efficiency than fibroblasts (Aasen 
et al., 2008; Maherali et al., 2008). Keratinocytes represent a more pluripotent state than 
fibroblasts and express more stem cell related genes (Maherali et al., 2008), pointing to a similar 
differentiation state related explanation for the efficiency of conversion. However, fibroblasts 
and keratinocytes do not represent different developmental stages of the same lineage, and 
keratinocytes, like embryonic stem cells, are epithelial whereas fibroblasts are mesenchymal. 
Other factors could, therefore, also explain the difference observed in conversion efficiency.   
 Taken together, these data suggest that the response of a cell to an ectopically expressed 
TF can be used as an indicator of cellular plasticity. These assays are most convincing when 
multiple cell types are tested at various stages of development. A small organism like C. elegans 
is ideal for such experiments as it provides both an adequate variety of developing cell types and 
the ability to easily visualize the activity of TFs in all of these cells as described in Chapter 2.  
 
Properties inherent to TFs also dictate their activity in an ectopic context 
In addition to the state of plasticity in the host cell, variability in TF activity can depend 
also on the TF itself or on the context of other factors present in the host cell. TF- dependent 
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variability is seen in C. elegans embryos, as mentioned above, even at early stages of 
differentiation (Fukushige and Krause, 2005; Zhu et al., 1998). Ectopic endodermal gene 
activation by end-1 can only be achieved in embryos that are at the 86 cell stage or younger. In 
contrast, overexpression of another endodermal regulator, GATA-TF elt-7, which in combination 
with elt-2 is required for intestine differentiation, results in broad activation of intestine genes 
even in late embryogenesis (Riddle et al., 2013; Sommermann et al., 2010). The difference in the 
activity of elt-7 and end-1 could perhaps be explained by their roles in intestine development. 
While end-1 expression is transient in early endodermal cells, elt-7 expression peaks at around 
the time end-1 expression declines and continues into adulthood (Sommermann et al., 2010).  
The function of end-1 seems to be the specification of the endodermal lineage and the activation 
of downstream TFs like elt-7, which are then responsible for the differentiation of intestine fate.  
A similar paradigm is apparent in muscle induction. hlh-1, along with unc-120 (MADS 
box TF) and hnd-1 (HAND domain bHLH) initiate the differentiation of muscle fate. While hnd-
1 is only expressed transiently during early development, hlh-1 and unc-120 remain expressed 
during the larval stages (Fukushige et al., 2006; Krause et al., 1990; Mathies et al., 2003). The 
myogenic potential of all three TFs was tested by ubiquitous expression in the early embryo 
(Fukushige and Krause, 2005; Fukushige et al., 2006). hlh-1 had the best ectopic activity, 
followed by unc-120, and hnd-1 had the least ectopic activity (Fukushige et al., 2006). hlh-1 and 
elt-7 also have the ability to positively autoregulate their own expression, unlike end-1, unc-120 
and hnd-1(Fukushige et al., 2006; Sommermann et al., 2010). The evidence from the intestinal 
and muscle TFs indicates that different TFs elicit different responses from the same, potentially 
pluripotent, cells. The TFs that are most potent seem to be fate specifying or master regulatory 
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TFs that regulate expression of a wide variety of target genes, autoregulate their own expression, 
and are possibly required for fate maintenance.  
In addition to the TF itself, the cellular context can also cause variability in the ability of 
a TF to act.  This is seen when one of the Drosophila homologs of the paired box TF Pax6, 
eyeless (ey) is ectopically expressed in various developing imaginal discs. Expression of ey in 
leg, antenna, wing, and haltere discs leads to the formation of normal looking compound eyes 
containing ommatidia in these imaginal discs (Halder et al., 1995). Expression of ey in the 
genital disks, however, did not lead to ectopic eyes. While ey contains a putative repressor 
element in its N-terminal domain, Toy, a second Drosophila Pax6 homolog does not. It was 
subsequently shown that a hybrid protein, in which the ey repressor element is replaced with the 
homologous region from Toy, is competent to induce ectopic eyes in the genital discs and a few 
head regions where ey was ineffective (Weasner et al., 2009). This suggests that ey interacts with 
potential co-repressors in the genital discs and the head regions that are not expressed in leg, 
antenna, wing, and haltere disks. Thus, even when target genes are in an accessible state, the 
properties of the overexpressed TF itself and the presence of possible co-regulators in the host 
cells can dictate whether they will get activated. 
 
Activity of TFs in differentiated cells 
 Although terminally differentiated cells are in their least plastic state, they can allow for 
the activity of very specific TFs. In these cases, the TFs being overexpressed are either lineally 
related to the host cell type, share co-factors with the host cell type, or are pioneer-like TFs, 
which can access difficult-to-access genes. 
Several examples of conversions within the same lineage have now been published. In 
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the hematopoietic lineage (Figure 1-2), it has been shown that monocytes can be converted into 
erythroid cells with the overexpression of GATA1 and the converse can be achieved with the 
overexpression of PU.1 (Kulessa et al., 1995; Nerlov and Graf, 1998). Additionally, committed 
B- and T-cells can be converted into macrophages by the overexpression of TF cEBP (Laiosa et 
al., 2006; Xie et al., 2004). The significance of the shared lineage history in these conversions 


















Figure 1-2: The Hematopoietic lineage 




In mice pancreas, exocrine cells can be converted into insulin producing β cells by the 
expression of TFs MafA, Pdx,1 and Ngn3 (Zhou et al., 2008). When the same TFs are 
overexpressed either in skeletal muscles in vivo or in fibroblasts in vitro, conversion into β cells 
is not observed. While the mechanisms in this case have not been further explored, this does 
suggest that the shared lineage history could account for the competence of these TFs.  
Many conversions between lineally distant cells have also been seen. MyoD, of course, 
has been shown to activate muscle fate in fibroblasts and a few other cell types (Davis et al., 
1987; Weintraub et al., 1989). Fibroblasts and hepatocytes can be converted into neurons with 
the overexpression of Brn2, Ascl1, and Myt1l also referred to as the BAM factors (Marro et al., 
2011; Vierbuchen et al., 2010). Fibroblasts have also been converted into neurons, 
cardiomyocytes, hepatocytes, and astrocytes with the use of different combinations of TFs 
(Caiazzo et al., 2015; Huang et al., 2011; Ieda et al., 2010). In C. elegans, endodermal TF elt-7 
can convert adult pharyngeal cells into intestine cells (Joshi et al., 2010).  
The mechanisms underlying these lineally distant transformations have been explored in 
a few cases. The fibroblast to neurons conversion driven by BAM factors, for instance, has been 
characterized in depth (Wapinski et al., 2013). This study found that the TF Ascl1 has pioneering 
capabilities and can bind to inaccessible genes that are defined by a specific chromatin signature. 
The binding of Ascl1 then facilitates the binding of Brn2 and Myt1l to their respective targets. 
The ability of BAM factors to impose a neuronal fate on multiple cells types, including 
hepatocytes, is explained by this mechanism (Marro et al., 2011; Wapinski et al., 2013). 
Additionally, the case of elt-7-driven pharynx to intestine conversion can perhaps be explained 
by the presence of pha-4 in both these tissues (Azzaria et al., 1996; Horner et al., 1998). pha-4 
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can act like a pioneer factor and could potentially facilitate the binding of elt-7 to its target genes 
in both these cell types (Fakhouri et al., 2010).  
A better understanding of why some differentiated cells are amenable to specific TFs 
while others are not could provide interesting insight into the activity of TFs. To understand this 
in depth, expression of TFs would have to be performed in numerous different cell types in a 
system that is easy to genetically manipulate. C. elegans is again ideal for such studies. In the 
case of elt-7 for instance, the TF is ubiquitously expressed but acts only in the pharynx in adults, 
providing a good platform for genetically dissecting the mechanisms of its cell-type-specific 
activity.  In Chapter 2, we show that the overexpression of neuronal Zn-finger TF, che-1, also 
provides a great platform for further dissecting the specificity in TF activity. 
 Cumulatively, TF overexpression studies demonstrate that early in development cells 
maintain their genes in a more accessible state and that accessibility generally decreases with 
differentiation. The accessibility of genes to TFs is defined by the presence of distinct chromatin 
structures. The next section is an overview of some of the chromatin-based mechanisms that 
change during the process of differentiation and may explain the loss of plasticity.  
 
III. Chromatin regulation during differentiation 
 The human genome comprises of 3.2 billion base pairs which have to be folded about 
400,000 fold to fit in a nuclear volume (Schneider and Grosschedl, 2007). Such structural 
complexity is a hallmark of eukaryotic nuclei. For this reason, the activation of fate-specific 
genes is dependent not only on the presence of cis-regulatory elements, but also on the 
accessibility of the DNA. The efficient packaging of DNA into chromatin has to be actively 
regulated in each differentiating cell type in order to achieve the correct gene expression profile. 
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Some factors that define the accessibility of genetic material include its location in the nucleus, 
the presence of structural compaction, modifications of DNA such as methylation and 
acetylation, and various post-translational modifications of histone proteins. The stability of any 
cellular state relies on the interactions between these processes and the presence of DNA binding 
TFs. Given the sheer number of possible modifications and trans-acting factors, these 
modifications are extremely dynamic and we are just beginning to understand how these factors 
change as differentiation progresses. This section is an overview of some of the changes in 
compaction, location, and histone modifications known to be associated with differentiation, as 
these processes are most relevant for the work done in my thesis.  
 
Compaction and localization of chromatin 
 In 1928, Heitz noted that the microscopic organization of chromatin consisted of distinct 
open and densely packed regions. He called the open regions ‘euchromatin’ and packed regions 
‘heterochromatin’ and further postulated that whereas the euchromatin would contain actively 
transcribed genes, the heterochromatin consisted of non-transcribed genes (Passarge, 1979). EM 
microscopy later showed that the higher order structure of chromatin seems to be more 
euchromatic in pluripotent cells than in differentiated cells. While embryonic stem cells (ESCs) 
contain granular and homogeneous chromatin, differentiated cells have heterogeneous chromatin 
with heterochromatic regions (Efroni et al., 2008; Park et al., 2004). The homogeneous 
chromatin of pluripotent cells is also more dynamic. This was observed in fluorescent recovery 
after photobleaching experiments, which measured the binding of fluorescently tagged histone 
and histone-associated proteins to chromatin. The fluorescent recovery of these proteins is faster 
in ESCs compared to differentiating neural progenitors suggesting a higher exchange of 
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chromatin binding proteins and more dynamic chromatin organization in pluripotent cells 
(Meshorer and Misteli, 2006; Meshorer et al., 2006).  
Moreover, an open chromatin configuration seems to be required for proper function of 
ESCs. For instance, the loss of Chd1, a chromodomain protein associated with methylated lysine 
4 on histone H3 (H3K4me), a mark of active chromatin, and RNA polymerase II (RNAPII), 
results in an increase of heterochromatin associated H3K9me3 foci in ESC lines, decreases their 
pluripotency, and increases their propensity for converting into neural cells (Gaspar-Maia et al., 
2009). These data provide compelling evidence that more open chromatin is found in pluripotent 
cells and that such open chromatin is required for the maintenance of pluripotency (reviewed in 
Gaspar-Maia et al., 2011; Keenen and de la Serna, 2009; Meshorer and Misteli, 2006; Orkin and 
Hochedlinger, 2011). As cells differentiate, an increase in compact heterochromatin is evident in 
the electron microscopy data, in the global increase of heterochromatin associated H3K9me 
levels, and the global decrease in euchromatin associated histone 3 acetylation levels (Efroni et 
al., 2008; Meshorer et al., 2006; Park et al., 2004). 
While the terms euchromatin and heterochromatin are still used to describe open and 
closed regions of chromatin, it is now clear that cytological openness and closeness does not 
strictly correlate with transcriptional states. For instance, an analysis of compact and open DNA 
content in human lymphoblastoid cells showed that open chromatin is enriched for gene-rich 
regions of chromosomes while closed chromatin in enriched for gene-poor regions. However, not 
all genes in the open chromatin are actively transcribed and conversely, some of the genes in the 
closed are actively transcribed (Gilbert et al., 2004). It is also clear that the euchromatin and 
heterochromatin can be divided further into more specialized chromatin states based on the 
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presence of specific histone modifications and other chromatin modifying enzymes (Ernst and 
Kellis, 2010; Filion et al., 2010; Meister et al., 2010).  
An additional dimension of chromatin organization is reflected in the radial localization 
of DNA within the nucleus. DNA FISH for chromosomal regions shows that gene-poor regions 
remain close to the nuclear periphery whereas gene-rich regions are found more centrally in both 
ES and differentiated cells (Peric-Hupkes et al., 2010; Wiblin et al., 2005). Even though global 
changes in chromosome locations are not apparent during differentiation, specific loci do move. 
For instance, Nanog is located in a cluster of ES-expressed genes within a gene rich region. This 
entire gene cluster is closer to the center of the nucleus in ESCs as compared to differentiated 
cells. Oct4, another ESC gene, is located in a gene-poor chromatin territory, which is generally 
localized to the nuclear lamina. This locus is looped out of its chromosome territory in ES cells, 
but not in differentiated cells (Wiblin et al., 2005). Similarly, using DamID (van Steensel et al., 
2001), Bas van Steensel’s group has shown that while 73-87% of chromatin that associates with 
the lamina is similar in ESCs and differentiated neurons, many cell-type-specific changes are 
observed at single loci and gene clusters as cells differentiate. Interestingly, they also note that 
while similar proportions of the genome interact with the nuclear lamina in stem cells and 
differentiated neurons, the interactions are less robust for ESCs suggesting, as before, that the 
pluripotent chromatin is more dynamic (Peric-Hupkes et al., 2010).  
These data from the Bas van Steensel group also suggest that there is not a strict 
correlation between location and transcriptional activity. Many genes that were located at the 
nuclear center were not actively transcribed and vice a versa (Peric-Hupkes et al., 2010). DNA 
FISH data from other systems provide similar evidence.  During neuronal induction, as the 
MASH1 locus gets activated, a 2MB region surrounding this locus has been shown to move 
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away from the nuclear lamina. However, not all of the genes in the 2MB region become actively 
transcribed (Williams et al., 2006). Conversely, activation of naïve T cells results in cytokine 
expression, but the cytokine genes remain at the nuclear periphery even as they are being 
actively transcribed (Hewitt et al., 2004). These data highlight that location is not predictive of 
transcriptional activity. When actively transcribed loci move away from the periphery, possibly 
because of structural reasons, some of the surrounding chromatin also sometimes moves, but is 
not always transcriptionally activated. As for genes that are transcribed while still located at the 
periphery, it is possible that these are located at a nuclear pore complex, where active 
transcription and RNA export can be coupled (reviewed in Akhtar and Gasser, 2007).  Finally, 
these discrepancies may be explained by other chromatin mechanisms that are not yet 
understood.  
 The data summarized above show that while the overall radial localization of chromatin 
does not change, the flexibility or dynamicity of chromatin does decrease as cells differentiate 
(reviewed in Schneider and Grosschedl, 2007). This can explain why cells that are less 
differentiated are more plastic and amenable to the activity of fate-specifying TFs. As 
differentiation progresses the formation of fate-specific heterochromatin decreases the 
accessibility of genes that are not expressed. 
 In addition to DamID and DNA FISH, in C. elegans, transgenes that contain a locus of 
interest flanked by bacterial LacO sites have been used to study the relationship between 
transcription, nuclear localization, and compaction of DNA. In these transgenic worms, the 
binding of LACI::GFP fusion protein to LacO sites allows one to visualize transgenic loci in all 
developing cell types (Figure1-3) (Meister et al., 2010a; Yuzyuk et al., 2009). These LacO-
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Figure 1-3: A schematic representation of the LacO array system used for nuclear spot 
assays 
In these assays, worms that ubiquitously express LACI::GFP are injected with DNA containing a locus of 
interest, LacO repeats, and sometimes, digested DNA from E. coli (to make the DNA in the array more 
complex and less repetitive). These fragments of DNA form transgenes in the worms that can either be 
kept as unstably inherited pseudo-chromosomes or, as depicted here, can be integrated into the genome. 
The binding of LACI::GFP to the LacO sites paints this genomic locus with GFP. The size and 
localization of the GFP dots in the nuclei can thus be used as a representation of the state of the locus of 
interest.  
 
Experiments with these transgenes reveal that similar principles of chromatin 
organization govern differentiation in C. elegans and in mammals, making the worm a relevant 
model organism for studying the role of chromatin organization in cellular plasticity. For 
instance, unintegrated transgenes that behave as pseudo-chromosomes become increasingly 
compact, as demonstrated by the sizes of the LACI::GFP foci, with developmental progress, 
reflecting the progressive formation of heterochromatin during differentiation (Fakhouri et al., 
2010; Yuzyuk et al., 2009). Additionally, the sub-nuclear localization of LacO arrays generally 
reflects the transcriptional state of the locus contained in the transgene; specifically, the arrays 
localize to the center of the nucleus in cells where they are expressed and to the nuclear 
periphery in cells where they are not expressed (Meister et al., 2010a). However, there is again 
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not a perfect correlation between transcriptional activity and sub-nuclear localization, as a 
ubiquitously expressed promoter has been shown to stay actively transcribed while also 
remaining at the nuclear periphery throughout development (Meister et al., 2010a). These arrays 
make powerful tools for studying the state of a locus in differentiating cells of live animals and 
will be used for experiments in Chapter 4.  
  
Histone modifications 
  In addition to chromatin structure, differentiation is also coupled with dynamic changes 
in covalent histone modifications. These histone modifications, in conjunction with one another 
and their effector proteins can influence the chromatin structure, nucleosome-DNA interactions, 
as well as accessibility to TFs (Rothbart and Strahl, 2014; Tessarz and Kouzarides, 2014). Many 
kinds of histone modifications are enriched at specific kinds of loci and their function at these 
loci is under ongoing investigation. Some of the best studied histone modifications include the 
monomethylation of Lysine 4 on Histone 3 (H3K4me1), which along with H3K27ac, mark 
active enhancers; H3K4me3, which is found on promoters; H3/H4 acetylation and H3K36me 
which are all found on actively transcribed gene bodies; H3K27me3 which is enriched on 
transcriptionally inactive developmentally regulated genes; and H3K9me which is enriched on 
constitutively silenced heterochromatin, but is also present on developmentally regulated 
inactive genes (reviewed in Rothbart and Strahl, 2014; Zhang et al., 2015). While numerous 
studies have uncovered regulations and functions of these and other histone modifications, the 
discussion here will be focused on H3K27me and H3K9me as they are most directly implicated 
in the mechanisms of plasticity studied in this work.  
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Function and regulation of H3K27me3 
 The H3K27me3 histone modification is deposited by the conserved Polycomb Repressive 
Complex 2 (PRC2) and is required for inherited transcriptional silencing, predominantly of 
developmentally-regulated genes. The repressive activity of the PRC2 complex and components 
of associated PRC1 and PhoRC complexes was first discovered in Drosophila polycomb mutants 
that displayed derepression of Hox genes and segment identity switches (Jürgens, 1985; Lewis, 
1978; McKenzie Duncan, 1982; Struhl, 1981).  Later, the observation that these proteins were 
not required for the establishment of silencing, but rather for maintaining the silencing that is 
established by transiently expressed embryonic patterning genes (Struhl and Akam, 1985) led to 
the hypothesis that there was a molecular mark that acted as the memory of repression. 
Purification of the PRC2 complex from Drosophila and human cells showed that the functional 
PRC2 complex comprised of E(z)/EZH2, ESC/Eed, SU(Z)12/JJAZ1, and NURF-55/RbAp46/8 
and that the enzymatic activity was performed by the SET domain of E(z), which methylates 
H3K27 (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Müller et al., 2002). It 
has also been confirmed that the repressive activity of PRC2 is mediated by the methylation of 
H3K27, as a Lysine to Arginine mutation of H3K27 phenocopies PRC2 mutants in Drosophila 
(Pengelly et al., 2013). 
 Genome-wide ChIP analyses of H3K27me3 and/or the PRC2 complex in human cells, 
Drosophila, and C. elegans have shown that H3K27me3 is enriched at developmentally 
regulated cell-type-specific genes, suggesting that the regulation of this mark is dynamic during 
differentiation (Boyer et al., 2006; Filion et al., 2010; Ho et al., 2014; Oktaba et al., 2008; early 
work reviewed in Ringrose and Paro, 2007). For instance, in embryonic stem cells, PRC2-
mediated H3K27me3 is enriched on genes that are not required in pluripotent cells but are 
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expressed later as cells differentiate (Boyer et al., 2006). These include many TFs that regulate 
development, organogenesis, morphogenesis, etc. An elegant example of the temporal regulation 
of H3K27me is found in the mouse Hox cluster: in ESCs the Hox cluster is enriched for 
H3K27me3, but this modification is sequentially lost and replaced with H3K4me3 and acetylated 
H3 in a cell-type-specific fashion as differentiation progresses (Soshnikova and Duboule, 2009). 
Similar developmentally regulated removal and acquisition of H3K27me3 is also seen in 
Drosophila genes that are off in embryos but turned on tissue specifically in imaginal discs or 
vice a versa; in this case, removal of H3K27me3 in PRC2 mutants results either in the complete 
derepression or upregulation of PRC2 regulated genes for which activating TFs are expressed in 
the cell type (Oktaba et al., 2008). These data suggest that H3K27 methylation contributes to the 
repression of genes that are not required for the current fate of a particular cell and that the 
repressive activity of PRC2 trumps the activating activity of available TFs in certain contexts.  
 While PRC2 is required for depositing H3K27me3, it has been shown that nucleosomes 
carrying the H3K27me modification can be inherited through cell divisions independent of PRC2 
activity (Gaydos et al., 2014), albeit these modifications get diluted over time as the number of 
nucleosomes that need the modification double with each division. It has also been shown that 
ESC/Eed can bind to the H3K27me3 modification and activate E(z) to methylate a neighboring 
unmethylated H3, thereby suggesting that the mark itself can facilitate its own propagation via 
the PRC2 complex (Figure 1-4) (Margueron et al., 2009). These two processes together can 
ensure that in wildtype cells, H3K27 methylation marks are stably inherited through cell 
divisions, which then raises the question of how tissue-specific patterns are achieved. To gain 
fate-specific patterns, both the removal and deposition of H3K27me3 would have to be actively 
regulated. Several histone demethylases have been identified, but their activity, like the activity 
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of PRC2, has to be guided to specific loci. Some mechanisms for this specificity are starting to 
emerge and include regulation by fate specifying TFs, non-coding RNAs (ncRNAs), cell-type-
specific co-factors of PRC2 and the presence of other histone modifications. 
 
 
Figure 1-4: Inheritance of H3K27me3 
The H3K27me3 histone modification can be inherited through cell divisions (Gaydos et al., 2014). After a 
cell division, there is a doubling of nucleosomes, and only half of these inherit the modifications that were 
present in the previous generation. However, the PRC2 component Eed can bind to these existing 
H3K27me3 marks and facilitate the EZH2-mediated deposition of new H3K27me3 at a neighboring non-
modified nucleosome, therefore ensuring a recapitulation of the original H3K27me3 pattern found in the 
mother cell. Figure from (Blackledge et al., 2015). 
 
There is increasing evidence that fate specifying TFs can facilitate some of the locus-
specific activity of PRC2. Examples of TFs directing both the deposition and removal of 
H3K27me3 from specific loci have been reported. The best studied example of TF-mediated 
PRC2 recruitment is seen in the repressive activity of homeodomain TF Msx1 in myoblasts. 
Msx1 directly binds to and recruits PRC2 to the genes that it represses causing an enrichment of 
H3K27me3 at these loci (Wang et al., 2011). Similarly, in B lymphocytes, the fate specifying TF 
Pax5 is required for the normal deposition of EZH2-mediated H3K27me3 on the VH  genes. 
There are many Pax5 binding sites along this locus and its binding is thought to facilitate the 
binding of EZH2 (Xu et al., 2008). A computational analysis of differentially regulated 
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H3K27me3 sites in 19 human cell lines also showed that regions of cell-type-specific 
H3K27me3 are enriched for fate-specific TF binding sites. This data predicted that Pax5 might 
act to recruit PRC2 in B lymphoblastoid cells, for which the above evidence already existed 
(Pinello et al., 2014). Additionally, as a further validation of the computational analysis, the 
authors showed that the hematopoietic regulator TAL-1, along with GFI1B, is required for 
wildtype H3K27me3 patterns in erythroid cells (Pinello et al., 2014). The role of TFs in 
removing H3K27me3 was shown by Wichterle and colleagues for the rostro-caudal patterning of 
Hox genes in the spinal cord. The cell-specific activation of the retinoic acid receptor and the TF 
Cdx-2 by extracellular signaling results in the binding of these TFs to cis-regulatory motifs in the 
Hox1-5 and Hox1-9 domains, respectively. The consequence of this binding is the rapid removal 
of H3K27me3 from these Hox domains and the activation of fate-specific Hox genes. In this 
way, the binding of fate-specific TFs to cis-regulatory elements can direct the removal of a 
repressive mark and the activation of fate-specific Hox genes (Mazzoni et al., 2014). While this 
evidence is compelling, the mechanisms that allow specific TFs to recruit PRC2 remain to be 
elucidated. 
ncRNAs too have been implicated in mediating the binding of PRC2 to sequence-specific 
loci (Chu et al., 2011; Kaneko et al., 2014; Rinn et al., 2007). For example the long ncRNA 
HOTAIR has been shown to direct the binding of PRC2 to many genomic loci, and an analysis 
of its genome-wide binding sites reveals a preference for GA enriched sequences (Chu et al., 
2011; Rinn et al., 2007). The genome-wide binding profiles of two other functionally defined 
ncRNAs have also been identified: roX2 shows a preference for GAGA motifs and TERC shows 
a preference of C rich regions. Additionally, an IP of EZH2 followed by RNA-seq resulted in the 
identification of ~1000 potential RNA partners of PRC2 (Zhao et al., 2010). While this latter 
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result suggests that ncRNA binding could be a very powerful mechanism for directing PRC2, 
more functional studies are needed to determine their overall significance. The IP technique 
pulled down thousands of RNAs, even in an EZH2 mutant, suggesting that many of these 
binding events might be artifacts and thorough functional studies are necessary to understand 
their significance.  
Cell-type-specific cofactors can also provide specificity for PRC2 activity. For example, 
the jumonji domain protein JARID2 binds PRC2 in ESCs. It is required for the localization of 
PRC2, PRC1, and Ser5P RNA Pol II to ESC-specific “poised genes” which carry modifications 
for both H3K27me3 and H3K4me3 (Landeira et al., 2010). The rapid activation of these genes is 
thought to be required for proper transition from pluripotency to specific differentiation 
programs. The absence of either PRC2 or JARID2, results in lower levels of H3K27me3 at these 
loci. However, while a concomitant increase in transcription of poised genes is seen in PRC2 
mutants, their transcription is actually reduced in JARID2 mutants. The authors show that this 
counterintuitive result can be explained by the fact that levels of H3K4me3 and RNAPII are also 
reduced at these loci in JARID2(-) cells. Therefore, JARID2 seems to have the unique function 
of balancing positive and negative regulation at poised loci in ESCs. In agreement with this, 
JARID2(-) ES cells divide and continue to grow, but show deficiencies in executing 
differentiation programs (Landeira et al., 2010).  Similarly, the knockdown of Jarid2 in X. laevis 
embryos leads to defects in developmental-gene induction in late blastula embryos (Peng et al., 
2009). Thus, the co-factor JARID2 facilitates the ESC-specific function of PRC2. It is possible 
that other such cofactors may regulate functions of PRC2 in other cell types. 
Lastly, positioning of H3K27me3 is also affected by the presence of other histone marks. 
The most convincing data is seen for the interaction between H3K36me3 and H3K27me3. 
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Studies in various systems both in vitro and in vivo have found that the presence of H3K36me3 
precludes the methylation of H3K27. In C. elegans, mutants with significantly reduced 
H3K36me3 show a spreading of H3K27me3 into normally H3K36 methylated regions (Gaydos 
et al., 2012; Yuan et al., 2011). Such interplay between histone modifications could contribute to 
a combinatorial histone code that both specify domains of modifications and diversify the 
functions of these modifications.  
 
Function and regulation of H3K9me3 
In 1930, Muller described the isolation of a fly with mosaic expression of the white+(w+) 
gene, which resulted in mosaic red/white eyes (Muller, 1930). Subsequent work showed that this 
phenotype was caused by a chromosomal rearrangement that placed the w+ locus near the 
centromeric heterochromatin. In some cells, the heterochromatin spread and silenced the nearby 
w+ locus, resulting in what is now called a position effect variegation (PEV) phenotype 
(reviewed in Spradling and Karpen, 1990). Numerous effectors of such PEV phenotypes were 
subsequently discovered in enhancer and suppressor screens. One of isolated suppressors was 
Su(var)3-9 (reviewed in Wallrath, 1998), which subsequently became the first SET domain 
protein to show histone methyltransferase activity, and the first histone methyltransferase to act 
on H3K9 (Rea et al., 2000).   
Unlike H3K27me3, for which the major methyltransferase is PRC2, numerous 
functionally diverse H3K9 methyltransferases have been discovered.  For instance, in mice, 
SUV39h1 and SUV39h2 are redundantly required for the deposition of H3K9me3 at 
pericentromeric regions while GLP and G9a are non-redundantly required for H3K9me2/3 
deposition in euchromatic regions (Liu et al., 2015b; Peters et al., 2001; Tachibana et al., 2005). 
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The function of H3K9me3 is also mediated by HP1, another protein isolated as a suppressor of 
PEV. HP1 binds methylated H3K9 through its chromodomain, and can dimerize or interact with 
various other proteins, including H3K9 methyltransferases via its chromoshadow domain 
(reviewed in Hiragami and Festenstein, 2005). HP1 is crucial for mediating many functions of 
H3K9me3 and is also found on chromatin independent of H3K9me3, suggesting it has many 
functions (Quivy et al., 2008). 
H3K9 methylation is enriched on repeat rich regions in many organisms (Ho et al., 2014; 
Martens et al., 2005). These repeat rich regions include centromeres and telomeres, which 
remain in a repressive state in all cell types to maintain genome stability (reviewed in Becker et 
al., 2015). For this reason, and because of the manner of its discovery, H3K9me3 is best studied 
as a marker of constitutive heterochromatin. The maintenance of H3K9me3 at these regions is 
shown to be dependent on RNA interference (RNAi) pathways in the yeast S. pombe. RNAi 
mutants in pombe show a decondensation of the pericentromeric heterochromatin (Volpe et al., 
2002). In wildtype conditions, low levels of transcription of the pericentromeric repeats leads to 
the formation of non-coding RNAs which are processed into small RNAs. These small RNAs 
associate with both the RNAi machinery and an H3K9 methyltransferase to target the pericentric 
locus in a sequence-specific manner and mediate the methylation of H3K9. Interactions between 
various components of this pathway create a positive feedback loop which can result in the 
spreading of this heterochromatin (reviewed in Martienssen and Moazed, 2015). Indeed, RNAi 
pathway genes have been shown to be required for the PEV-mediated silencing of w+ genes 
inserted near heterochromatin. In RNAi mutants, these w+ loci get desilenced, show 
mislocalization of HP1, HP2, and a significant decrease in H3K9me3 (Pal-Bhadra et al., 2004). 
Similarly, in C. elegans, transcriptional silencing of a repetitive transgene in somatic cells has 
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been shown to be mediated by the RNAi pathway and is dependent on hpl-2, one of two HP1 
orthologs in worms (Grishok et al., 2005).  
In addition to its constitutive presence on repetitive DNA, H3K9me3 also has cell-type-
specific localization patterns. While pluripotent ES cells usually have low genome-wide levels of 
H3K9me3, as detected by immunofluorescence and western blots, there is an increase in the 
abundance of this mark as cells differentiate (Meshorer and Misteli, 2006). This pattern is also 
seen in a comparison of genome-wide ChIP signals in human ESCs vs. fibroblasts—the number 
of base pairs spanned by H3K9me3 is about 3.4 times larger in fibroblasts compared to ESCs 
(Hawkins et al., 2010). Additionally, as is seen in large-scale genomic studies, not all 
differentiated cell types have the same blocks of H3K9 methylation (Ho et al., 2014), suggesting 
that H3K9 methylation, like H3K27me3, is also involved in some cell-type-specific gene 
expression and must be regulated dynamically at these loci.  
Such dynamic regulation of H3K9me3 is observed as cells leave the pluripotent state. In 
ESCs, the TF Oct4 is known to directly bind to and control the expression of two H3K9 
demethylases, Jmjd2c and Jmjd1a. The expression of these demethylases is severely decreased in 
Oct4 knockdowns. Additionally, the knockdown of the Jmjds themselves leads to an increase in 
H3K9me2/3 levels and loss of self-renewal properties of ESCs. Some of the targets of these 
demethylases include known pluripotency regulators such as Nanog, thereby suggesting that the 
transcriptional activation of these demethylases by Oct4 is required to maintain an ES-specific 
H3K9me profile (Loh et al., 2007). Conversely, as ESCs differentiate, Oct3/4, but not all ESC 
regulators (Nanog, for example), undergo an increase in H3K9me3, which is controlled by G9a 
both in vivo and in vitro. In vitro RA induced differentiation of G9a mutant ESCs does lead to a 
loss of expression of Oct3/4 as differentiation progresses, however this loss is not permanent as it 
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can be reverted if differentiated cells are put back in ESC culture conditions, suggesting that 
H3K9 plays an important role in the long-term inactivation of specific ESC genes (Feldman et 
al., 2006). Similarly, mutants of GLP, another euchromatic H3K9 methyltransferase, also show 
reduced H3K9me2 and delayed repression of pluripotency genes during differentiation (Liu et 
al., 2015b).  
H3K9 methylation is also modulated in later stages of development. In the hematopoietic 
lineage, subtype specification during T cell differentiation requires H3K9me3-mediated 
silencing. A balance between H3K9me3 and H3K9ac is required to keep specific TH1 genes off 
in TH2 cells (Allan et al., 2012). SUVH1 and HP1α deficient TH2 cells differentiate normally but 
show activation of some T H1 genes both in vitro and in vivo. Not all tested TH1 genes showed 
misregulation, perhaps because SUVH1 and SUVH2 act redundantly in early mouse 
development (Peters et al., 2001). And finally, H3K9me3 plays an essential role during 
oligodendrocyte differentiation from oligodendrocyte progenitors. ChIP analysis of 
oligodendrocytes shows H3K9me3 localization on numerous other fate-specific genes, and a 
knockdown of H3K9me3 levels has a detrimental effect on differentiation (Liu et al., 2015a).  
In sum, these studies suggest that H3K9me3 may play a role in differentiation-related 
gene silencing. While the known roles of H3K9me3 at developmentally regulated genes are not 
yet as diverse as those of H3K27me3, these examples do suggest that H3K9me3 also has to be 
recruited to, and removed from, specific loci during fate specification. In this case, there has 
been one example in which a TF, the co-repressor retinoblastoma protein, recruits SUV39H1 and 
HP1 to the promoter of Cyclin E to regulate its expression during the cell cycle (Nielsen et al., 
2001). Not much else is known the mechanisms that direct the deposition of H3K9me3 at non-
repetitive loci. 
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While both H3K27me3 and H3K9me3 function to repress fate-specific genes, there must 
be some difference in their repressive properties, as the two show enrichment on non-
overlapping regions of the genome (Ho et al., 2014). A difference in these properties is 
highlighted in mechanisms that underlie the reprogramming efficiency of fibroblasts into iPSCs 
by overexpression of the Yamanaka factors. When expressed in fibroblasts, TFs Sox-2, Oct4, 
and Klf4 bind their respective DNA binding sites even in DNAse resistant regions, which 
represent less-accessible, nucleosome-enriched, regions of the chromatin (Soufi et al., 2012). 
This pioneering function of the three TFs plays a major role in their reprogramming ability 
(Soufi and Zaret, 2013). Nevertheless, the reprogramming efficiency of this procedure is very 
low and extensive profiling of cells that do not reprogram show blocks of DNA where Sox-2, 
Oct4, and Klf4 cannot bind efficiently. These blocks are enriched for H3K9me3, and not 
H3K27me3. In cells that do reprogram, binding at these sites occurs later in the reprogramming 
process suggesting that H3K9 methylated chromatin is harder to access than H3K27 methylated 
chromatin (Soufi et al., 2012). Knockdown of various H3K9 methyltransferases and of HP1 is 
found to increase iPSC reprogramming efficiency, showing that the presence of H3K9me3 is a 
functionally relevant impediment to the reprogramming process (Onder and Daley, 2012; 
Sridharan et al., 2013). In contrast, knockdown of EZH2 is detrimental to reprogramming, 
highlighting the difference in function of H3K27me3 and H3K9me3 (Onder and Daley, 2012; 
Pereira et al., 2010). My work in Chapter 3 and Chapter 4 further expands the known functions 
of H3K27me3 and H3K9me3 and potential differences in their regulation. 
In summary of this section on chromatin regulation, the modulations of chromatin by 
location, compaction, and histone modifications all correlate with the loss of plasticity that 
accompanies cellular differentiation. How these mechanisms are coordinated with one another 
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and with the process of cell-fate specification is an exciting area of investigation as it aims to 
bring together all known aspects of cell fate acquisition. The work in my thesis aims to 
understand these mechanisms using C. elegans as a model system.  
To accomplish this, we first developed a TF-overexpression assay to study cell fate 
restriction in differentiating cells. We found that the ubiquitous overexpression of the neuronal-
TF che-1 in embryonic cells results in the broad activation of target genes. However, expression 
of che-1 in most differentiated cells of larval and adult worms does not lead to activation of 
target genes  (Chapter 2). This assay provided a great platform to genetically dissect the 
mechanisms that restrict the fate of differentiated cells such that they no longer respond to che-1. 
By performing RNAi and mutant analysis we looked for genes, which when knocked down, 
allowed che-1 to activate target genes even in adult cells. As a result, we found that H3K27me3 
is required for the restriction of fate in germ cells and cholinergic motor neurons (Chapter 3,4) 
and that fate-specifying TFs restrict the differentiated fates of neurons, possibly by regulating 





CHAPTER 2: Using ectopic CHE-1 to study the loss of plasticity in developing cells 
 
SUMMARY 
The progressive loss of developmental plasticity in differentiating cells in apparent in the 
response of these cells to the activity of an ectopically expressed TF.  In C. elegans, certain fate-
specifying TFs can activate target genes in almost all cells if they are ubiquitously overexpressed 
at the embryonic stages. However, expression at later stages of development results in limited or 
no response from differentiated cells. Similar trends are observed in various other systems. In 
order to understand that mechanisms that restrict the plasticity of differentiated cells such that 
they no longer respond to an ectopically expressed TF, we created an assay for the temporally-
regulated overexpression of Zn-finger-TF CHE-1, which is the terminal selector for ASE 
neurons, in the worm. In this chapter, we report that the ability of CHE-1 to activate target genes 
in developing cells is also inversely proportional to the progression of differentiation. Many cells 
remain responsive to CHE-1 for a small window of time after terminal division, but become 
refractory as differentiation was completed. We additionally found that a small group of neurons 
continue to respond to CHE-1 throughout development, and that there is a discrepancy in the 
sufficiency of CHE-1 to activate different kinds of target genes. The work in this chapter forms 
the basis for dissecting the mechanisms that change the receptivity of differentiating cells to 
CHE-1 activity. 
All of the experiments in this chapter were designed and performed by me. Some of the 





The discovery that the overexpression of a single TF, MyoD, could convert fibroblasts 
into muscle-like cells had powerful implications (Davis et al., 1987). It demonstrated that master 
regulator TFs are sufficient to impose their fate-determining activity even in a foreign cellular 
context. It also showed that there is context dependency in the activity of such TFs; for whereas 
MyoD is effective in fibroblasts, its activity is restricted in other host cells such as hepatocytes 
and neuroblasts (Weintraub et al., 1989).  
Since then, numerous studies have demonstrated the efficacy of single or groups of TFs 
to impose specific cell fates. If these TFs are expressed early in differentiation, they can often act 
in a variety of host cells. For instance, ectopic expression of Drosophila eyeless in the 
developing leg, antennae, wing, and haltere discs results in the formation of ectopic eyes in all of 
these tissues (Halder et al., 1995). Similarly, expression of hlh-1, the C. elegans ortholog of 
MyoD, in early embryonic stages results in expression of muscle markers in almost all somatic 
cells (Fukushige and Krause, 2005). However, cells are decreasingly responsive to hlh-1 as 
embryonic development progresses, becoming completely non-responsive after terminal 
differentiation. In the best of cases, ectopic expression of TFs in differentiated cells leads to 
context dependent activity, as in the case of MyoD. Other TFs have also been shown to have 
such context dependent activity. For instance, in C. elegans larvae, the ubiquitous expression of 
GATA TF elt-7 leads to conversion of differentiated pharyngeal cells into intestinal cells, while 
having little or no effect on all the other cell types (Riddle et al., 2013). Thus, it can be 
summarized from these experiments that the ability of master regulator TFs to exert their activity 
is negatively co-related with the progression of differentiation. Additionally, the fact that cells 
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become less receptive to the activity of foreign TFs as they differentiate demonstrates that 
differentiating cells progressively lose their plasticity.  
The aim of my thesis is to understand the mechanisms that coordinate the gain of a 
differentiated fate with the loss of plasticity. To understand these mechanisms, we first 
developed a TF overexpression assay as a readout for the state of plasticity in a cell. While the 
loss of an ectopically expressed TF’s ability to activate target genes in differentiated cells has 
been well documented, the underlying mechanisms that make differentiated cells non-responsive 
to ectopic TFs have not been thoroughly investigated. Here, the goal is to uncover exactly these 
mechanisms using TF overexpression assays as a tool. C. elegans is an ideal model system for 
such experiments as it is genetically tractable and the activity of TFs can easily be visualized 
with the use of fluorescent reporters for target genes. Additionally, since the worm is small, 
transparent, and has a 3-day life cycle (Figure 1-1) this analysis can be performed in all of its cell 















Figure 2-1: The C. elegans life cycle 
After embryogenesis, the worm goes through 4 larval molts before becoming an adult. Most of the 
somatic cells in the worm are born during embryonic development. However some cells divide and 
differentiate during the larval stages. The germline proliferates from L2-adulthood, making gametes at 
L4. Figure from wormatlas.org. 
 
Numerous TFs that act as master regulators or terminal selectors for various cell fates 
have been identified in C. elegans. Of these, some of the neuronal terminal selectors have been 
very well studied in our lab (Hobert, 2011). For ectopic expression assays, we chose to use che-
1, a Zn-finger TF required for the terminal differentiation of a pair of glutamatergic sensory 
neurons, the ASEs. che-1 is endogenously expressed exclusively in the ASEs (Tursun et al., 
2009). Here it directly binds to and activates transcription of a variety of terminal battery genes, 
such as chemoreceptors, neuropeptides, a glutamate transporter, and other TFs. The binding site 
of CHE-1 is called the ASE motif and has been identified and experimentally verified. 
Additionally, using a heterologous promoter to drive ectopic expression, CHE-1 has been shown 
to be sufficient to activate ASE genes in a handful of other sensory neurons (Etchberger et al., 
2007; Serrano-Saiz et al., 2013; Uchida, 2003). All of these factors make che-1 an ideal TF for 
ectopic expression assays, and for this reason, we use the ubiquitous expression of che-1 to study 
the plasticity of developing cells in the worm.  
 In this chapter, I describe the tools we used for the ectopic ubiquitous expression of che-1 
and the effect it elicits at various stages of worm development. We found that ubiquitous 
expression of CHE-1 during development leads to the activation of ASE gene expression in 
many cell types, while ubiquitous expression in adults results in activation of target genes only in 
a few neurons. This recapitulates the loss of cellular plasticity that is seen in other experimental 
paradigms and expands it all the cell types of a developing organism. The data in this chapter 
formed the basis for further experiments in which we investigate mechanisms involved in the 
loss cellular plasticity as measured by che-1 activity in the following chapters. 
! 37!
RESULTS 
Temporally controlled ubiquitous expression of CHE-1 
In order to test the plasticity of developing cells, we needed to temporally control the 
ectopic expression of che-1. To this end, we built a transgenic line containing an HA-tagged 
CHE-1 driven by a heat-shock inducible promoter, hsp16.41 (Stringham et al., 1992).  In the 
absence of heat-shock, these transgenic lines contained very low levels of ectopic che-1 mRNA 
and no detectable levels of ectopic CHE-1 protein, as measured by che-1 smFISH and α-HA 
immunostaining respectively (Figure 2-2a). After heat-shock, high levels of che-1 mRNA were 
immediately detectable in all cell types. These molecules were localized primarily in the nucleus 
if worms were fixed immediately after heat-shock, and primarily in the cytoplasm if worms were 
fixed 15min after heat-shock (Figure 2-2c).  Immunostaining for the induced HA::CHE-1 protein 
was performed 5hrs after heat-shock and also showed broad expression (Figure 2-2b).  However, 
24hrs after induction, most of the ectopic CHE-1 had degraded, with the remaining protein 
present mainly in the germline and muscle cells (not shown).   
This transgenic heat-shock(hs)prom::che-1 line was created using classical C. elegans 
transgenesis, which results in the formation of a multi-copy transgenic array randomly integrated 
into the genome. Using the recently optimized miniMOS technique (Frøkjær-Jensen et al., 2014), 
we also created single-copy insertion lines of hsprom::che-1. While most experiments in this 
thesis utilized the multi-copy line, some were repeated with the single-copy line to ensure 
consistency. All experiments are performed with the multi-copy line, unless the use of the single-
copy line is specifically mentioned. For brevity, ubiquitous CHE-1 expressed under the control 
of the heat-shock promoter in both these lines will hereon be referred to as CHE-1hs. 
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Figure 2-2: Heat-shock driven expression of che-1 
A) FISH for che-1 mRNA before and after heat-shock. Pictures show heads of adult worms. In the 
absence of heat-shock, a few mRNA molecules can be detected, however after heat-shock the expression 
is much more robust. B) Antibody staining for HA tag. Mid-bodies of adult worms are shown. No CHE-
1::HA protein is detected without heat-shock, while nuclear localized protein is clearly visible after heat-
shock. C) FISH for che-1 mRNA 0 and 15 min after heat-shock. Immediately after heat-shock the FISH 
signal is primarily in the nucleus and 15 min later, it is primarily in the cytoplasm. Presumably this is a 
visualization of the movement of the mRNA out of the nucleus for translation. 
 
 
Expression of CHE-1 targets in response to ubiquitous CHE-1 at various developmental 
stages 
To detect whether cells are receptive to CHE-1hs activity, we checked the expression of 
several che-1 target genes. One of these genes, gcy-5, is a receptor guanylate cyclase normally 
expressed in the ASER and RIGL/R neurons. We used several tools to detect the expression of 
gcy-5, including two kinds of transgenic reporters (gcy-5prom::gfp and gcy-5fosmid::gfp), smFISH 
probes against gcy-5 mRNA, and a CRISPR allele in which the gcy-5 locus is co-transcribed 
with mNeonGreen (Figure 2-3a-c). Of the transgenic reporters, gcy-5prom::gfp uses the 3.2 kb 
upstream of gcy-5 TSS, while the gcy-5fosmid::gfp contains ~33 kb of information around the gcy-
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Figure2-3: Tools used for the detection of gcy-5 expression 
A) Schematic representation of the fosmid and promoter reporters of gcy-5. The fosmid contains ~33kb of 
DNA surrounding the gcy-5 locus. A trans-splicing sequence, SL2, and GFP are recombineered after the 
stop codon of gcy-5. This ensures that gcy-5 and gfp get transcribed together but get spliced and translated 
separately. The promoter reporter contains 3.2kb of information upstream of the gcy-5 TSS fused to the 
gfp coding region. B) Images of heads of transgenic neurons containing the gcy-5prom::gfp, gcy-5fosmid::gfp, 
and a CRISPR engineering allele containing an SL2::mNeonGreen inserted into the genomic gcy-5 locus 
after the gcy-5 stop codon. RIG expression in the promoter is not completely penetrant. Expression of the 
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CRISPR allele is very dim. C) FISH for gcy-5 mRNA also shows expression in the ASER and RIGS. D) 
Expression of gcy-5 in the RIGs is dependent on lim-6, not che-1. Two RIGS can ben seen in 100% of the 
wildtype worms. 0 RIGs can be seen in 100% of lim-6 mutant worms. 
 
CRISPR alleles should demonstrate the endogenous transcription of gcy-5. All of these tools 
show wildtype expression of gcy-5 in the ASER and RIG neurons with the exception of gcy-
5prom::gfp, expression of which is strongly biased to ASER with very faint RIG expression 
detectable only in about 30% of worms (Figure2-3b). This suggests that gcy-5prom::gfp lacks the 
regulatory region required for robust RIG expression, and since che-1 is only expressed in the 
ASER, gcy-5 expression in the RIGs must be independently activated. We found that 
homeodomain TF, lim-6, which was previously shown to be expressed in the RIG neurons 
(Hobert et al., 1999a) is required for gcy-5fosmid::gfp expression in the RIGs (Figure2-3d). Based 
on this information, the variable expression of gcy-5prom::gfp in the RIGs should not play a role 
in our assays since gcy-5prom::gfp expression in the ASER is dependent on che-1 (Uchida, 2003) 
and the lim-6 dependent expression of gcy-5 should not affect ectopic induction by che-1 in other 
cells. 
Transgenic reporters were also used to detect expression of additional che-1 target genes 
gcy-6 and gcy-7. Both these genes are receptor guanylate cyclases expressed exclusively in the 
ASEL neuron during normal development. gcy-6 does get activated in AWCOFF and two 
unidentified neurons during the dauer stage, however as che-1 is not expressed there, this 
activation is independently regulated and should not affect ectopic activation in other cell types.  
When CHE-1hs is induced during embryonic stages, gcy-5prom::gfp is broadly activated in 
numerous cells (Figure 2-4a). However, these animals arrest, making it difficult to score exactly 
which non-neuronal cell types are responsive. As CHE-1hs is induced later in development, 
activation of gcy-5 is increasing restricted and the animals retain a normal morphology (Figure 2- 
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Figure 2-4: Expression of gcy-5 in response to CHE-1hs at different developmental stages 
A) Expression of gcy-5prom::gfp. Asterisks indicate gut autofluorescence. Top row, left to right: L1 worm 
without CHE-1hs, expression in ASER; adult without CHE-1hs, expression in ASER (arrow); embryonic 
CHE-1hs, broad gcy-5prom::gfp induction; L1 CHE-1hs,expression of gcy-5prom::gfp in various tissues 
including hypodermis, various neurons, muscles, pharynx. Bottom row, left to right: L2 CHE-1hs, gcy-
5prom::gfp in seam, muscles, ventral nerve cord, other neurons and pharynx; L3 CHE-1hs, gcy-5prom::gfp in 
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seam, vulva cells, neurons and pharynx; adult CHE-1hs, gcy-5prom::gfp is seen only in neurons and 
pharynx. B) Scoring of the expression of gcy-5prom::gfp in various tissues after CHE-1hs induction at 
various ages, as listed on the X-axis. n=10-20 for each stage C) Ectopic induction of endogenous gcy-5 in 
response to heat-shock. FISH for gcy-5 mRNA after CHE-1hs induction in miniMOS strain containing a 
single copy hsprom::che-1 transgene integrated into the genome and gcy-5prom::gfp. Expression of gcy-5 
mRNA shows great overlap with gcy-5prom::gfp. Bottom panels show a vulva with gcy-5 expression and a 
vulva without. The worm that does not have vulva induction shows gcy-5 in a neuron, showing that the 
fixing procedure worked. 
 
4a). With the exception of a few neurons and the pharynx, cells that express gcy-5 in response to 
larval CHE-1hs are those that have not yet acquired their terminal fate or have just reached the 
terminal fate. For instance, CHE-1 induction in the L3 stage activates gcy-5 in the vulval muscle 
cells, which are dividing and differentiating at around this time. Similarly, seam cells and ventral 
nerve cord cells are dividing and differentiating during the L2 stage and they too active gcy-5 in 
response to ectopic CHE-1 at L2 and L3. The exception to this trend is the germline. Germ cells 
proliferate throughout the larval stages and start forming gametes at the L4 stage (Kimble and 
Crittenden, 2005). However, these cells remain refractory to the activity of CHEhs throughout the 
life of the worm. At the L4 and adult stage, when all tissues have acquired a terminal fate, the 
only cells that activate gcy-5prom::gfp in response to CHE-1hs are a handful of neurons and 
pharyngeal muscle cells, suggesting that these cells have a cellular context amenable to che-1 
activity. This pattern of gcy-5prom::gfp induction is also seen when CHEhs is induced with a the 
single copy hsprom::che-1 transgene. Additionally, gcy-5 smFISH on these worms shows that 
expression of gcy-5prom::gfp largely overlaps with the expression of endogenous gcy-5 mRNA, 
indicating that gcy-5prom::gfp reliably replicates the activity of the endogenous gcy-5 locus 
(Figure 2-4c).   
Expression of gcy-6fosmid::gfp and gcy-7prom::rfp in response to CHE-1hs is also broadly activated 
in embryonic stages and becomes restricted as development progresses. However, compared to 
























































































Figure 2-5: Expression 
of gcy-6 and gcy-7 in 
response to CHE-1hs 
at different 
developmental stages  
A) Images of worms heat-





regions in the gcy-6 
images highlight regions 
of ectopic expression as 
the autofluorescence 
makes it difficult to 
visualize. B) 
Quantification of the 
ectopic expression. Every 
dot in this graph 
represents a worm and the 
number on the y-axis 
represents the total 
number of marker 
expressing cells counted. 
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when CHEhs is induced in larval stages (Figure2-5). This suggests a difference in the sufficiency 
of che-1 to activate different target genes. 
In contrast to the expression of these genes, a transgenic reporter containing a synthetic 
gcy-5 enhancer with the che-1 binding motif, the ASE motif, multimerized 4X times is broadly 
activated by CHE-1hs at all developmental stages (Figure2-6). Hence, it can be concluded that 
while CHE-1hs is active as a TF in all tissue types, at all stages, and can activate a synthetic 
strong enhancer, it is not able to activate the endogenous cis-regulatory regions of target genes. 
Overall, these experiments show that as differentiation progresses, che-1 target genes become 








Figure 2-6: Expression of gcy-54XASE::gfp after L4 CHE-1hs induction 
A synthetic ~300 bp region of the gcy-5 promoter in which the single ASE motif has been multimerized 4 
times can be broadly induced by CHE-1hs at all stages, including L4s, as shown here. Some of the tissues 
that express gcy-54XASE::gfp are labeled. gcy-54XASE::gfp is normally expressed only in the two ASEs. 
 
Ectopic expression of CHE-1 using cell-type-specific promoters 
Since embryonic expression of CHEhs leads to developmental arrest, we expressed CHE-
1 using tissue-specific promoters to understand more thoroughly its activity in various cell types.  
This was done with a muscle (unc-27prom), hypodermal (dpy-7prom), pan-neuronal (ric-19prom), 
and two neuron-type-specific promoters (unc-47prom- GABAergic MNs, and ift-20prom- sensory 
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neurons) With the exception of the hypodermal promoter, these promoters are all active only in 
post-mitotic cells as these cells are undergoing terminal differentiation and remain active 
throughout the life of the worm. The hypodermal promoter is active L1-adulthood, however, the 
hypodermis continues to acquire more cells and endoreduplicate throughout early larval 
development.  
In all of the neuronal promoters tested, expression of gcy-5prom::gfp, gcy-5fosmid::gfp, and 
ceh-36fosmid::yfp (another che-1 target, a homeodomain TF expressed in ASEL/R and AWC 
neurons) is activated broadly throughout the life of the worm. However, gcy-6fosmid::gfp and gcy-
7prom::rfp show restricted activation in only 1-2 extra cells (Figure 2-7). This, along with the data 
from CHE-1hs induction suggests that while CHE-1 is sufficient to activate expression of gcy-5 
and ceh-36, it is not sufficient to activate expression of gcy-6 and gcy-7 in most post-mitotic 
cells.  
Stable lines of animals containing CHE-1 in the muscles and hypodermis could not be 
acquired. However, the few animals expressing che-1 in the hypodermis and muscle that were 
imaged also showed gcy-5prom::gfp expression in the respective cells (Figure 2-8,9c). 
Cumulatively, these experiments show that a wide range of cell types are receptive to che-1 
activity after post-mitotic division, while they are acquiring a terminal fate. 
Whether the cells containing ectopic CHE-1 retain their original fates was also checked 
in some of these animals. Original fate was assessed with the use of fate markers. In worms that 
expresses che-1 under the control of a pan-sensory promoter, the expression of odr-1prom::rfp, a 
reporter that is usually expressed in 4 sensory neurons, is dim or missing in 40% of the neurons, 
while a majority of neurons retain normal expression (Figure 2-9a). In a line expressing che-1 in 












































































































Figure 2-7: Expression of ASE markers in response to continuous che-1 expression in post-
mitotic neurons 
Promoters used for che-1 expression are listed on the vertical axis, markers used are listed on the top. gcy-



















Figure 2-8: Hypodermal expression of che-1 induces gcy-5prom::gfp 
More markers were not assayed as worms containing hypodermal che-1 arrest during larval stages and do 
not form stable lines. 
 
 
In this case 23% of the gcy-5 expressing neurons show dim or no GABA staining, while a great 
majority of cells again retain normal staining (Figure 2-9b). In contrast to neurons, expression of 
che-1 in muscle cells leads to a significant transformation of muscle cells into neuron like cells. 
83% of the muscle cells that express gcy-5 lose expression of a muscle marker myo-3.  












Figure 2-9: Markers of the original fate show varying effects after CHE-1hs induction 
A) Expression of odr-1prom::rfp is slightly reduced if che-1 is continuously expressed in post-mitotic 
sensory neurons. B) GABAergic MNs expressing che-1 retain GABA staining. C) Expression of che-1 in 
muscles induces expression of gcy-5prom::rfp and eliminates the expression of a muscle marker, myo-
3prom::gfp. As shown in the insets, the normal muscle nuclear morphology (bottom panel), is lost in many 
cells that express gcy-5prom::rfp (top panel). 
 
 
This loss of muscle fate might explain why these worms do not form stable lines. Similarly, 
while hypodermal markers were not tested in worms containing hypodermal che-1, these worms 
did not develop well and remained small, suggesting loss of normal hypodermal development 
(Figure 2-8). All together, the continuous expression of che-1 in post-mitotic cells seems to 
affect the original cell fate by varying degrees depending upon the host cell type in question. 
 
 
Neurons that remain receptive to CHE-1 activity throughout development 
 
Induction of CHE-1hs in adults results in the activation of gcy-5 in a limited number of 
neurons in the head and tail of the worm and in pharyngeal muscles. The activity of CHE-1 in 
pharyngeal muscles was not further studied as no other CHE-1 target showed ectopic expression 
in the pharynx and it seemed that this was a gcy-5-specific effect, rather than a general reflection 
of CHE-1 activity. The activity of CHE-1 in neurons however, was pursued a bit further.  
Most head and tail neurons undergo terminal division and differentiation during 
embryonic stages, suggesting that the neurons remain susceptible to che-1 activity long after they 
have developed. We hypothesized that these neurons either share co-factors with ASEs, which 
permit the activity of CHE-1, or remain in a relatively plastic state throughout development. To 
test these hypotheses, we first sought to identify the susceptible neurons.  
To this end, we induced CHE-1hs in worms with gcy-5prom::gfp and che-1-independent 
red markers that label known sets of neurons. Based on this analysis, some of the cells that 
frequently expressed gcy-5prom::gfp in response to adult induction of CHE-1hs were identified as 
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RIS, CEPV, CEPD, CEPL, CEPR, ASK, ASI in the head and possibly PQR and PVQ in the tail 
(Figure 2-10a). The CEPs and RIS neurons express the TF nhr-67, which had been previously 
identified and characterized in our lab as playing several important roles in ASE development. In 
addition to contributing to the lateralization of ASEL vs. ASER fate, nhr-67 also contributes to 
the transcriptional activation of che-1 in the ASEs (Sarin et al., 2009). We therefore 
hypothesized that expression of nhr-67 may make these cells receptive to CHE-1hs function. In 
addition to the CEPs and RIS, nhr-67 is also expressed in RIR and RMEL/R/V/D neurons in the 
head of the worm. However, we found that these neurons are not receptive to adult CHE-1hs 
(Figure2-10d), suggesting that nhr-67 is not sufficient to make cell receptive to CHE-1. Since 
nhr-67 mutants die at the L1 stage, we attempted to check the requirement of nhr-67 using 
mosaic analysis, however this proved to be inconclusive as the RIS and CEPs were difficult to 
identify in mutant mosaics (not shown). 
The second hypothesis that these neurons remain plastic throughout development was 
tested in the RIS neuron since it is easy to identify.  In this regard, expression of other ASE 
markers after adult CHE-1hs induction was first tested. In addition to gcy-5prom::gfp, expression 
of gcy-5fosmid::gfp, ceh-36fosmid::gfp, and ift-20prom::rfp  was also detected in the RIS (ceh-
36fosmid::gfp however was not activated in the CEPV/D/L/R neurons), suggesting that adult CHE-
1hs can activate a broad range of target genes (Figure2-10b). If the RIS does stay plastic 
throughout development, it should also be susceptible to other terminal selector TFs. To test this, 
unc-3, the terminal selector for cholinergic motor neurons was induced using a heat shock 
promoter and expression of its target genes were checked. Two of the three cholinergic reporters 
tested did show ectopic expression in RIS after UNC-3hs induction in adults (Figure2-10c). This 
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suggests that perhaps the RIS does retain a more plastic state throughout development. Whether 





















Figure 2-10: Neurons that remain responsive to CHE-1hs 
All pictures show worms after heat-shock induction of CHE-1 or UNC-3 at the adult stage. Markers listed 
at the top of images are being scored, and markers listed on the bottom of the images are being used to 
identify specific cells. A) Expression of gcy-5prom::gfp is seen in the 4 CEP neurons, ASK, and ASI 
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neruons in >70% adult worms after CHE-1hs induction. ceh-36fosmid::yfp is not seen in CEP neurons under 
the same experimental conditions. ceh-36fosmid::yfp was not checked in ASK and ASI. PVQ and PVR 
neurons often show induction of gcy-5prom::gfp, but they were not scored as they cannot always be 
unambiguously identified. B, C) Expression of ASE and cholinergic MN markers in the RIS neurons after 
CHE-1hs and UNC-3hs respectively, in adults. D) Not all cells that express nhr-67 activate gcy-5prom::gfp 
in response to CHE-1hs. The RIR and RMEs only activate gcy-5prom::gfp at background levels. 
 
DISCUSSION 
The loss of developmental plasticity in differentiating cells can be experimentally 
demonstrated as a cell’s inability to respond to ectopically expressed TFs. In this chapter, we 
show that the overexpression of che-1, a master regulator TF, can be used to assay this loss of 
plasticity in the cells of a developing worm. Early in the process of differentiation, most cells are 
receptive to the activity of ectopic CHE-1hs, as demonstrated by the activation of fluorescent 
target reporters; however, as post-mitotic cells terminally differentiate, they gradually become 
refractory to CHE-1hs activity. This finding provides a visual assay for following the state of 
plasticity in all cells of the worm, which will be utilized in the next two chapters to uncover the 
mechanisms that make differentiated cells less receptive to CHE-1hs.  
 
Cells are progressively less receptive to CHE-1 
For the most part, we find that cells remain receptive to che-1 activity while they are 
dividing and for a small window of time after terminal division. This change in the ability of 
CHE-1 to act could reflect the presence or absence of a transcriptional co-regulator at different 
time points or it could suggest that che-1 target loci undergo a change that makes them 
inaccessible for activation. It is unlikely that the former is the case as continuous expression of 
che-1 with the use of neuronal promoters results in the continuous activation of target genes 
throughout the life of the worm. If it was the case that che-1 could only act early in development 
because a co-activator was present or a repressor absent at this time, then promoter driven che-1 
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would also only induce target gene expression for a short window of time, after which its activity 
would be hampered and target genes would turn off. It seems rather the case that if che-1 is 
expressed early while target genes are accessible, it can activate their expression and prevent the 
loss of accessibility at these loci. However, if che-1 is activated after differentiation, these loci 
become inaccessible and remain inaccessible through the life of the worm in a wildtype 
condition. It is still possible that the co-regulation of the transcriptional activity of CHE-1 are 
regulated in a manner that can explain the observed results, however since this hypothesis cannot 
be easily tested in our system as multiple co-regulators might be playing important roles, we 
favor the accessibility hypothesis over the regulation-of-co-factors hypothesis in the rest of this 
thesis. A more detailed discussion of the co-factor hypothesis as it pertains to results in Chapters 
2-4 can be found in Appendix B. 
A progressive loss of TF activity in post-mitotic cells has also been reported in the mouse 
brain.  Fezf-2, a master regulatory gene for corticospinal motor neurons, is capable of activating 
target genes in embryonic and early postnatal callosal projection neurons and retains its ability to 
act at post-mitotic day 3 and 6. However this ectopic activity progressively declines and is 
exhausted by day 21 (Rouaux and Arlotta, 2013).  
The change is accessibility of genes during differentiation is correlated with changes in 
chromatin organization. It has been shown in C. elegans that fate-specific genes are less compact 
and show flexible sub-nuclear location in embryonic cells, but that they become more compacted 
and carry silencing histone marks in differentiated cells in which they are not expressed at the L1 
stage (Meister et al., 2010a). It would be interesting to look at the chromatin structure and 
histone modifications on the gcy-5 locus at many times points before and after terminal division 
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to gain a more detailed understanding of the dynamics of chromatin based changes and their 
correlation to the time when they become inaccessible for activation by che-1.   
 
Loss of original identity depends upon the cell type 
Ectopic and continuous expression of che-1 starting in early post-mitotic cells leads to a 
mild loss of the original cell fate in neuronal cells and a strong loss of original cell fate in muscle 
cells. This difference in the ability of che-1 to disrupt original fate may simply be a result of 
differences in levels of che-1 being expressed, as the expression is under the control of different 
promoters for these experiments. For instance, it is possible that the muscle promoter being used 
for ectopic expression activates higher levels of che-1 than the neuronal promoters, and this uses 
up the limited transcriptional machinery in muscle cells and indirectly results in muscle genes 
not getting activated. On the other hand, it is also possible that downstream effects of che-1 
activity, rather than a competition for resources, leads to the repression of alternative fates.  
In other examples of ectopic TF overexpression the original identity of the host cells is 
often lost. For instance, the expression of Fezf-2 in mice callosal projection neurons leads to a 
loss of callosal neuronal features in addition to a gain of Fezf-2 driven characteristics. Many such 
examples of TF driven transdifferentiations have been observed in cell culture (as discussed in 
section II of the Introduction). However, it is unclear how an ectopically expressed TF 
outcompetes the original fate in these cases and whether it is again a consequence of the levels of 
expression. Some mechanistic insight into this question is provided in C. elegans cec-4 mutants. 
Ubiquitous expression of hlh-1 in worm embryos leads to 100% embryonic arrest and almost all 
somatic cells expressing muscle fate markers. Furthermore, in the intestine a loss of intestinal 
fate markers is seen after hlh-1 dependent muscle induction. However, in cec-4 mutants about 
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25% of hlh-1 induced embryos escape embryonic arrest and develop to become sick L1s. In 
these escapers, muscle fate and intestinal fate are co-expressed, i.e., expression of hlh-1 does not 
lead to a conversion of intestine into muscle but rather a mixed fate. cec-4 is a protein required 
for anchoring H3K9methylated heterochromatin to the nuclear periphery. The authors argue that 
expression of hlh-1 in wildtype embryos leads to the adoption of muscle fate and concomitantly 
results in the terminal genes of all other fates becoming inaccessible to transcriptional activation. 
However, in cec-4 mutants, these genes fail to anchor to the nuclear periphery and therefore 
remain accessible (Gonzalez-Sandoval et al., 2015). This explanation assumes, without direct 
evidence, that expression of hlh-1 results in ectopic specification of muscle fate that causes loci 
of all other cell fates to move to the periphery. It also does not provide insight into why hlh-1 
wins over the endogenous TF. It does, however, suggest that the loss of original fate is not 
always a matter of levels of expression as hlh-1 expression is unchanged between wildtype and 
cec-4 mutants. How TFs compete and why some win in certain cellular contexts remains an open 
question.  
 
Adult cells that remain susceptible to CHE-1 activity 
A small group of embryonically born neurons remain susceptible to CHE-1hs activity 
even during adulthood. We identified these neurons to test the hypothesis that they might express 
co-factors of che-1. These neurons are not all lineally related to ASEs, and neither are they all 
sensory or glutamatergic neurons like the ASEs. Additionally, they do not all share any known 
factors that are key for ASE differentiation.  All these facts make it likely that different neurons 
remain susceptible to che-1 activity for different reasons. One of these neurons, the RIS, has a 
cellular context that is amenable not only to che-1 activity, but also to unc-3 activity. This could 
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suggest that the RIS neuron expresses co-factors for both che-1 and unc-3 or it could suggest that 
the RIS neuron maintains a relatively plastic state throughout development. More work is needed 
to determine the molecular basis of the susceptibility to che-1. 
 
Differences in responsiveness of various target genes to CHE-1  
An additional interesting aspect of ectopic che-1 activity is the difference in its ability to 
activate gcy-5 and ceh-36 as opposed to gcy-6 and gcy-7. While ceh-36 is bilaterally expressed in 
both ASER and ASEL, gcy-5 is expressed only in the ASER and gcy-6/7 are expressed only in 
the ASEL. The ability of CHE-1hs to broadly activate an ASER-specific and a bilaterally 
expressed gene (gcy-5, ceh-36), but not ASEL genes (gcy-6/7) in post-mitotic cells suggests that 
ectopic che-1 is not sufficient for the activation of ASEL genes, assuming that these genes are 
representative examples. The lateralization of the ASEs has been thoroughly studied in our lab, 
in part by extensive cis-regulatory analysis of bilateral, ASEL, and ASER-specific genes. These 
analyses have demonstrated that while a che-1 input through the ASE motif is sufficient to drive 
bilateral and ASER-specific gene expression, activation of ASEL-specific genes requires 
additional positive inputs- the ectopic activity of che-1 underlines this difference. It has been 
postulated that the co-factors required to activate ASEL-specific genes are downstream of che-1 
and may include inputs from TFs die-1 and ceh-36. However, as die-1 itself is broadly expressed 
throughout the life of the worm and ceh-36 is broadly activated by ectopic CHE-1, the inability 
of broad gcy-6/7 activation suggests the requirement for additional factors, or the presence of 
repressors.   
In contrast to all these genes, CHE-1hs continues to broadly activate the synthetic gcy-















enhancer and the negative regulatory inputs, such that a strong enhancer can be accessed by 
CHE-1 even in the presence of negative regulation.   
 
Simple model for the activity of ectopic CHE-1 
 The data in this chapter shows that while CHE-1 can activate target genes in many cells 
types early in development, it cannot do so once cells have differentiated. We hypothesize that 
this change in the ability of CHE-1 to act is brought about by the acquisition of a factor “Y” 
which stops CHE-1 from activating targets in differentiated cells (Figure 2-11). If this is the case, 
the removal of such a factor Y should allow CHE-1hs to activate target genes in more 
differentiated cells (Figure 2-11). In the next chapters we test this hypothesis by first performing 
RNAi screens (Chapter 3) and then taking a candidate approach (Chapter 4) to look for genes, 
which when knocked down, expand the number of gcy-5+ cells in response to L4/adult induction 
of CHE-1hs. As responsiveness to CHE-1 is being used as an assay for cellular plasticity, the 
genes found in this way should also point to the mechanisms that ensure the loss of plasticity 










Figure 2-11: Hypothesis about ectopic CHE-1 activity 
Early in development, ubiquitous CHE-1 induction results in the activation of target genes in many cell 
types (represented by green circles). As differentiation progresses cells acquire a hypothetical factor, Y, 
which makes CHE-1 target genes inaccessible for activation, resulting in the limited activity of L4/adult 
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induced CHE-1hs. In the next chapters, we remove factors that may act as Y and determine if L4/adult 
CHE-1hs induction can now result in the activation of target genes in more differentiated cells. We 
hypothesize that factors that act as Y are required for restricting the fate of differentiated cells. 
 
MATERIALS AND METHODS 
Strains and transgenes 
 All strains were maintained using standard procedures, unless otherwise noted. For heat-
shock experiments, worms were grown at either 15°C or 20°C, heat-shocked at 37°C for 30 min. 
and left at 20°C overnight. Marker expression was scored around 24hrs after heat-shock. 
The following strains and transgenes were used (Strains in bold were created by me) : 
OH9846: otIs305 [hsp16-41prom::che-1::2xFLAG; rol-6(d)]; ntIs1 [gcy-5::gfp; lin-15(+)]  
OtTi6: hsp16-41prom::che-1::2xFLAG (miniMos single copy insertion)  
OH13139: otIs587 [gcy-5fosmid::sl2::1xnlsgfp; ttx-3prom::mcherry] 
OH13140: otIs588 [gcy-5fosmid::sl2::1xnlsmcherry; ttx-3prom::gfp] 
OH13102: otIs586 [gcy-6fosmid::sl2::1xnlsgfp; ttx-3prom::mcherry] 
OH13984: ot835 (gcy-5::sl2::1xnls::mNeonGreen) CRISPR engineered into the genome 
OH13152: otIs590 [gcy-5prom::rfp; ttx-3prom::gfp] 
OH14049: otIs629 [gcy-7prom::tagrfp; ttx-3prom::gfp] 
OH13099: otIs583 [gcy-5prom306bp4XASE::gfp; ttx-3prom::mcherry] 
OH14218: otEx6597 [ric-19prom::che-1; myo-2prom::bfp] 
OH14219: otEx6598 [unc-47prom::che-1; myo-2prom::bfp] 
OH11979: otEx5430 [ift-20prom::che-1; rol-6(d)] 
OH7110: otEx3103 [nhr-67fosmid::mcherry] 
OH8882: otEx3909 [ceh-36fosmid::yfp] 
OH11671: otIs434 [dat-1prom::2xnlstagrfp; ttx-3prom::mcherry] 
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VH905: hdIs30 [glr-1::dsred2] 
OH9969: otEx4431 [ace-2fosmid::sl2gfp; elt-2prom::nlsdsred] 
OH10821: juls14[acr-2prom::gfp]; otIs361[hsp16.2prom::unc-3] 
OH10689: otis355 [rab-3prom::nlstagrfp]  
OH11157: otIs393 [ift-20prom::nlstagrfp; pha-1] 
OH10418: lim-6(ot146); oxIs12 [unc-47prom::gfp] 
Building transgenic lines: 
The 3.3 kb che-1 genomic locus was inserted into the backbone of the pPD49.78 plasmid (from 
the Fire vector kit; (1)) containing the heat shock promoter. Additionally, a 3xHA tag was fused 
to the C-terminus of CHE-1. The 1.5 kb unc-3 cDNA containing plasmid pKP10_hsunc_3cDNA 
is a gift from Piali Sengupta which had been cloned into the pPD49.78 backbone. Both 
constructs were injected into young adult hermaphrodites as complex arrays, using 1 ng/µL 
linearized pPD49.78 based plasmid DNA, 150 ng/µL PvuII digested bacterial genomic DNA and 
2 ng/µL pRF4(rold-6d) co-injection marker. Integration of these transgenes was performed using 
gamma-irradiation. Multiple stable integrated lines of hsp::che-1 and hs::unc-3 were obtained 
and all showed similar induction. All experiments in this chapter were done with otIs305 and 
otIs361. 
unc-47prom::che-1, ift-20prom::che-1 and ric-19prom::che-1 were cloned by replacing the heat-
shock promoter with the neuron-specific promoter in the pPD49.78 plasmid containing che-1 
genomic locus used above. In these plasmids the 3XHA tag was replaced with a 2XFLAG tag. 
Linearized plasmid were injected as complex array containing 5ng/ul of prom::che-1, 4ng/ul of 
myo-2::bfp, and 100ng/ul of digested bacterial genomic DNA. Extra chromosomal lines derived 
from the injections were used for experiments. 
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miniMOS was performed exactly as presented in (Frøkjær-Jensen et al., 2014). 
hsp16.41prom::che-1::2Xflag was cloned into the miniMOS vector pCFJ910 and integrated into 
the genome following the protocol from (Frøkjær-Jensen et al., 2014). Three independent 
insertions were obtained of which OTti6 was used for all experiments. 
CRISPR engineering to insert SL2::1XNLS::mNeonGreen after the stop codon of gcy-5 was 
performed exactly as described in (Dickinson et al., 2015). 
Fosmid recombineering to create otIs586 and otIs587 was performed as in (Tursun et al., 2009). 
The recombineering fosmids were linearized and injected into hermaphrodites as complex arrays 
with 15ng/ul of the linearized fosmid, 3ng/ul of ttx-3prom::mcherry used as a co-injection marker 
and 100ng/ul of digested bacterial genomic DNA. Extrachromosomal lines acquired after 
injection were integrated into the genome using gamma irradiation. 
 
Antibody staining 
 A freeze crack antibody staining protocol on whole worms was used (Duerr, 2006). 
Worms were washed, suspended in 0.025% glutaraldehyde and spread out in between two frost-
resistant glass slides. These slides were frozen on dry ice and cracked open to break the cuticle of 
the animals. Acetone/methanol fixation was used for the HA antibody to prevent gonad 
extrusion. Freeze cracked worms were incubated for 5 min each in ice cold acetone and 
methanol. The worms were then washed off the slides in 1X PBS, blocked and stained. Blocking 
was done in 1x PBS with 0.2% gelatin and 0.25% Triton for 30 min at room temperature. 
Antibodies were diluted in 1x PBS containing 0.1% gelatin and 0.25% Triton. Primary antibody 
was left on overnight at 4°C and secondary antibody was applied for 3 hours at room 
temperature. After washing off the secondary antibody, worms were incubated with DAPI for 15 
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minutes, washed again and mounted on glass slides. A Roche anti-Ha primary antibody was used 
at 1:50 dilution.  
 
smFISH and microscopy 
smFISH was performed using Custom StellarisTM FISH probes, purchased from 
Biosearch Technologies and staining was done according to the manufacturers protocol. 
µManager and Zen were used for the image acquisition and processing (Edelstein et al., 2010).  
 
DiI filling 
The amphid sensory neurons of worms can uptake fluorescent dyes (Shaham, 2006). DiI labeling 
was performed by washing worms into 1mL of M9 butter containing 1:500 dilution of DiI. 
Worms were left to incubate with the dye for 1 hour at room temperature, washed 3 times with 
M9 and placed on NGM plates with E. coli for >1hr to recover before imaging. 
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 When compared to embryonic cells, the differentiated cells of various organisms contain 
more domains of densely packaged heterochromatin. In Chapter 2 we reported that while the 
ubiquitous overexpression of TF CHE-1 in C. elegans embryos results in broad induction of 
target genes, expression in L4s and adult worms does not. Our current understanding of 
chromatin organization suggests that the packaging of DNA into heterochromatin might be 
making target genes inaccessible to CHE-1 at later stages of worm development. In this Chapter, 
we tested this hypothesis by performing RNAi screens against chromatin related factors. We 
found that the removal of lin-53, and all of the components of the C. elegans PRC2 complex, 
allowed CHE-1 to activate its target genes in the germline of the worm. We also found that the 
removal of three other genes, mes-4, mrg-1, and isw-1, results in the same phenotype. While it 
was known that the enzymatic function of PRC2 is to deposit the H3K27me3 mark, we showed 
that lin-53 is also required for germline H3K27me3. Additionally, mes-4 was shown to indirectly 
regulate correct H3K27me3 deposition and mrg-1 and isw-1 might mediate this function. 
Therefore, the relevant function of all the genes isolated in these screens might be to ensure 
proper distribution of H3K27me3, suggesting that this mark is necessary to keep somatic genes 
in an inaccessible state in the germline.  
 Almost all of the data presented in the Results section of this chapter is published (Patel 
et al., 2012). I added a few experiments that we did not include in the paper as they bolster the 
arguments made in this chapter. I designed and performed all of these experiments with the 
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following exceptions: the lin-53 fosmid (Figure 3-3a,b) was built and imaged by Dylan Rahe, 
and the experiment in Figure 2-11c was designed and performed by Inés Carrera and Nikos 
Stefanakis. The primary screen against 461 chromatin factors mentioned in the Introduction was 
performed in collaboration with Baris Tursun. Baris also did most of the work in Tursun et al., 
2011 to characterize the phenotype of lin-53.  
 
INTRODUCTION 
The process of cellular differentiation goes hand in hand with changes in chromatin 
modifications and structure. In this chapter, we asked whether chromatin-modifying enzymes are 
directly responsible for restricting the plasticity of differentiating cells. To answer this question, 
we designed a TF overexpression assay using the heat shock dependent conditional expression of 
Zn-finger-TF che-1 (Chapter 1). When ubiquitously expressed during embryonic development or 
in the early larval stages, the ectopically induced CHE-1hs can induce target gene expression in 
many developing somatic cells. However, if CHE-1hs expression is induced at the L4 stage, when 
most cells have differentiated, activation of target genes is only seen in a few neurons. 
Interestingly, germ cells are refractory to the activity of CHE-1hs throughout development. This 
suggests that the fate of somatic cells becomes restricted after differentiation while the fate of 
germ cells is continuously restricted.  
To understand the role of chromatin-related mechanisms in restricting the fate of these 
cells, we performed an RNAi screen against 461 genes in the C. elegans genome that encode for 
factors with known chromatin modifying activities or domains (Tursun et al., 2011). CHE-1hs 
was induced in worms after the individual RNAi-mediated knockdown of each of these genes 
and expression of target reporter gcy-5prom::gfp was scored. We looked for genes, which when 
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knocked down, allowed CHE-1hs to act in cells that would normally be restricted in wildtype 
worms. We hypothesized that the factors encoded by such genes would be involved in restricting 
the plasticity of cells during normal differentiation.   
From this primary screen we isolated two genes that showed strong phenotypes: the 
knockdown of lin-53 resulted in the activation of gcy-5prom::gfp in mitotic germ cells, and the 
knockdown of usp-48 resulted in the activation of gcy-5prom::gfp in the epidermis of the worm 
when CHE-1 was induced at L4/adult stages. Dylan Rahe, another graduate student in the Hobert 
Lab, is currently studying the function of usp-48. A detailed analysis of lin-53, a histone 
chaperone protein which is known to act in many chromatin complexes was completed by a post-
doc, Baris Tursun, and has been published (Tursun et al., 2011). Baris found that the knock-
down of lin-53 resulted not only in the activation of gcy-5prom::gfp, but several other ASE-
specific, pan-sensory, and pan-neuronal genes in the mitotic germ cells after CHE-1 induction. A 
concomitant loss of germ cell fate, as assessed by immunostaining for a germline-specific p-
granule protein was also seen. Additionally, these cells adopted a neuron-like morphology 
suggesting that the loss of lin-53 and activation of CHE-1hs allows for the conversion of germ 
cells into ASE-like neurons. Two other neuronal fate-specifying TFs, unc-3 and unc-30, were 
also able to activate their target genes if ectopically expressed after the knockdown of lin-53. All 
of this shows that lin-53 plays a crucial role in restricting the accessibility of a wide range of 
genes in wildtype germ cells. Since the knockdown of lin-53 does not in itself lead to the 
activation of somatic genes, but requires the presence of trans-acting TFs, and since lin-53 is a 
histone chaperone, it is likely that is functions by modulating the chromatin structure of germ 
cells, and not simply by acting as a repressor of non-germline genes. 
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After this initial assessment of the lin-53 knockdown phenotype, we wanted to further 
understand the exact function of lin-53 in germ fate restriction. lin-53 is the homolog of 
Nurf55/Caf-1 in drosophila, and RbAp46/48 or Rbbp in humans. The protein contains seven 
WD-40 repeat domains, which facilitate protein-protein interactions and have been shown to 
bind histones H3 and H4 (Henikoff, 2003; Suganuma et al., 2008). With the use of genetic and/or 
biochemical approaches, lin-53 has been shown to be a part of several chromatin-modifying 
complexes, including the histone acetyltransferase Hat1, the nucleosome remodeling and 
deacetylase complex NuRD, the nucleosome remodeling NURF complex, the histone 
deacetylase and transcriptional repressor Sin3, the chromatin assembly factor CAF-1, the 
DREAM complex which mediates gene expression during the cell cycle, and the PRC2 complex 
(Henikoff, 2003; Loyola and Almouzni, 2004; Philpott et al., 2000). Mutation of Nurf55 in 
Drosophila imaginal disks results in cell death, indicating an essential role for the gene. lin-53 
knockdown by RNAi in worms results in incompletely penetrant embryonic lethality (Nakano et 
al., 2011; our experiments), suggesting that it is essential in worms too. The model plant 
Arabidopsis has five genes that encode for RbAp48 related proteins and loss of one of these 
genes, AtMSI1, causes progressive failure to silence developmental genes, suggesting a role in 
epigenetic silencing (Hennig, 2003).  
In C. elegans, lin-53 has also been characterized as a SynMuvB gene. The SynMuvB 
genes act redundantly with SynMuvA genes to inhibit inappropriate EGF/Ras/MAPK signaling 
that results in ectopic vulva induction (Cui et al., 2006). While these genes were first found in 
screens for vulva defects, many of the SynMuvB genes have subsequently shown to be 
chromatin regulators (Fay and Yochem, 2007). 
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In order to understand the precise function of lin-53 that is required for the restriction of 
germ cell fate, we performed a secondary RNAi screen against the components of all the 
chromatin-modifying enzymes that lin-53 has been found to associate with. Additionally, we also 
performed an RNAi screen against RNAi factors (Fischer, 2010), as the RNAi pathway has also 
been shown to play a role in modulating chromatin (see Introduction) and might have had a role 
in mediating lin-53 function. We found that the function of lin-53 in germ cell restriction can be 
phenocopied by removal of the PRC2 complex and three genes, mes-4, mrg-1, and isw-1, which 
deposit or bind H3K36me3. We also show that the lin-53 knockdown, like the knockdown of 
PRC2, results in the loss of H3K27me3. Work done in Susan Strome’s lab at this time, showed 
that removal of H3K36me3 from germ cells results in a reduction in levels of H3K27me3 on 
somatic genes in the germline. These data suggest that the reduction of H3K27me3 is the 
molecular mechanism that allows CHE-1 and other TFs to activate their target genes in germ 
cells. Therefore, the correct deposition of H3K27me3 plays a crucial role in making unexpressed 
genes inaccessible and restricting the fate of germ cells. 
 
RESULTS 
Secondary RNAi screens 
Tables 1-3 contain lists of genes that have been found in complexes with lin-53, all 
SynMuvB genes, and the genes that play a direct role in or modulate RNAi. For this secondary 
screen, we used a strain that contained the multi-copy hsprom::che-1, and the  gcy-5prom::gfp 
reporter. The stain used in the primary screen also contained an rrf-3 mutation, which is known 
to enhance RNAi (Simmer et al., 2003), however this mutation was left out in the secondary 
screen as the lin-53(RNAi) phenotype was just as strongly evident in rrf-3(+) worms.  
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lin-53 (RbAp46/48, Nurf55) associated complexes 
DRM complex CAF-1                        







DP dpl-1 CAF1 (p60) Y71G12B.1 HDAC1 hda-1 
Mip120 lin-54 CAF1 (p150) T06D10.2 HDAC2 hda-3 
Mip130 lin-9 Sin3 complex HDAC1 like mep-1 
 lin-37 Sin3 sin-3 p66 dcp-66 
HAT histone acetylase 
complex 
SAP18 C16C10.4 Mi-2/CHD4 let-418 
SDS3 T07C12.14 CHD3 chd-3 
HAT1 tag-235 SAP30 Y67D2.7 RbAp48 rba-1 
PRC2 - polycomb 
repressive complex 2 
SAP130 teg-4 MTA1/2 egl-27 
NuRF MTA1/2 lin-40 
E(z) (EZH2) mes-2 SNF2H/ ISW1 isw-1 
ESC (EED) mes-6 NURF301 nurf-1 
 mes-3 NURF38 pyp-1 
RNAi Factors 
C04F12.1 ego-1/6 rrf-3 isw-1 rde-1 
ppw-1 drh-3/ekl-3 tsn-1 csr-1 T22H9.3 
F55A12 eri-6 vig-1 M03D4.6 ergo-1 
sago-2 eri-7 ZK1248.7 prg-2 Zk218.8 
prg-1 drsh-1 C14B1.7 T22B3.2 mes-4  
R06C7.1 pash-1 C16C10.3 gfl-1 mut14 
T23D8.7 ain-2 ZK757.3A mes-6 mut15 
ppw-2 alg-2 zfp-1 eri-1 hda-1/gon-10 
mes-3 C06A1.4 mrg-1 eri-5 ain-1 
mut-8/rde-2 F58G1.1 mut-7 drh-1 nrde-3 
mut16/pqn-3 Y49F6A.1 rde-4 drh-2 alg-1 
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in green showed 
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the knockdown 
of these genes 













After screening most of the listed factors in triplicates, we found that all of the 
components of the C. elegans PRC2 complex, i.e., mes-2, mes-3, and mes-6 phenocopy lin-53. 
For mes-3 and mes-6, which were also screened as RNAi modulating factors, the germline 
phenotype was evident in both screens. Additionally, we found that mes-4, mrg-1, and isw-1 
showed a germline phenotype as well. isw-1 was screened both in the RNAi library screen and as 
a part of the lin-53 containing NURF complex. As no other components of the NURF complex 
showed a phenotype, we concluded that isw-1 affects the germline through an independent 
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mechanism. Similarly since mes-4 and mrg-1 are not in known complexes with lin-53, their 
activity must also be lin-53 independent. 
 We turned our attention first to the PRC2 complex, which in C. elegans is required for 
the deposition of H3K27me3 in all cells of the embryos and in the germline at all stages of 
development. We analyzed in detail the phenotypes of PRC2(RNAi) as well as lin-53(RNAi) 
worms to understand the mechanistic similarities. 
 
Extent of CHE-1 activity in PRC2(RNAi) germlines  
 To characterize the phenotypes of PRC2(RNAi) and lin-53(RNAi) germlines, we grew 
P0 worms on bacteria containing dsRNA against mes-2, mes-3, mes-6, or lin-53 and induced 
CHE-1hs expression in  the F1 progeny at the L4 stage. CHE-1hs induction in control dsRNA or 
no dsRNA fed worms results in the activation of gcy-5prom::gfp only in a small number of 
neurons, as discussed in Chapter 2. In contrast, knockdown of PRC2 and lin-53 by RNAi results 
in CHE-1hs dependent gcy-5prom::gfp expression in the germline (Figure3-1a). The percent of 
worms that show this phenotype varies from ~12% to  ~42% depending upon the gene being 
knocked down. Mutants of the mes genes are maternal effect sterile: while the maternal+ 
zygotic- (M+Z-) germlines have a normal number of germ cells, M-Z- germlines do not develop 
normally and only contain about 10 germ cells at the adult stage.  
We tested putative null alleles of mes-2 and mes-3 to determine if the RNAi phenotype 
could also be observed in the mutants. Neither M+Z-, nor M-Z- germlines of either mutant 
showed expression of gcy-5prom::gfp in response to CHE-1hs. This may be because in M+Z- 
worms, the maternally contributed mes-2/3 is sufficient to stop CHE-1hs from acting, and in M-
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Figure 3-1: Knockdown of PRC2 complex components allows che-1 to activate gcy-
5prom::gfp in the germline 
Larval progeny of RNAi-treated animals were scored in all panels. A) gcy-5::gfp expression ~24 hours 
after heat-shock induction of CHE-1. Right panels show boxed regions in middle panels, with germlines 
outlined by brown stippled lines. Top right panel shows penetrance of gcy-5prom::gfp expression after che-
1 induction at the ~L4 stage (at least 3 independent experiments, n=90-300 for each RNAi). Error bars 
represent the S.E.M. B) Partial knockdown of the PRC2 genes reduces but does not eliminate the 
germline. Quantification of the number of germ cells present in individual gonad arms of mes-2, mes-3, 
and mes-6 (RNAi) worms. The che-1-dependent phenotype is generally observed in gonad arms with 30-
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140 germ cells. C) Immunostaining of CHE-1::HA 4 hours after heat-shock in the germlines of wildtype 
and RNAi worms. Levels of CHE-1 expression are comparable between wildtype and RNAi germ cells. 
 
partial knockdown that is achieved by RNAi is needed to strike a balance between germ cell 
survival and susceptibility to CHE-1hs. Indeed, counting the number of germ cells in mes-2/3/6 
(RNAi) worms shows a great variability in the number of remaining germ cells and may also 
explain the variability seen in the penetrance of the gcy-5prom::gfp expression phenotype (Figure 
3-1b). 
Multi-copy transgenes sometimes get silenced and heterochromatinized in the C. elegans 
germline and it is known that in PRC2 mutants, these transgenes can be desilenced (Holdeman et 
al., 1998). To ensure that the PRC2(RNAi) phenotype in the germline is not simply a result of 
the hsprom::che-1 transgene getting desilenced, we stained for the HA protein tag present in the 
induced CHE-1hs. Similar levels of CHE-1hs are induced in wildtype and RNAi germlines, 
suggesting that a change in CHE-1hs levels do not explain this phenotype (Figure 3-1c). 
 We then checked if the expression of other reporters could be activated in PRC2(RNAi) 
and lin-53(RNAi) germlines in response to CHE-1hs. These included a second ASE fate marker, 
ceh-36, and two pan-neuronal markers, snb-1 and unc-33. We found that all of these markers 
were expressed in RNAi, CHE-1hs(+) germlines (Figure3-2a). In addition to these fluorescent 
reporters, neuronal gene expression was also confirmed by RNA smFISH, which showed 
induction of endogenous gcy-5 mRNA and unc-10 mRNA (Figure 3-2b,c). Moreover many of 
these germ cell nuclei lose their characteristic fried egg morphology and acquire a speckled 
nuclear morphology characteristic of neurons, and show a concomitant loss of germ cell protein 
PGL-1, as detected by immunofluorescence (Figure 3-2d,e). Some cells that express ASE 
reporters, also extend cellular axo-dendritic projections which show clusters of presynaptic 
proteins, as assessed by UNC-10/Rim antibody staining, demonstrating that germ cells do no 
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merely derepress marker genes but broadly transform into neuron-like cells (Figure 3-2d,f). All 
of these phenotypes are highly similar between lin-53 and PRC-2 complex components and show 
that the loss of PRC2 and lin-53 leads to a CHE-1hs dependent conversion of germ cells into ASE 










Figure 3-2: Detailed characterization of RNAi germ cells after CHE-
1hs 
A) Expression of several additional markers  is seen in RNAi germlines ~24 
hours after CHE-1hs induction at L4. The penetrance of this phenotype ranged 
from 20% to 50% for the various markers (n = 30 to 60 for each marker, for each 
RNAi). Gonads are outlined. B,C) Single molecule FISH shows induction of 
endogenous genes in germ cells. In panel B, overlap between gcy-5prom::gfp and 
gcy-5 mRNA can be seen. Gonads are outlined. D) Germ cells acquire a neuron-
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"speckled" neuronal cell nuclei; right panels, including blow-up in white box) and axo/dendritic 
extensions (arrowheads; left panels, including blow-up in white box). E) PRC2 germlines retain the 
germline-specific PGL-1 protein, as detected here by antibody staining. However, this protein is not 
longer detected after CHE-1hs induction. PGL-1 and gcy-5::gfp are mutually exclusive in over 90% of 
converted gonads. In ~10% of converted gonads faint PGL-1 is seen in some gcy-5 positive cells. F) 
CHE-1hs(+), RNAi germ cells express the presynaptic protein UNC-10/Rim, which clusters along the 
length of a neuronal extension (arrowheads). 
 
Focus of action of the PRC2 complex 
MES-2, MES-3, and MES-6 proteins are known to be broadly expressed in embryonic somatic 
cells and in embryonic and adult germ cells using antibody staining (Holdeman et al., 1998; Korf 
et al., 1998; Xu et al., 2001a). To analyze lin-53 expression, Dylan Rahe generated a fosmid-
based lin-53 reporter. In contrast to mes-2/3/6, transgenic animals expressing this reporter 
showed broad LlN-53::GFP expression in all somatic tissues and in the mitotic germ cells at all 
stages examined (Figures 3-3a, b). To test that lin-53 and PRC2 act autonomously in the germ 
cells rather than in the surrounding somatic gonad to prevent CHE-1hs from activating its target 
genes, we sought to eliminate PRC2 specifically in germ cells by using animals that lack the 
RNA-directed RNA polymerase rrf-1. rrf-1 is required for RNAi in many somatic cells 
(including the somatic gonad), but is not required for RNAi in the germline (Kumsta and 
Hansen, 2012). RNAi against mes-2/3/6 and lin-53 in an rrf-1(pk1417) mutant background 
therefore knocks down these genes in germ cells but not in the somatic gonad. We found that in 
such animals, the CHE-1hs-dependent expression of gcy-5prom::gfp is still observed in germlines 









Figure 3-3:  
 
lin-53 expression pattern and focus of lin-53 and PRC2 
action  
A) The lin-53 gene is contained within fosmid WRM0634aA12.  
gfp was recombineered in frame at the C-terminus of lin-53. B) 
Expression pattern of LIN-53::GFP. LIN-53::GFP is broadly 
expressed in all life stages and in many cells.  Clockwise from the 
top left; adult head; adult germline, faint LIN-53::GFP expression 
observed in germ cells (inset); 3-fold stage embryo; mid-
gastrulation stage embryo; L1 Larva.  As is characteristic of extrachromosomal transgenes, expression is 
mosaic and variable in intensity. C) rrf-1(pk1417) mutants, which can perform RNAi in the germline but 
not the somatic gonad, also show gcy-5prom::gfp expression in mes(RNAi) and lin-53(RNAi) animals ~24 






























































































C. The penetrance of the germline conversion phenotype is not diminished in rrf-1(-/-) animals compared 
to rrf-1(+) animals. In fact, rrf-1 mutants show a slight increase in penetrance. While this could be an 
artifact of RNAi experiments, it could also be a result of the fact the rrf-1 mutants are generally healthier 
after RNAi knockdown of mes-2/3/6 and lin-53. Error bars represent S.E.M. 
 
Mitotic cycling is not required for germ-cell-to-neuron conversion 
 We next asked if germ cells have to be in a specific cellular state to be receptive to CHE-
1hs activity. In wild-type animals, germ cells are in various stages of mitotic and ensuing meiotic 
maturation. We could rule out that being in a meiotic state is required for CHE-1hs-induced 
neuron conversion, because we found that RNAi against PRC2 components prevents meiotic 
entry of germ cells, as deduced by a lack of staining of the meiotic marker HIM-3 (Figure 3-4a).  
Cell division has been proposed to be an important mediator of transitions between 
different states of gene expression, and transcription-factor-induced cellular reprogramming is 
often aided by cells being mitotically active (Egli et al., 2008; Halley-Stott et al., 2014; Hanna et 
al., 2009). We therefore asked whether the susceptibility of PRC2(RNAi) and lin-53(RNAi) 
mitotic germ cells to conversion requires mitosis. To address this question, we treated worms 
with dsRNA for PRC2 and lin-53 and arrested cell cycle a few hours before inducing CHE-1hs, 
and then determined whether the arrested cells were still convertible. Cell-cycle arrest was 
achieved in two independent ways. First, we blocked the cell cycle chemically through 
hydroxyurea (HU) treatment. HU arrests the cell cycle in S phase, as previously documented in 
many defined settings, including the C. elegans germline (Fox et al., 2011). We confirmed the 
effect of HU by counting the reduction of germ cell number and by observing the loss of 5-
ethynyl- 20-deoxyuridine (EdU) incorporation (Figures 3-4b, c). We found that germ cells of 
RNAi knockdown worms treated with HU could still activate gcy-5prom::gfp in response to CHE-
1hs with a similar penetrance and expressivity to untreated worms(Figure 3-4c). As an 
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genetically with the use of a temperature-sensitive allele of the cell-cycle regulator emb-30, an 
anaphase-promoting complex/cyclosome component (Furuta et al., 2000). We grew dsRNA-
treated emb-30(tn377ts) animals at 15°C and inactivated emb-30 by shifting the worms to 25°C, 
8hrs before CHE-1hs induction. Through staining with PH3, a marker of metaphase, we 
confirmed that within these 8hrs, a higher number of germ cells indeed became mitotically 
arrested (Figure 3-4d). Again, we found that CHE-1hs could still activate gcy-5prom::gfp in PRC2 
and lin-53(RNAi) animals in the emb-30(tn377ts) background (Figure 3-4d). We conclude from 
these results that PRC2(RNAi) and lin-53(RNAi) germ cells can be directly reprogrammed into 
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Figure 3-4: Neither meiosis nor active mitosis is required for CHE-1hs activity 
A) RNAi knockdown of MES proteins inhibits entry into meiosis, as assessed by staining with the meiotic 
marker HIM-3. Knockdown of lin-53 does not completely abolish entry into meiosis. Germ cells were 
still present in all cases, as assessed by staining with a P-granule specific antibody (OIC1D4). In the case 
of mes-3(RNAi) and mes-6(RNAi), 80-90% of animals that stained positive for OIC1D4 did not contain 
HIM-3 positive cells. The remaining 10-20% animals that expressed HIM-3 had healthier-appearing 
gonads, indicating that RNAi knockdown was inefficient in these worms. Over 90% of lin-53(RNAi) 
animals that stained positive for OIC1D4, also expressed HIM-3. Asterisks point out the distal most part 
of the gonad in the image. B) No EdU incorporation is seen in the germline after a 5 hour HU 
treatment. C) Cell cycle arrest by hydroxyurea (HU) treatment. Left Panel: reduced germ cell number in 
gonads of HU treated animals. Middle panel: expressivity of gcy-5prom::gfp expression remained 
unchanged after HU-mediated cell cycle arrest. HU "-" or "+" indicates "no HU treatment" or "5 hours 
HU treatment" (see Experimental Procedures). Each dot represents an individual animal. Right panel: the 
penetrance (i.e. number of animals displaying phenotype) of phenotype is also not significantly altered. 
D) Cell cycle arrest by shifting emb-30(tn377ts) mutants to the non-permissive temperature. Left panel: 
on average, there were about 3 times more germ cells in metaphase after an 8 hour temperature shift. 
Middle panel: expressivity of gcy-5prom::gfp expression upon CHE-1hs induction remained unchanged 
after emb-30-mediated cell cycle arrest. Each dot represents an individual animal. Right panel: The 
penetrance of gcy-5prom::gfp expression is also not significantly altered. The student t-test is used. Error 
bars represent S.E.M. 
 
 
Germ-cell-specific loss or reduction of H3K27me3 makes these cells susceptible to CHE-1 
activity 
 Previous studies have shown that genetic removal of mes-2, mes-3, and mes-6 results in a 
genome-wide loss of H3K27me3 in the germline that can be readily assessed by staining mutant 















































































knock downs and found that not only mes-2/3/6 (RNAi), but also lin-53(RNAi) caused a loss of 
H3K27me3 in germ cells (Figure 3-5a). These results suggest that the removal of H3K27me3 
correlates with the susceptibility of germ cells to CHE-1hs activity, and they further underscore 
the phenotypic similarity between lin-53(RNAi) and mes-2/3/6(RNAi).  Additionally this shows 
that lin-53 is a functional part of the PRC2 complex in C. elegans, as its orthologs are in 
Drosophila and humans. 
 Interestingly, we noted that a complete loss of H3K27me3 from the genome is not 
required for CHE-1 to activate target genes. When H3K27me3 staining was performed on mes-
6(RNAi), CHE-1hs(+) worms, expression of gcy-5prom::gfp was often seen in germ cells that still 
retained some H3K27me3 staining (Figure 3-5b). This suggests that perhaps the expression of a 
CHE-1 target gene simply requires that removal or reduction of H3K27me3 from that particular 


































































































Figure 3-5: lin-53(RNAi) results in loss of germline H3K27me3, but global loss of 
H3K27me3 is not required for CHE-1hs to activate target genes 
A) RNAi knockdown of mes-2, mes-3, mes-6 and lin-53 leads to a loss of global H3K27me3 in the 
germline (outlined), as assessed by staining for H3K27me3. Such global loss is not obvious in the somatic 
cells (marked with arrowheads). B) CHE-1hs can activate gcy-5prom::gfp in RNAi germ cells with low and 
high levels of H3K27me3, suggesting levels of H3K27me3 at specific loci, rather than global H3K27me, 
dictate CHE-1hs activity. C) CHE-1hs does not activate all target genes in all cells. When two target genes, 
gcy-5prom::gfp, and ceh-36prom::mcherry are scored together, they only show partial overlap in induction. 
 
 
in lin-53(RNAi) and PRC2(RNAi) germlines, their expression does not overlap. Cells positive for 
one, both, or neither marker can be found in all germlines (Figure 3-5c). Perhaps this variability 
results from a partial knockdown of PRC2 by RNAi; some cells may have sufficient reduction of 
H3K27me3 at one locus, some at both, and others at neither. Overall this data points to a possible 
mechanism where a loss or reduction of H3K27me3 at specific loci allows them to be activated 
by an ectopically expressed TF. 
 
Phenotypic characterization of mes-4(RNAi) and mrg-1(RNAi) 
In addition to the PRC2 complex, our secondary screen also showed CHE-1hs-dependent 
expression of gcy-5prom::gfp in the germ cells of mes-4(RNAi), mrg-1(RNAi), and isw-1(RNAi) 
worms. mes-4 is an H3K36 histone methyltransferase which contributes to the deposition of 
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H3K36me2 and H3K36me3. While neither mrg-1 nor isw-1 have been shown to be required for 
H3K36 methylation, they share many phenotypes with mes-4 mutants. For example, in C. 
elegans, mutants of all three genes suppress many of the phenotypes of SynMuvB mutants (Cui 
et al., 2006; Petrella et al., 2011). Both mrg-1 and mes-4 bind preferentially to the autosomes, but 
contribute to the silencing of X-linked genes (Takasaki et al., 2007). Additionally, the 
chromodomain of human MRG15 (ortholog of worm mrg-1), binds H3K36me3 in in vitro assays 
and the yeast homolog Eaf3 requires the presence of H3K36me to bind nucleosomes (Keogh et 
al., 2005; Zhang et al., 2006). Similarly, in yeast the Isw1 complex associates with H3K36me3 
and yeast Isw1 mutants phenocopy yeast H3K36 methyltransferase, set-2 (Smolle et al., 2012).  
Of these three genes, we studied the phenotypes of mes-4 and mrg-1 in greater detail to get a 
better understanding of their function in relation to PRC2. 
In addition to gcy-5prom::gfp, we observed that activation of CHE-1hs in mes-4(RNAi) and 
mrg-1(RNAi) results in the activation of pan-neuronal gene reporters rab-3, and unc-33 (Figure 
3-6a). Additionally, this phenotype is also seen in rrf-1 mutants suggesting that the focus of 
action of mrg-1 and mes-4 is also in the germline, as apposed to the somatic gonad (Figure 3-6b). 
We then checked to see if mes-4 and mrg-1 affect global patterns of H3K27me3 as these genes 
also share many phenotypes with PRC2 mutants (Petrella et al., 2011; Takasaki et al., 2007). A 
reduction in H3K27me3 is not observed in mes-4 and mrg-1(RNAi) (Figure 3-6c, d) a phenotype 
that was previously reported for mes-4 mutants (Rechtsteiner et al., 2010). Since mes-4 
dependent H3K36 methylation is a mark that is usually found at active chromatin, we found it 
confounding that mes-4(RNAi) phenocopied PRC2(RNAi) in our assay.  
This phenotypic similarity was explained by work in Susan Strome’s lab which showed 
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Figure 3-6: Phenotypes of mes-4(RNAi) and mrg-1(RNAi) germ cells 
A) CHE-1hs induction in L4 worms treated with mes-4 and mrg-1 RNAi results in induction of gcy-
5prom::gfp and two pan-neuronal markers unc-33prom::gfp and rab-3prom::nlsrfp. gcy-5prom::gfp and rab-
3prom::nlsrfp were tested in the same worms and showed only partial overlap, similar to the effect of PRC2 
(Figure 3-5c). Worms outlined in while lines, gonads outlined in brown lines. Penetrance is 20%-40%, 
n>30 for each RNAi. B) mrg-1(RNAi) and mes-4(RNAi) worms retain their CHE-1hs dependent phenotype 
in an rrf-1 mutant background suggesting that the focus of action of mes-4 and mrg-1 is in the germline as 
apposed to the somatic gonad. Gonads outlined in brown lines. C, D) mes-4(RNAi) and mrg-1(RNAi) 
worms do not show an apparent reduction in germline H3K27me3, as assessed by antibody staining 
against H3K27me3. These cells still express gcy-5prom::gfp after CHE-1hs induction (D). E) Summary of 
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the data produced in (Gaydos et al., 2012). ++ = wildtype levels, + = reduced from wildtype, - = none. 
This data also represented in the model in Figure 3-7. 
 
that would have otherwise been H3K36me3(+), and results in a titration of H3K27me3 from its 
normal domains (Gaydos et al., 2012). In the germline, H3K36me3 is enriched on germline 
genes, which are actively expressed, while H3K27me3 is enriched on somatic genes, which are 
not expressed. The spreading of H3K27me3 from somatic genes into germline genes in mes-
4(RNAi) results in a decrease in H3K27me3 levels at somatic genes, including CHE-1 targets 
(Gaydos et al., 2012), which then makes these loci accessible for activation in our assay. The 

















Figure 3-7: Model for H3K27me3-mediated germ fate restriction 
In wildtype germlines, somatic genes are enriched for H3K27me3 and germline genes are enriched for 
H3K36me3. The presence of H3K27me3 makes somatic genes inaccessible for activation by ectopically 
expressed CHE-1, and, other somatic TFs, like HLH-1 (Figure 3-8,9). The knockdown of PRC2, and lin-
53, results in a reduction or loss of H3K27me3 from loci of somatic genes, making them accessible for 
transcription. The knockdown of mes-4, results in the loss or reduction of H3K36me3, which results in a 
concomitant titration and reduction of H3K27me3 at its normal domains (based on H3K27me3 ChIP data 
in Gaydos et al., 2012). Therefore, in mes-4(RNAi) gonads, the indirect reduction of H3K27me3 at 
somatic genes makes them accessible for activation by somatic TFs.  
 
Based on these results, we propose a model suggesting that the correct distribution of 
H3K27me3 is required for the restriction of germ cell fate. And that a reduction of this 
modification from CHE-1 targets in both PRC2(RNAi) and mes-4(RNAi) worms results in the 
observed phenotype (Figure 3-7). As for mrg-1 and isw-1—these factors may act as readers of 
H3K36me3 and mediate the exclusion of H3K27me3 in H3K36me3 domains, thereby preventing 
the titration of HK27me3. However, to show this conclusively, an ideal experiment would 
require looking at H3K27me3 levels at somatic loci in the mrg-1/isw-1 (RNAi) germlines, which 
was technically not possible since these germlines could not be successfully dissected.  
 
Diverse somatic fates can be induced in PRC2(RNAi) germ cells 
 If the removal of H3K27me3 is the functionally relevant basis for the ability of CHE-1hs 
to access and activate its target genes, this would suggest that other somatic fate-specifying TFs 
should also be able to activate and access their respective target genes in PRC2 knockdown 
germlines (Figure 3-7). We tested this hypothesis by inducing the expression of unc-3, a COE TF 
which is required for specifying the cholinergic motor neuron (MN) fate (Kratsios et al., 2012) in 
lin-53(RNAi) and mes-6(RNAi) worms. UNC-3hs induction at the L4 stage in RNAi worms 
resulted in the activation of acr-2prom::gfp, a marker of cholinergic MN fate in germ cells, 











Figure 3-8: Knockdown of lin-53 and PRC2 allows UNC-3hs to activate target gene acr-
2prom::gfp in the germ cells 
Brown lines outline gonads. acr-2prom::gfp is not expressed in the gonads after UNChs in wildtype worms. 
 
 
We next asked whether the removal of PRC2 components makes mitotic germ cells also 
susceptible to be driven to non-neuronal somatic fates. To address this, we turned to the C. 
elegans MyoD homolog hlh-1, a factor that acts, in analogy to neuronal terminal selectors, as a 
direct regulator of terminal muscle features (Lei et al., 2010). Previously, we found that in lin-
53(RNAi) animals, ectopic induction of hlh-1 was not able to convert mitotic germ cells to 
muscle (Tursun et al., 2011). To probe this issue further, we generated new hlh-1 transgenic lines 
that are less repetitive than the ones previously used and therefore less prone to partial or 
complete silencing in the germline (Experimental Procedures). We found that upon knockdown 
of the PRC2 component mes-6 or lin-53, HLH-1hs was indeed able to convert germ cells into 
muscle-like cells, as assessed by the induction of transgenic markers for two distinct muscle 
proteins, UNC-97/PINCH (a muscle dense body component that also localizes to muscle nuclei 
(Hobert et al., 1999b)), and muscle myosin, myo-3 (Fire and Waterston, 1989)(Figures 3-9a, b). 
Moreover, using antibody staining (Figure 3-9c), we observed the induction of two additional 
muscle proteins: Kettin, a normal component of myofibrils (Ono et al., 2006), and the TF UNC-
































































MH44 (anti-Kettin) DAPI overlay























(Fukushige et al., 2006). A morphological transformation was also observed as these germ cells 
now displayed a distinctive muscle nuclear morphology, based on size of the nucleus and 
perinuclear localization of UNC-97 (Figure 3-9a). In this case too, immunostaining for the 
FLAG tag present in the ectopically induction HLH-1hs showed similar levels of HLH-1 protein 
in wildttype and RNAi germlines, suggesting that this phenotype is not simply a result of higher 

















































































MH44 (anti-Kettin) DAPI overlay































Figure 3-9: Knockdown of lin-53 and PRC2 allows HLH-1hs to activate multiple target 
genes in germ cells  
The progeny of RNAi-treated animals were analyzed for muscle marker expression ~24 hours after HLH-
1hs induction at larval stages. A) Induction of the LIM domain protein UNC-97, as observed with an unc-
97::gfp translational fusion transgene. UNC-97 protein is known to localize in muscle cells to both dense 
bodies (cellular attachment structures) as well as the nuclear periphery (Hobert et al., 1999b). Similar 
patterns are seen in these germ cells. Some converted nuclei also showed a muscle-like morphology based 
on size and localization of UNC-97 at the nuclear periphery (insets). B) Induction of the myosin gene, as 
assessed with the myo-3prom::rfp transgene. C) Induction of the myofibrillar, actin-binding Kettin protein 
as assessed with antibody MH44, and of the myogenic TF UNC-120, as assessed by anti-UNC120 
antibody staining. 
 
Figure 3-10: HLH-1::HA expression 
is comparable in wildtype and RNAi 








These data strongly suggest that numerous somatic genes become accessible to 
ectopically expressed TFs in germ cells where levels of H3K27me3 have been reduced, 
supporting the idea that H3K27me3 plays a crucial role in restricting the germ cell fate. 
After HLH-1 induction





















Specificity in the activity of TFs 
 We had shown previously that CHE-1hs induction in lin-53(RNAi) germ cells leads 
specifically to the induction of neuronal markers expressed in the ASEs, as 5/5 tested markers of 
other neuronal fates did not show induction (Tursun et al., 2011). Here we confirmed the 
specificity of CHE-1hs induction again in PRC2(RNAi) worms (Figure 4-11a). Markers of 
serotonergic fate, and cholinergic MN fate were not induced by CHE-1hs after RNAi knockdown 
of the relevant genes. This again suggests specificity in the activity of CHE-1hs. 
 We next wondered about the extent of this specificity. CHE-1 activates target genes by 
directly binding to the well defined ASE motif (Etchberger et al., 2007). However, not all genes 
that contain a good ASE motif are expressed in the ASEs. We tested reporters of two such genes, 
srw-85 and srt-63, after RNAi treatment and induction of CHE-1hs. As controls, we grew worms 
containing gcy-5prom::gfp on the same RNAi plates and induced CHE-1hs in all worms at the same 
stage. Surprisingly, the specificity in the activity of CHE-1 is maintained even in the foreign 
context of the germ line, transcription of neither srw-85 nor srt-63 is induced in germ cells of 
PRC2/lin-53(RNAi) worms (Figure 4-11b, only srw-85 shown). 
 An additional testament to this specificity was seen in experiments performed by Inés 
Carrera and Nikos Stefanakis, former members of the Hobert Lab who were studying the 
regulation of pan-neuronal genes. Expression of pan-neuronal genes is regulated in a highly 
redundant manner, and this expression is normally retained in mutants of terminal selectors, 
showing that terminal selectors are not required for pan-neuronal gene expression (Stefanakis et 
al., 2015). This is true for the expression of pan-neuronal gene snb-1 in the ASEs of che-1 
mutants. However CHE-1hs induction is sufficient to activate expression of a snb-1 reporter in the 








































wondered if in the context of the germ line CHE-1 binding is now required to activate snb-1 
expression. Inés and Nikos found that even if the ASE motif is mutated, this snb-1 reporter could 
still be activated in the RNAi germlines in a CHE-1hs dependent manner (Figure 4-11c, 
experiment performed by Inés/Nikos). This showed that, just like in the ASE neurons, CHE-1 is 
acting redundantly with other factors to activate expression of snb-1 in the germline of lin-
53/PRC2 (RNAi) worms. This data shows a staggering breadth and specificity in the activity of 
CHE-1, such that even in a foreign cellular context it can both directly and indirectly activate a 













Figure 3-11: Specificity in the activity of CHE-1hs  in lin-53 and PRC2 RNAi germlines 
All worms were treated with respective RNAi and heat-shocked at around L4 A) Expression of 
cholinergic MN marker unc-17, and dopaminergic marker dat-1 is not seen in response to CHE-1hs. dat-
1prom::rfp worms also contained gcy-5prom::gfp, which was induced in response to CHE-1hs. B) A srw-
85prom::gfp reporter that contains an ASE motif in its promoter, but is not expressed in ASE neurons 
(Etchberger et al., 2007) is not induced in response to CHE-1hs. Control worms with gcy-5prom::gfp under 
the same experimental conditions show induction. C) snb-1prom::nlsrfp is a reporter of pan-neuronal fate 
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which is induced in response to CHE-1hs in the germline. This reporter contains an ASE motif, however 
this motif is dispensable for induction in response to CHE-1hs. The same snb-1prom::nlsrfp carrying a 
mutation in the ASE motif, which stops CHE-1 from binding (Etchberger et al., 2007), is also expressed 
in a CHE-1hs dependent manner. Data for C produced by Carrera, I., and Stefanakis, N. 
 
DISCUSSION 
 We have shown that in addition to lin-53, the loss of all the defined components of the C. 
elegans PRC2 complex makes germ cells susceptible to the activity of fate specifying TFs. In 
addition, the loss of mes-4, mrg-1, and isw-1 also results in a similar phenotype, although these 
phenotypes have been studied in much less detail. Among these genes, lin-53 and the PRC2 
directly affect the deposition of H3K27me3. mes-4, an H3K36me3 methyltransferase plays a role 
in restricting H3K27me3 to genes that are repressed in the germline and its loss causes a 
reduction of H3K27me3 at these regions. mrg-1 and isw-1 phenocopy mes-4 in many respects 
and have been shown to bind H3K36me3 in many systems, suggesting that they might mediate 
the function of mes-4 in maintaining regions of concentrated H3K27me3. Thus, the phenotype 
caused by all of these genes can be explained by the reduction of H3K27me3 at somatic loci.  
 
lin-53 is a part of the C. elegans PRC2 complex 
The mes proteins were found in a genetic screen for maternal effect sterility or a 
“grandchildlless phenotype” in which a lack of maternally loaded protein causes sterility in the 
progeny.  21 mutants representing 6 loci were found in the screen and four of them, mes-2, mes-
3, mes-4, mes-6 had the same phenotype—severe underproliferation of germ cells and a 
degeneration of most of the germ cells that are born (Capowski et al., 1991; Garvin et al., 1998). 
mes-2 which is a homolog of the Drosophila Polycomb gene E(z), and mes-6, which is a 
homolog of Polycomb gene ESC, were then found to form a complex with C. elegans-specific 
protein mes-3. This complex has an estimated molecular weight of ~255kD, and as the sum of 
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the molecular weights of mes-2, 3, 6 proteins is ~230kD, they were thought to be the sole 
members of the complex. However, direct binding was only seen between mes-2 and mes-6 in 
vitro, which suggested a fourth protein might mediate mes-3 binding (Xu et al., 2001b). This 
complex was subsequently shown to be required for H3K27me2/3 deposition in the germ cells 
and embryonic somatic cells (Bender et al., 2004).  
Here we show that lin-53, a homolog of the Drosophila Nurf55 and human RbAp46/48, is 
also required for the H3K27me3 deposition in germ cells, suggesting that it is a part of the PRC2 
complex. Additionally lin-53 and PRC2 complex components show very similar phenotypes in 
response to ectopic induction of TFs. As a part of the Drosophila PRC2 complex, Nurf55 has 
been shown to be required for the nucleosome binding activity of PRC2 (Nekrasov et al., 2005). 
lin-53 in C. elegans possibly serves the same function. Additionally, as lin-53 and its homologs 
are known to interact with numerous chromatin-modifying complexes, its major function might 
be to use its WD-40 repeat domains as a scaffold to bring the multi-subunit PRC2 complex to its 
nucleosome substrates. 
 
Germline-specific phenotype of lin-53(RNAi) and PRC2(RNAi) 
 Although CHE-1hs is induced ubiquitously, lin-53 and PRC2 knockdowns lead to 
activation of ASE like fate only in germ cells. It has been previously suggested that the germ 
cells of C. elegans can be analogous to multi-potent stem cells because they retain the ability to 
self-new (Joshi et al., 2010). Similarly studies in vertebrates have shown that germ cells, if 
cultured under specific conditions, can form pluripotent stem cells (Ko et al., 2009). However, as 
defined by our TF overexpression assay, wild type germ cells of the worm, unlike the dividing 
cells in the early embryo, do not fall into the category of stem-like cells because of the inherent 
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inaccessibility of non-germline genes. Therefore, the germline specificity of the phenotype is 
probably not explained by the fact that these cells are stem cell like. Additionally, the fact that 
they are the only mitotically cycling cells in adult worms might also not influence their 
susceptibility as CHE-1 can act even after the cell cycle is blocked.  
mes-2/3/6 are expressed in all cells during early embryonic stages, however, their 
expression in the somatic cells decreases in the later stages of embryonic development and by 
immunostaining, the proteins are seen predominantly in the germline, with some expression in 
the intestine, in larvae and adult worms (Holdeman et al., 1998; Korf et al., 1998; Xu et al., 
2001a). Consequently, global reduction of H3K27me3 is only observed in germ cells and 
embryonic somatic cells in mes-2/3/6 mutants (Bender et al., 2004). And, mes-2/3/6 adults have 
predominantly normal somatic development, with the exception that mild defects have been 
observed in somatic Hox gene regulation (Ross and Zarkower, 2003). Similarly, although lin-53 
expression is ubiquitous at all stages, H3K27me3 is noticeably reduced only in the germline of 
lin-53(RNAi) animals.  
Loss of PRC2 has also been shown to increase the window of plasticity in C. elegans 
embryos in response to ubiquitous hlh-1 and end-3 expression (Yuzyuk et al., 2009), suggesting 
that loss of H3K27me3 also makes somatic cells of the ~112 cell embryo more plastic. The 
germline specificity of the phenotypes seen here could therefore either indicate that mes-2/3/6 
and lin-53 are only required for H3K27me3 deposition in the germ cells of L4s and adults, or 
that RNAi-mediated knockdown only results in a sufficient reduction of these genes in the 
germlines of L4s and adults, such that conclusion about their function in restricting fate of 
somatic cells cannot be drawn from RNAi experiments.  
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Loss of PRC2 in the context of other fate conversions 
 In mouse ESCs removal of PRC2 leads to the activation of developmental regulators and 
a loss of pluripotency, suggesting that PRC2-mediated H3K27me3 is important for maintaining 
the fate of ESCs (Boyer et al., 2006). Additionally, a loss of PRC2 function has been shown to 
decrease the efficiency of iPSC reprogramming from fibroblasts (Onder and Daley, 2012) and a 
loss of the ability of ESCs to reprogram B lymphocytes in heterokaryon experiments (Pereira et 
al., 2010). All this data suggests that in the context of the ESCs, PRC2 is required for acquiring 
and maintaining a pluripotent state. Similarly, in our experiments we observe that PRC2 is 
required for the maintenance of a germ cell fate.  PRC2 activity is not only required for the 
proper proliferation and maintenance of germ cells (Garvin et al., 1998; Holdeman et al., 1998; 
Korf et al., 1998), but, as we show here, it is  also required for ensuring that non-germline genes 
are kept in a inaccessible state in germ cells. 
 It is also important to keep in mind that proper H3K27me3 is required for proper 
specification of differentiated fates. In this respect, it would be interesting to understand the 
stability of cell types produced by the overexpression of CHE-1 and HLH-1 in PRC2 mutant 
germ cells and to determine if the converted cells that retain fairly high levels of H3K27me3 
redistribute it to a pattern that is more like that of a neuron or muscle.  
 
RNAi machinery is not required for restricting germ cell fate 
While mes-4, mes-6, mes-3, mrg-1 and isw-1 have all been shown to modulate RNAi 
pathways in the worm, none of them have been shown to be a part of the RNAi machinery. mes-
3, mes-4 and mes-6 were identified as factors that reduce the efficiency of RNAi (Dudley et al., 
2002; Kim et al., 2005). However, the molecular mechanism of this action is unknown and it 
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possible that it may be in indirect effect as the loss of these proteins results in the misexpression 
of many genes (Dudley et al., 2002; Gaydos et al., 2012; Grishok, 2005). mrg-1, and isw-1 were 
both identified in screens for factors that mediate the inheritance of RNAi, rather than RNAi 
efficiency in the first generation (Vastenhouw et al., 2006). This, in addition to the fact that no 
RNAi factors that are directly part of the RNAi machinery were identified in our secondary 
screen suggests that the RNAi pathway per se is not involved in maintaining the inaccessibility 
of somatic genes in the germline.  
 
Specificity and breadth of CHE-1 activity 
 One of the most surprising aspects of these results is the breadth and specificity of CHE-1 
activity. A similar potency is seen in the activity of hlh-1 in fibroblasts, where it has been shown 
to bind a wide variety of target genes and even activate co-activators (reviewed in Tapscott, 
2005). These assays also highlight some of the functions of CHE-1 that are not apparent in the 
endogenous context of the ASE neurons. For instance, terminal selector like TFs were thought to 
not play an important role in activating pan-neuronal genes. However, our results and extensive 
analysis of the cis-regulatory regions of pan-neuronal genes (Stefanakis et al., 2015) have shown 
that such TFs are a part of an extensively redundant network of genes that regulate pan-neuronal 
gene expression.  
Overall, the work in this chapter shows that various chromatin modifying enzymes work 
in coordination to restrict the fate of germ cells and that the state of a wildtype germline is 
actively maintained by the these dynamic interactions. We also show that the removal or 
reduction of H3K27me3 is sufficient to make genes accessible for activation. However, most of 
the genes found using RNAi screens affected the restriction of germ cells, and one affected the 
! 92!
epidermis. This could imply that disruption single chromatin factors only affects germ cells and 
the epidermis. But we think that this discrepancy is more likely a limitation of the screening 
technique. RNAi is very effective in the germline and epidermis, but even in sensitized 
backgrounds, not all tissues are responsive. Additionally, the hypodermis and germline are both 
very big tissues and therefore ectopic expression of gcy-5prom::gfp might have been easier to spot 
there in our relatively low magnification screens. Both these reasons would preclude finding 
mutations that affected smaller somatic tissues like individual neuron types. For this reason, we 
next used to candidate approach to identify genes that may coordinate the gain of a cell fate with 
the loss of plasticity in differentiating neurons.  
 
MATERIALS AND METHODS 
Strains and transgenes 
 All strains were maintained using standard procedures, unless otherwise noted. The 
following strains and transgenes were used (strains in bold were created by me): 
OH9846: otIs305 [hsp16-2prom::che-1::2xFLAG; rol-6(d)]; ntIs1 [gcy-5::gfp; lin-15(+)]  
OH10993: otEx4944 [lin-53fosmid::gfp; rol-6(d)] 
OH10994: otEx4945 [hsp16-2prom::hlh-1::2xFLAG; rol-6(d)]; mgIs25[unc-97::gfp] 
OH10821: juls14[acr-2prom::gfp]; otIs361[hsp16.2prom::unc-3] 
SS186: mes-2(bn11) unc-4(e120)/mnC1 dpy-10(e128) unc-52(e444)II 
SS262: mes-3(bn35) dpy-5(e61) I; sDp2(l;f) 
OH9209: otIs264 [ceh-36prom::tagrfp] 
OH4833: otis181 [dat-1prom::mcherry; ttx-3::mcherry] 
OH10689: otis355 [rab-3prom::nlstagrfp]  
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LX929: vsIs48 [unc-17prom::gfp] 
OH439: otIs118 [unc-33 prom::gfp]  
otEx3024: [srw-85 prom::gfp; elt-2prom::nlsgfp] 
otEx3020: [srt-63prom::gfp; elt-2prom::nlsgfp] 
OH11440: pha-1; otEx5188[snb-1ASEmutprom::NLSrfp; pBX] 
OH10003: pha-1; otEx4445[snb-1prom::NLSrfp; pBX]  
DG627: emb-30(tn377)III 
NL2096: rrf-1(pk1417)I 
OH10995: otIs377 [myo-3::mCherry] 
 Like the che-1 heat shock array otIs305 (Chapter 2), the hlh-1 heat shock array otEx4945 
is a complex array, generated by co-injection of PvuII-digested, bacterial genomic DNA (~150 
ng/µl), the hlh-1 expression construct (0.5 ng/µl) and pRF4 (2 ng/µl). In contrast to simple 
arrays, such complex arrays are not normally silenced in the germline (Tursun et al., 2009, L. 
Cochella, B.T. and O.H., unpublished data). The previously used hlh-1 transgene is a (Tursun et 
al., 2011) simple array (Fukushige and Krause, 2005). The lin-53 fosmid reporter was generated 
with 10 ng/µl lin-53::gfp fosmid, 2 ng/µl pRF4, 135 ng/µl PvuII-digested, bacterial genomic 
DNA. The lin-53 fosmid reporter was generated by fosmid recombineering(Tursun et al., 2009), 
using fosmid WRM0634aA12. This transgene does not rescue the putative null (n3368). The 
resulting transgene, again generated as a complex array, is called otEx4944. 
 
Antibody staining 
 A freeze crack antibody staining protocol on whole worms was used (Duerr, 2006). 
Worms were washed, suspended in 0.025% glutaraldehyde and spread out in between two frost-
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resistant glass slides. These slides were frozen on dry ice and cracked open to break the cuticle of 
the animals. Acetone/methanol fixation was used for most antibodies to prevent gonad extrusion. 
Freeze cracked worms were incubated for 5 min each in ice cold acetone and methanol. The 
worms were then washed off the slides in 1X PBS, blocked and stained. Blocking was done in 1x 
PBS with 0.2% gelatin and 0.25% Triton for 30 min at room temperature. Antibodies were 
diluted in 1x PBS containing 0.1% gelatin and 0.25% Triton. Primary antibody was left on 
overnight at 4°C and secondary antibody was applied for 3 hours at room temperature. After 
washing off the secondary antibody, worms were incubated with DAPI for 15 minutes, washed 
again and mounted on glass slides. Primary antibodies used were: RIM2 (developed by Michael 
Nonet; obtained from the Developmental Studies Hybridoma Bank; used 1:10 with 3.5% 
paraformaldehyde fixation) anti-PGL-1 (rabbit polyclonal antibody: 1:500, gift from Susan 
Strome); P-granule component monoclonal antibody OIC1D4 (developed by Susan Strome; 
obtained from the Developmental Studies Hybridoma Bank; used 1:5), anti-HIM-3(1:500, gift 
from Monique Zetka), Kettin MH44 antibody, described in (Francis and Waterston, 1985), was 
obtained from Pamela Hoppe and used at 1:250, H3K27me3 (Millipore, 1:500), anti-UNC-120 
antibody (a gift from Michael Krause, used with 3.5% paraformaldehyde fix at 1:10 dilution), 
anti-HA (Roche,1:50 with paraformaldehyde fixation), anti-FLAG (Sigma, paraformaldehyde 
fixation). All secondary antibodies were Alexa Flour dyes used at 1:1000 dilution. 
 
smFISH and microscopy 
smFISH was performed using Custom StellarisTM FISH probes, purchased from 
Biosearch Technologies and staining was done according to the manufacturers protocol. 




 Transgenic worms expressing heat-shock inducible che-1, hlh-1, or unc-3 and various 
fate markers in either the N2 wildtype background or mutant backgrounds (emb-30 or rrf-1) were 
transferred to plates that were seeded with bacteria containing specific RNAi clones against 
either lin-53, mes-2, mes-3 or mes-6 at the L4 stage. F1 progeny of these worms that are born on 
RNAi were heat-shocked at the L3 to young adult stage by incubating them at 37°C for 30 min. 
Heat-shocked worms were kept at 25°C overnight and scored the following day. emb-30 mutants 
were grown at 15°C, shifted to 25°C for 8hr when F1 progeny on RNAi plates were at the L3-
young adult stage, heat shocked at 37°C, then kept overnight at 25°C and scored the next day. 
 
Cell cycle arrest by hydroxyurea treatment 
HU treatment was performed as described previously (Fox et al., 2011). In brief, plates 
were seeded with MG1693 bacteria that incorporated 5-ethynyl-2’-deoxyuridine. To access cell 
cycle arrest, hydroxyurea, at a final concentration of 250 µM, was added to some of the plates. 
L4 animals, grown on OP50, were moved to the HU treated and untreated EdU-labeled bacteria 
plates. After 5 hours, these animals were washed off, freeze cracked on poly-L-lysine coated 
slides, fixed with 3% paraformaldehyde, and DAPI stained. Following this, the EdU detection 
reaction, which labels EdU with an alexa-fluor dye, was performed using an EdU labeling kit 
(Invitrogen). 
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CHAPTER 4: Terminal selector transcription factors orchestrate cell fate restriction in 
addition to specification 
 
SUMMARY 
 Cell fate specification is coordinated with the acquisition of fate-specific chromatin 
landscapes. Differentiated cells contain fate-specific domains of chromatin modifications that 
characterize active and inactive loci. The presence of such chromatin domains ensures the 
accessibility of genes required for a specific cell fate while restricting access to genes that are not 
required for that fate. How the formation of repressed chromatin is coordinated with fate 
specification is not well understood. In this chapter we show that the activity of fate-specifying 
terminal selectors is required for the restriction of non-fate genes. When CHE-1 is ubiquitously 
expressed in wildtype L4s and adults, it cannot access target genes in many neuron types. In 
mutants of various terminal selector TFs, this barrier is removed and CHE-1 can activate target 
genes in affected cell types. We further found that one of these terminal selectors, unc-3, might 
mediate the repression of unexpressed genes by ensuring the correct distribution of H3K9me3. In 
sum, the data in this chapter suggests that terminal selector TFs coordinate the activation of fate-
specific genes with the formation of repressive chromatin on unrequired genes. 
 All of the experiments in this chapter were designed and performed by me. The CRISRP 
engineered tag on unc-3(n3413) was build in collaboration with John Kerk, another graduate 
student in the lab. The data presented in this chapter along with some of the data in Chapter 2 





 As fate-specific transcriptional programs are activated, differentiating cells acquire 
unique heterochromatin and euchromatin signatures. Among other features, the heterochromatin 
on silent genes is characterized by H3K27 methylation and H3K9 methylation, whereas the 
euchromatin on active genes is characterized by H3K4 methylation and various acetylation 
marks on H3 and H4 (reviewed in Rothbart and Strahl, 2014; Zhang et al., 2015). In many cases, 
the functional relevance of the histone modifications is inferred from the loss of function analysis 
of the enzymes that deposit, remove, or bind to these marks. In the case of H3K27me3, the loss 
of its histone methyltransferase and the loss of the modification itself result in the same 
phenotype, i.e., de-repression of developmentally regulated genes (Pengelly et al., 2013). 
H3K9me3, on the other hand, is enriched on repetitive DNA and is required for maintaining 
genome stability in every cell type. Nevertheless, some H3K9me3 is also localized to loci in a 
cell-type-specific manner, and its function has also been shown to be required for repressing a 
few developmentally regulated genes (Becker et al., 2015; Ho et al., 2014). A mark of active 
transcription, H3K4me, seems to be important to recruit TFs to their binding sites and thus 
contribute to gene activation (Lupien et al., 2008; Wapinski et al., 2013). Other active histone 
modifications act structurally to loosen the chromatin (Rothbart and Strahl, 2014). The 
identification of new histone modifications and the enzymes that deposit, remove, and read them, 
is a continuing field of study that highlights the complexity of establishing and maintaining cell-
type-specific transcriptional programs.  
Given the diversity of known histone modifications, a question of great interest is how 
active and repressive marks are localized to the correct loci in a given cell type. In this regard, 
genomic analysis of TF binding profiles along with maps of chromatin accessibility and histone 
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modifications have revealed that the deposition of euchromatic marks in differentiated cells is 
partially coordinated by TFs that bind specific DNA sequences (reviewed in Iwafuchi-Doi and 
Zaret, 2014; Natoli, 2010; Zaret and Mango, 2016). Some of these TFs are called pioneer factors 
as they can bind nucleosome occupied cis-regulatory regions and subsequently facilitate 
nucleosome remodeling, changes in histone modifications, and the binding of more TFs 
(reviewed in Iwafuchi-Doi and Zaret, 2014; Zaret and Carroll, 2011; Zaret and Mango, 2016).  
One example of such a pioneer TF is Zelda, the maternal Zn-finger TF, which 
coordinates the transition from maternal to zygotic gene activation in Drosophila embryos 
(Liang et al., 2008). Zelda is expressed in the early embryo before most other TFs and binds to 
~10,000 genomic loci that are contain the Zelda binding motif. This binding changes the histone 
modifications and accessibility of many of these loci, which then facilitates the binding of other 
patterned TFs, resulting in robust gene expression patterns (Foo et al., 2014; Harrison et al., 
2011; Nien et al., 2011; Sun et al., 2015). Similarly, the binding of PU.1 in macrophages and 
FoxA homolog pha-4 in C. elegans leads to nucleosome remodeling and the acquisition of 
enhancer-specific histone modifications (Fakhouri et al., 2010; Ghisletti et al., 2010; Heinz et al., 
2010). PU.1 is shown to bind ~40,000 genomic sites; about 20% of these are at transcription start 
sites, and ~80% are at genomic regions that show enhancer-specific histone signatures, 
suggesting that these binding events are likely to be biologically relevant (Ghisletti et al., 2010; 
Heinz et al., 2010). Such widespread binding by a single TF has lead to the hypothesis that 
certain TFs might function as organizers of fate-specific active chromatin (Natoli, 2010).  
TFs that regulate the formation of euchromatin landscapes have been easier to spot as 
their loss leads to the loss of a fate, or as in the case of Zelda, the inability to start zygotic 
transcription. However, much less is known about the organization of cell-type-specific 
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heterochromatin, as it is possible that the loss of these regulators would not necessarily lead to 
the de-repression of numerous genes under wildtype conditions. The loss of heterochromatin 
would simply makes genes accessible for activation, but a phenotype would only be obvious if 
trans-activators are also present in the cell to transcribe these genes. For instance, the B cell 
regulator Pax5, has been found to be required for H3K27me3 deposition at specific loci, as these 
loci do get derepressed and transcribed in Pax5 mutant cells (Xu et al., 2008). The role of other 
TFs has been suggested by computational analysis which shows that H3K27me3 regions are 
often enriched for binding sites of fate-specifying TFs (Pinello et al., 2014). And, recruitment of 
Groucho co-repressors by TFs has been shown to lead to compaction of nucleosomes and histone 
deacetylase recruitment (Sekiya and Zaret, 2007). These examples suggest that TFs may play an 
important role in the formation of heterochromatin. But, general principles about how the 
formation of cell-type-specific heterochromatin is coordinated genome-wide are lacking. 
 Our finding that cells lose their receptivity to ectopically expressed TF CHE-1 after 
differentiation (Chapter 2) led us to hypothesize that the loss of cellular plasticity might be 
coordinated with the acquisition of a terminal identity. In C. elegans, the terminal identities of 
many neurons are established by single or groups of terminal selector TFs. These TFs are 
generally expressed after the terminal cell division and are required for both the activation and 
maintenance of fate-specific gene batteries (Hobert, 2011). We asked whether these terminal 
selector TFs might also facilitate the process of cell fate restriction, thereby coordinating it with 
terminal differentiation. If this were the case, in the absence of a terminal selector gene, a cell 
would remain in a more plastic state, and in our experimental paradigm, retain its receptivity to 
CHE-1. Alternatively, if an independent mechanism triggers the process of cell fate restriction, 
cells would lose their receptivity to CHE-1 regardless of the presence of the terminal selector.  
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 We tested these alternative hypotheses by expressing CHE-1 in mutants of TFs that act as 
terminal selectors of specific neurons. We find that five out of seven neuron types tested show 
increased receptivity to CHE-1hs in terminal selector mutants. This suggests that terminal selector 
TFs do coordinate the acquisition of a cell fate with fate restriction. Additionally, we find that 
three of three tested TFs, which do not act as terminal selectors but regulate expression of 
smaller subsets of genes, do not show this phenotype, suggesting that this function may be 
limited to TFs that play a broad role in fate specification. We further found that the function of 
one of these terminal selectors, unc-3, might be mediated through the H3K9me3 histone 
modification and the methyltransferase met-2. Further experiments to establish the nature of this 
regulation are ongoing. Overall, the work discussed in this chapter opens up the exciting 
possibility that fate-specifying TFs mediate the organization of fate-specific repressed chromatin. 
This work also highlights the value of overexpression assays in understanding heterochromatin 
organizers, which have otherwise been difficult to find. 
 
RESULTS 
Cholinergic motor neurons of unc-3 mutants retain plasticity 
To test the hypothesis that terminal selector like TFs co-ordinate the gain of a terminal 
fate with the loss of plasticity, we induced CHE-1hs in unc-3 mutants. unc-3 is a COE TF that 
acts as the master regulator for A/B-type and AS cholinergic motor neuron (MN) fate (Kratsios 
et al., 2012; Prasad et al., 1998). unc-3(-) cholinergic Mns are born and found in approximately 
their wildtype positions in the ventral nerve cord (VNC), retro-vesicular ganglion (RVG), and 
pre-anal ganglion (PAG) of the worm; they also express pan-neuronal fate markers and form 
axonal projections. However, these neurons lack expression of all the acetylcholine pathway 
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genes, numerous other fate-specific terminal identity genes, show defects in synaptogenesis and 
are non-functional. To test if such unc-3(-) neurons retain plasticity, we induced CHE-1hs in 
wildtype and unc-3 mutant worms and scored the expression of gcy-5prom::gfp in the RVG, VNC, 
and PAG. In addition to fifty unc-3 dependent Mns, these ganglia contain 19 GABAergic MNs 
and 13 other unc-3 independent neurons (Figure 4-1a).  To decrease the ambiguity in scoring, we 
used a red fluorescent GABAergic marker in the background and counted the number of gcy-5+ 
cells that were non-GABAergic. Since about half of the unc-3 dependent neurons are born in the 
L2 stage and remain plastic till early L3, CHE-1hs activity was scored in L4, and adult mutants 
vs. wildtype MNs. We found that a significantly higher number of unc-3 mutant neurons express 
gcy-5prom::gfp as compared to wildtype at both developmental stages (Figure 4-1b). gcy-
5prom::gfp expression in the MNs was not seen when unc-3(-) worms were heat shocked in the 
absence of the hsprom::che-1 transgene. Similar results were obtained when expression of gcy-
5fosmid::rfp was scored in response to CHE-1hs induction in L4s (Figure 4-1c). 
To check the breadth of CHE-1hs activity, we also tested the activation of other CHE-1 
target genes in the VNCs of unc-3 mutants. Genes that showed increased induction after L4 
CHE-1hs in unc-3 included the glutamate transporter eat-4fosmid::yfp, the homeodomain TF ceh-
36fosmid::yfp, and the ciliary protein ift-20prom::rfp. No induction of gcy-6fosmid::gfp or gcy-
7prom::rfp was seen in wildtype or unc-3(-) neurons, which is consistent with the idea that che-1 
may not be sufficient for the ectopic induction of these genes, as discussed in Chapter 2 (Figure 
4-1c, gcy-6/7 not shown).  
As the transgenic markers that show increased induction in unc-3(-) neurons are 
randomly integrated into the different chromosomes of worm, this phenotype suggests that 









Figure 4-1: Several 
CHE-1 targets remain     accessible in unc-3 
mutant cholinergic MNs  
A) A schematic representation of the neurons in the 
RVG, VNC, and PAG of the worm. The white and blue 
neurons are unc-3 dependent. In most heat-shock 
experiments with unc-3 mutants, unc-47prom::rfp, a 
marker of GABAergic fate is used in the background 
and only unc-47prom::rfp(-) neurons are scored. With the 
exception of 6 VC and 13 other neurons, this strategy 
ensures that the 50 unc-3 dependent cholinergic MNs 
are predominantly scored. B) Images of wildtype and 
unc-3 worms with and without CHE-1hs. A 
quantification of this data is presented in the right panel. 
Every dot in these plots represents an individual worm. 
The entire RVG, VNC, and PAG of the worm was scored, unless otherwise noted. A significantly higher 
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number of gcy-5prom::gfp neurons are seen in unc-3 mutants as compared to wildtype when CHE-1hs is 
induced either at L4 or adult stage. No gcy-5prom::gfp neurons are seen in unc-3 mutant worms that get 
heat-shocked but do not contain the heat-shockprom::che-1 array. C) Expression of various other markers 
is similarly seen in significantly higher number of neurons in unc-3 mutants as compared to wildtype. 
Some markers are scored in the anterior and posterior regions of the worm, as represented in (A). These 
worms were heat-shocked at the L4 stage. The student t-test is used, ***= p<.0001, n.s.= p>.01. 
 
 
mechanistic explanations for this phenotype are the following: first, unc-3 activity may be 
required to make the chromatin at these genomic loci inaccessible; or unc-3 may simply be 
regulating expression of a transcriptional co-factor of CHE-1. Before addressing these 
possibilities, we first wanted to ensure that this phenomenon is not reflective of a specific 
interaction between unc-3 and che-1, but rather a general characteristic shared by terminal-
selector-like TFs. 
 
Other terminal selectors are also required for fate restriction 
We checked the expression of gcy-5prom::gfp and gcy-5fosmid::gfp in response to adult 
CHE-1hs in six additional neuronal terminal selector mutants. Four of the six mutants showed a 
phenotype similar to unc-3. These were the ETS-domain-TF ets-5, and homeodomain-TFs ceh-
14, ttx-1 and lin-11. Expression of both gcy-5prom and gcy-5fosmid were detected in all cases and 
the gcy-5fosmid::gfp expression is reported here. The neurons differentiated by these TFs are found 
in neuron dense regions of the head and the tail of the worm; a separate red fluorescent marker 
was therefore used to label a neighboring neuron, to disambiguate and correctly identify the 
neuron of interest. In ets-5 mutants, the CO2 sensing BAG neurons lose their terminal identity 
(Guillermin et al., 2011). In our assay, 30% of them express gcy-5fosmid::gfp in response to adult 
CHE-1hs as opposed to 4% of wildtype BAG neurons (Figure 4-2a). Similarly, in ttx-1 mutants, 
thermosensory AFD neurons lose their terminal identity (Satterlee et al., 2001; Serrano-Saiz et 
al., 2013) and 23% of ttx-1(-) AFD neurons express gcy-5fosmid::gfp after adult CHE-1hs whereas 
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2% of wildtype AFD neurons do (Figure 4-2b). ceh-14 acts as a terminal selector for several tail 
neurons. Among these, only the glutamatergic interneuron DVC can be unambiguously 
identified. This neuron shows activation of gcy-5fosmid in 38% of ceh-14(-) worms, as opposed to 
0% in wildtype. Additionally, since the other ceh-14 dependent tail neurons (the PHAs, PHBs, 
PHCs, and PVR) cannot be individually identified, the total number of gcy-5fosmid expressing 
neurons after adult CHE-1hs was counted in the tails of wildtype and ceh-14 mutants. We found 
an average increase of 5 gcy-5fosmid(+) neurons in the tails of ceh-14 mutants as compared to 
wildtype animals (Figure 4-2c). Lastly, lin-11 is required for terminal fate specification of ASG 
neurons (Serrano-Saiz et al., 2013), and preliminary results suggest that gcy-5fosmid::gfp can be 
activated in the lin-11 mutant ASG neurons, but not wildtype ASG neurons (Figure 4-2d).    
Unlike unc-3, the loss of these additional terminal selector genes does not lead to a 
complete elimination of the terminal gene expression in mutant neurons. All of these terminal 
selectors work synergistically with additional known and unknown co-factors to specify the 
respective neuronal fate (Van Buskirk and Sternberg, 2010; Guillermin et al., 2011; Sarafi-
Reinach et al., 2001a; Serrano-Saiz et al., 2013). Since the loss of single TFs was sufficient to 
elicit a phenotype in all these cases, a double mutant was only checked for the AFD neuron. Here 
ttx-1 acts with ceh-14 for fate specification (Van Buskirk and Sternberg, 2010; Satterlee et al., 
2001; Serrano-Saiz et al., 2013). An increase in the proportion of neurons that express gcy-
5fosmid::gfp was observed in the double mutant compared to a ttx-1 single mutant (34.3 % in ttx-1; 
ceh-14 as opposed to 23% in ttx-1); however, as there is an inherent variability in the phenotype, 
and the wildtype animals scored with the double mutants also showed a slight increase (4.8% as 
opposed to the 2% average seen before), it is difficult to assign biological significance to this 


















Figure 4-2: Affected neurons of 4 
other terminal selector mutants 
show increased susceptibility to 
CHE-1hs 
CHE-1hs was induced in adults for all 
experiments except lin-11, for which 
L4s were heat-shocked for technical 
reasons. The markers in red are used 
to correctly identify the neuron of interest. A) gcy-5fosmid::gfp is more accessible for activation by CHE-1hs 
in BAG neurons of ets-5 mutants. B) gcy-5fosmid::gfp is more accessible for activation by CHE-1hs in AFD 
neurons of ttx-1 mutants. C) gcy-5fosmid::gfp is more accessible for activation by CHE-1hs in DVC, and a 
few other unidentifiable neurons of ceh-14 mutants. D) gcy-5fosmid::gfp is more accessible for activation 
by CHE-1hs in ASG neurons of lin-11 mutants. E) The phenotype in the AFD neurons remains partially 
penetrant in ttx-1; ceh-14 double mutants, similar to ttx-1 single mutant. All error bars represent SEM. 
The data in A-C represent a combination of three biological replicates. The student t-test is used, ***= 
p<.0001, n.s.= p>.01. 
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Overall, these results suggest that numerous terminal selector genes play a role in 
restricting the activity of ectopically expressed CHE-1. As for the potential mechanism, it is 
difficult to prove that all of these factors do not regulate a co-activator or repressor of CHE-1, 
but the generality of the phenomenon and variability seen in the phenotype supports the idea that 
the accessibility of the target gene as apposed to the regulation of transcriptional activator or 
repressor is at play.  We also favor this mechanism based on the results seen when che-1 is 
continuously expressed under the control of pan-neuronal or pan-sensory promoters (Chapter 2). 
In these cases, che-1 is expressed in neurons throughout the life of the worm starting shortly after 
terminal division. And, this leads to the transcription of gcy-5prom::gfp, gcy-5fosmid::rfp, and ceh-
36fosmid::yfp throughout the life of the worm in diverse neuron types. If other neuronal terminal 
selectors were regulating a co-factor of che-1, then the CHE-1 expressed using heterologous 
promoters would only activate target genes for a short time while terminal differentiation was 
taking place, and then become inactive. The ability of che-1 to continue to activate target genes 
in diverse neuron types, suggests that terminal selector dependent co-activators or co-repressors 
are not playing a role.   
Two terminal selector mutants, the homeodomain TFs unc-30 and unc-42 did not share 
this phenotype. unc-30 is the terminal selector for GABAergic motor neurons in the VNC and 
unc-42 is the terminal selector for ASH sensory neurons (Baran et al., 1999; Cinar et al., 2005; 
Jin et al., 1994; Serrano-Saiz et al., 2013). Higher induction of neither gcy-5prom::gfp, nor ceh-
36fosmid::yfp was not detected in the VNC in response to CHE-1hs  in the GABAergic MNs of 
unc-30 (Figure 4-3a, data only shown for ceh-36fosmid::yfp). In the case of unc-42 also, neither 
gcy-5fosmid::rfp, nor ceh-36fosmid::yfp was detected in the ASH neurons (Figure 4-3b, data only 
shown for gcy-5fosmid::rfp). Expression of che-1 early in the development of GABAergic MNs 
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and ASH neurons does lead to activation of target genes, based on tissue-specific promoter 
driven expression of che-1 (Chapter 2, Figure 2-7). Additionally, activation of CHE-1hs in 
L4s/adults results in the expression of gcy-54XASE::gfp in both sets of neurons (Figure 4-3c, d). 
This means that CHE-1 is competent to activate target genes in these neurons while they are 
differentiating and that its activity as a TF is uncompromised in these neurons during the adult 
stage. Therefore, the inability of CHE-1 to activate target loci at later larval and adult stages 
suggests an inability to access them. While unc-30 and unc-42 are required for terminal 
differentiation, it seems that they are dispensable for a loss of plasticity to occur. The phenotypes 
of the respective mutant neurons suggest that unc-30 and unc-42 also work with unidentified co-
















Figure 4-3: Two terminal selectors, unc-30 
and unc-42 do not restrict the ability of CHE-
1hs to activate target genes 
CHE-1hs was induced in adults for all experiments. 
) An average increase of ceh-36fosmid::yfp 
expression is seen in 2 neurons in unc-30 compared to wildtype worms. As there are 19 total unc-30 
dependent neurons, this difference does not seem biologically significant. Every dot in the graph 
represents an individual worm. B) No gcy-5fosmid::rfp expression is seen in the ASH neurons of unc-42 
mutants. C) gcy-54XASE::gfp can be induced in wildtype GABAergic neurons after CHE-1hs induction in 
adults, showing CHE-1 is functional as a TF in these neurons. D) gcy-54XASE::gfp can be induced in 
wildtype ASH neurons after CHE-1hs induction in adults. 
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TFs that regulate small subsets of genes are not required for cell fate restriction 
 To further understand the mechanism behind the activity of terminal selectors in 
restricting cell fates, we continued to perform experiments in the unc-3 dependent cholinergic 
MNs. As unc-3 is required broadly for both cholinergic MN fate specification and function, we 
asked if TFs that regulate expression of smaller groups of genes also contribute to the restriction 
of plasticity. The unc-3 dependent cholinergic MNs include six subtypes of MNs; the 
diversification of these MNs is achieved in part by the activity of various subtype-specific 
repressors. Ongoing work in our lab, in addition to work done in other labs, suggests that the 
paired homeodomain TF unc-4, the nuclear receptor TF unc-55, and the T-box TF mab-9 are 
expressed in specific MN subtypes where they are required for repression of other subtype-
specific genes. In contrast to the activity of the tested terminal selector TFs, the function of these 
subtype TFs is primarily repressive. However, the loss of these TFs does result in fate disruption 
in neurons with mixed subtype identities and subsequent functional defects, making these results 
informative. In unc-4 mutants, VA neurons express a VB marker (acetylcholine receptor, acr-5) 
and show a disconnection from their usual pre-synaptic partners, which results in a loss of 
backward locomotion (Miller and Niemeyer, 1995). Similarly, mab-9 is required to prevent 
VA/VB fate in DAs and DBs, and works redundantly with unc-55 to prevent VA/VB fate in AS 
neurons (ongoing work from John Kerk, Sze in our lab). Neither unc-4 mutants, nor unc-55; 
mab-9 double mutants, however, show increased induction of gcy-5prom::gfp in response to CHE-
1hs in the cholinergic MNs, suggesting that they do not play a role in restricting plasticity (Figure 
4-4). Since the loss of these transcription factors causes a loss of function in affected neurons, 



















































































Figure 4-4: Loss of three TFs that specify subtype-specific fates in cholinergic MNs is not 
sufficient to make these neurons susceptible to CHE-1hs activity 
L4 worms were heat-shocked for all experiments. mab-9;unc-55 double mutants and unc-4 mutants are 
not significantly different from wildtype and are significantly different from unc-3. Every dot in the graph 
represents an individual worm. The student t-test is used, ***= p<.0001, n.s.= p>.01. 
 
DNA binding domain of unc-3 is required for its function in cell fate restriction  
unc-3 elicits most of its known function in cholinergic MN development by directly 
binding to and activating target genes. Therefore, we wondered if the DNA binding domain of 
unc-3 is also required for its function in restricting cell fate. To this end, we used an unc-3 allele 
(n3413) that has a point mutation in the conserved Arginine 166 of the DNA binding domain. 
This residue corresponds to Arginine 163 in the human ortholog Ebf, which has been shown to 
be required for DNA binding and transcriptional activation (Fields et al., 2008; Siponen et al., 
2010). Induction of CHE-1hs in L4 unc-3(n3413) worms resulted in the activation of gcy-
5prom::gfp in significantly more affected neurons than wildtype (Figure 4-5a). Additionally, the 
activation in this allele was not significantly different from the e151 early stop allele used for all 
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other experiments. This data suggests that the DNA binding domain of unc-3 is required for its 
activity in the context of cell fate restriction. In collaboration with John Kerk, we also engineered 
CRISPR alleles in which the wildtype unc-3 and unc-3(n3413) proteins are tagged with 
mNeonGreen. Both the wildtype and mutant proteins show expression in the VNC suggesting 
that the mutant UNC-3::MNEONGREEN protein is expressed (Figure 4-5b). Assuming that the 
Arg163Trp mutation does not lead to the destabilization of the rest of the protein, this data 
indicates that the DNA binding domain of UNC-3 is required for its function in restricting cell 
fate.  
 
Figure 4-5: A mutation in the 
unc-3 DNA-binding domain is 
sufficient to make cholinergic 
MNs susceptible to CHE-1hs 
activity 
A) Phenotypes of unc-3(e151) and 
unc-3(n3413) are not significantly 
different. e151 is the canonical 
allele of unc-3, which is used in all 
other experiments in this thesis, it 
encodes an early non-sense 
mutation. n3413 encodes a point 
mutation in the DNA-binding 
domain. The student t-test is used, 
***= p<.0001, n.s.= p>.01. B) 
mNeonGreen tag added to the 
endogenous unc-3 wildtype 
protein and unc-3(n3413) protein. 
Both are 























































Change in H3K9me3 levels on gcy-5 reporter transgene in unc-3 mutants 
Our working hypothesis is that terminal selector activity contributes to the formation of 
heterochromatin on genes that are not required for a specific cell fate. A simple schematic model 
of such a mechanism is presented in Figure 4-6. This model predicts that a terminal selector like 
unc-3 would either activate target genes, or function in protein complexes, that direct the 
deposition of histone modifications and other chromatin associated proteins to genes that are not 
expressed. In our experimental paradigm, the activity of unc-3 would be required to ascertain the 
formation of repressive chromatin on the gcy-5::fp reporter locus, such that when CHE-1 is 
expressed, it cannot activate its expression. Consequentially, this model would predict that there 
should be a difference in the chromatin state of the gcy-5 locus in wildtype vs. unc-3 mutants. 
We wanted to check if this difference is reflected in the levels of H3K27me3 and H3K9me3 
present at the gcy-5 locus, since these are reliable markers of repressed chromatin.  According to 
our model, levels of these modifications would be decreased on a gcy-5 reporter in an unc-3 


















Figure 4-6: A simple model for the function of terminal selectors in restricting cell fate 
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unc-3 is being used as a representative terminal selector in this model. In the wildtype condition, unc-3 
activates its target genes and specifies the cholinergic MN fate. We hypothesize that in addition to doing 
this, it mediates the formation of heterochromatin on all the genes that are not required for the cholinergic 
MN fate, thus stopping ectopically expressed TFs, like CHE-1, from activating their target genes. unc-3 
could be performing this function directly or indirectly in many ways, by either transcriptional regulation 
of specific target genes or by protein-protein interaction. Regardless of the mode of function, in unc-3 
mutants, the heterochromatin state at non-cholinergic MN genes would be affected, as these genes are 
now accessible for activation. This is depicted here as the loss of chromatin binding factors, which could 
include changes in histone modifications. 
 
Ideally, this experiment would be performed using ChIP-seq or ChIP-qPCR; however, 
since we are looking for a fate-specific phenotype in a small number of neurons, ChIP on whole 
worms would not provide reliable results. And, while specific nuclei can be purified from whole 
worms (Steiner et al., 2012), this method had not been optimized until recently in our lab and 
may still not provide enough material for ChIP experiments. This being the case, we decided to 
use the bacterial LacI/LacO system to tag a gcy-5prom::rfp transgene and use 
immunofluorescence microscopy to estimate the presence of H3K27me3 and H3K9me3 at this 
transgenic locus (Meister et al., 2010b). To do this, we created a repetitive transgene containing 
gcy-5prom::rfp and bacterial LacO sites which was randomly integrated into the genome. These 
transgenic worms also carry a separate transgene to ubiquitously express a LACI::GFP fusion 
protein. Thus in every nucleus of this worm, the LACI::GFP binds to the LacO sites surrounding 
the gcy-5 reporter, thereby labeling the gcy-5 transgenic loci as two green dots (Figure 4-7a). 
Immunostaning against H3K27me3 and H3K9me3 were performed on these transgenic animals 
and by quantifying the colocalization between the green dots and the histone staining, a relative 
measure of the enrichment of these histone marks in wildtype and unc-3 VNC neurons was 
obtained. Only about 50% of the ventral nerve cord neurons are unc-3 dependent, so even if there 
is a change in histone modifications, it would not be apparent in all scored neurons. 
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During the larval stages, the LACI::GFP dots on two independently integrated gcy-
5prom::rfp arrays were present in a compact form at the nuclear periphery in all cells, even in the 
ASER, where it is expressed normally (Figure 4-7b). This may suggest that the gcy-5 arrays got 
integrated into gene poor regions of the chromatin. We also made LacO arrays using an unc-3 
dependent reporter, ace-2prom::rfp, as a control. In this case, the structure and localization of the 
array depended on its transcriptional state—in cells where ace-2prom::rfp is expressed, the dots 
are diffused and located in the nuclear lumen, while in cells where it is not expressed, the dots 
are compact and located at the nuclear periphery (Figure 4-7c). This may suggest that the 
location and compaction of the arrays is a feature inherent to each promoter. However, the 
influence of the surrounding chromatin is difficult to parse out with just two independent 
integrants.  
Nevertheless, as we knew that the gcy-5prom::rfp LacO array was transcriptionally active 
and noted that induction of CHE-1hs in these worms lead to ectopic expression reminiscent of 
other gcy-5 reporters (not shown), we proceeded to perform experiments with this array.  As 
explained above, we tested if levels of H3K27me3 or H3K9me3 were different on the gcy-5 
LacO array in wildtype vs. unc-3 MNs. This analysis showed that the gcy-5 LacO array showed 
high overlap with H3K27me3 but low overlap with H3K9me3. However, the colocalization of 
H3K27me3 with the gcy-5 LacO array looked the same on both wildtype and unc-3 mutant 
neurons (Figure 4-7d). The localization of H3K9me3, on the other hand, did show a significant 
difference between the wildtype and unc-3(-) MNs. We found that colocalization between 
H3K9me3 and the gcy-5 LacO array was reduced in unc-3(-) MNs compared to wildtype MNs 
(Figure 4-7d). This difference was significant and was observed in two biological replicates. 
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locus might make it accessible for activation by CHE-1hs in unc-3 mutants. This may be part of 
the regulation that terminal selectors use to restrict cell fate plasticity. We also note that the 
transgenic array used in this experiment may not reflect the status of the genomic locus, but it did 




















Figure 4-7: Visualizing a gcy-5prom::rfp transgenic locus with LacI/LacO spot assay 
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A) Schematic representation of the spot assay. A transgene containing a gcy-5prom::rfp reporter and LacO 
binding sites is integrated into the genome of worms that ubiquitously express LACI::GFP. In the 
resulting transgenic worm every nucleus contains two GFP spots representing the LACI::GFP bound to 
the gcy-5 LacO array. The structure and location of this locus can be visualized by GFP, and these worms 
can be stained for histone modifications. An overlap between the histone modification and the GFP spots 
are representative of the histone modifications present on the gcy-5prom::rfp reporter. B) The gcy-5 arrays 
localize to the nuclear periphery in all cells in which expression was checked, including the ASEs. The 
array is transcriptionally active in the ASER, as evident by the presence of RFP, suggesting that this locus 
localizes to the nuclear periphery regardless of its transcriptional state. 2 independent array integrants 
were checked, one is shown here. C) ace-2prom::rfp LacO arrays built in a identical way show sub-nuclear 
localization that correlates to its transcriptional state. In cells that express ace-2prom::rfp, as seen by the 
presence of RFP (yellow arrows), the GFP spots are diffused and in the nuclear lumen, suggesting that the 
locus is decompacted. In cells that do not express ace-2prom::rfp (magenta arrows), the GFP spots are 
compact and localized to the nuclear periphery. 2 independent array integrants were checked, one is 
shown here. D) Immunostaining of H3K27me3 and H3K9me3 on the gcy-5prom::rfp LacO array. L4s were 
scored. Each dot represents a single nucleus in the VNC. For technical reasons, a GABAergic marker 
could not be used in the background, therefore only about 2/3 of the neurons scored are relevant. 
H3K27me3 levels are high, but remain unchanged between wildtype and unc-3, H3K9me3 levels are 
reduced in unc-3 mutants in two biological replicates. The student t-test is used, *=p<.01, **=p<.001, 
***= p<.0001, n.s.= p>.01. 
 
H3K9 and H3K27 methyltransferases are required for cell fate restriction 
  We next sought to investigate if H3K9me3 indeed plays a role in restricting CHE-1 from 
activating its target. To do this, we tested mutants of SET domain proteins met-2 and set-25, 
which have been shown to be required for H3K9 methylation in C. elegans embryos. met-2 
mutant embryos lack H3K9me1/2/3 whereas set-25 embryos lack H3K9me3 (Towbin et al., 
2012). If H3K9me3 plays a role in decreasing the accessibility of a gcy-5prom::gfp, then this locus 
should remain more accessible in met-2 and set-25 mutants. We found that induction of CHEhs 
does lead to increased activation of gcy-5prom::gfp in the cholinergic MNs of met-2 single 
mutants and met-2 set-25 double mutants, but not in set-25 single mutants (Figure 4-8a).  This 
induction was not as strong as the one observed in unc-3 mutants, so we asked how unc-3 
genetically interacts with met-2 and set-25. To answer this, we checked CHE-1hs dependent 
induction of gcy-5prom::gfp in met-2; unc-3, set-25; unc-3 and met-2 set-25; unc-3 double and 
triple mutants. None of these double and triple mutants show an additive effect. While there is a 
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statistically significant difference in the number of gcy-5prom::gfp(+) cells in met-2; unc-3 and 
met-2 set-25; unc-3 compared to unc-3 single mutants, the average increase was ~2 gcy-
5prom::gfp (+) cells (Figure 4-8b), which, given the variability of this assay is difficult to 
interpret. Overall, these data seem to suggest that met-2 and unc-3 act in the same pathway rather 
than in parallel pathways.  
 
Figure 4-8: met-2, an H3K9 
methyltransferase, and mes-2, an 
H3K27 methyltransferase are 
required for restricting the fate of 
cholinergic MNs 
CHE-1hs was induced at L4. The data in A 
and B cumulatively represents three 
independent heat-shock experiments in 
which all genotypes were scored together. 
The experiment in C has only been 
performed once. Every dot represents an 
individual worm. A) Both met-2 and set-25 
mutants have significantly more gcy-
5prom::gfp expressing cholinergic MNs 
compared to wildtype. However, for set-25 







































































































the increase is only modest, and a met-2 set-25 double mutant is not significantly different from met-2, 
suggesting met-2, has a greater role in making the gcy-5prom::gfp locus inaccessible to CHE-1. B) An 
additive phenotype is not evident in met-2; unc-3, set-25; unc-3, or met-2 set-25; unc-3, suggesting that 
these factors might act in the same pathway to restrict the accessibility of gcy-5prom::gfp. A statically 
significant difference is seen in met-2; unc-3, and met-2 set-25; unc-3 compared to unc-3, but the average 
increase is only that of 2 cells, the biological significance of which is unclear. C) mes-2 mutants also 
show increased induction of gcy-5prom::gfp in response to CHE-1hs. The induction in mes-2 mutants is 
significantly higher than unc-3, with an average difference of 8 neurons, which might be biologically 
significant. Since the mes-2 mutant allele is linked to an unc-4 mutation, the unc-4 mutant was used as a 
control. Further analysis of a mes-2; unc-3 double mutant will be performed to test the genetic interaction 
between these genes. The student t-test is used, *=p<.01, **=p<.001, ***= p<.0001, n.s.= p>.01. 
 
 
Since the gcy-5prom::rfp LacO array was highly enriched for H3K27me3, we also checked 
if mes-2, the histone methyltransferase of PRC2 affects the accessibility of gcy-5. To this end, we 
scored the induction of gcy-5prom::gfp in wildtype, unc-3, and mes-2 mutants and found that 
CHE-1hs does induce expression of gcy-5prom::gfp  in more mes-2 mutant cells than wildtype 
(Figure 4-8c). Moreover, we found that significantly more gcy-5prom::gfp(+) cells are induced in 
mes-2 mutants compared to unc-3 mutants (difference of 8 cells on average). Since we did not 
observe a change in H3K27me3 on the gcy-5 LacO array in unc-3 mutants, it is possible that 
mes-2 works in a parallel, unc-3-independent pathway to decrease the accessibility of 
unexpressed loci. A mes-2; unc-3 double mutant is currently under construction and if it has an 
additive phenotype, that may suggest that these are separate parallel pathways. However, again 
the caveats of a variable and complex phenotype have to be considered when interpreting these 
and future results. 
 Another important caveat in these chromatin mutant experiments is that the transgenes 
containing the hsprom::che-1 and gcy-5prom::gfp used here are multi-copy transgenes and thus may 
be regulated as repetitive DNA. Repetitive DNA is generally kept in a heterochromatin state in 
all cells. If this is the case, the increased activation of gcy-5prom::gfp in these met-2 and mes-2 
mutants may result from a derepression of arrays, but not reflect the state of the genomic gcy-5 
locus. To overcome this, we attempted to perform these experiments using the single copy 
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hsprom::che-1 transgene and a CRISPR engineered reporter of the endogenous gcy-5 locus 
(Chapter 2). However, the expression from this reporter is too dim to confidently score ectopic 
expression in the MNs (not shown). We will repeat these experiments using smFISH to detect 
gcy-5 expression. 
 
H3K9me binding proteins HPL-1 and HPL-2 also restrict accessibility 
 HP1 is a conserved chromodomain-containing protein that is known to bind H3K9me3 
(Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002; Jacobs et al., 2001; Lachner et al., 
2001; Nielsen et al., 2002).  The C. elegans genome encodes two homologs of HP1, hpl-1 and 
hpl-2 (Couteau et al., 2002; Schott et al., 2006). hpl-1 has been shown to colocalize with 
H3K9me3 in embryos by immunofluorescence, and hpl-2 shows enriched binding at H3K9me1/2 
regions by whole embryo ChIP analysis (Garrigues et al., 2014; Vandamme et al., 2015). 
Fluorescent-tagged HPL-1 and HPL-2 proteins localize to distinct foci on chromatin. However, 
the proteins seem to have both unique and redundant functions: whereas hpl-1 mutants develop 
normally, hpl-2 mutants show temperature dependent sterility at 25°C, and hpl-2;hpl-1 double 
mutants arrest as L2/L3 larvae at 25°C (Schott et al., 2006). We asked if mutants of these 
proteins phenocopy the loss of met-2 and unc-3 in the MNs after CHE-1hs expression.  
Indeed, an increased induction of gcy-5prom::gfp was seen in the MNs after removal of 
both hpl-1 and hpl-2, and this phenotype was enhanced in the double mutant (Figure 4-9a).  The 
experiment with the single mutants was performed 4 independent times, with >15 animals scored 
each time. While the phenotype of hpl-2 was consistent in all 4 repeats, the phenotype of hpl-1 
was not. In two of the fours experiments, the phenotype of hpl-1 was not statistically different 
from that of hpl-2, but in the remaining two it was significantly weaker than hpl-2. No conscious 
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changes were made in the experimental setup, therefore it is difficult to determine the cause for 
this variability. However, the hpl-2 and hpl-2; hpl-1 mutant data does suggest that hpl-1/2 do 
play a role in restricting the activity of CHE-1hs. We also wondered if these proteins genetically 
interact with unc-3. hpl-2; unc-3 mutants show a significantly higher induction of gcy-5prom::gfp 
than either single mutant (Figure 4-9b). However since the average increase is that of 5 cells, it is 
difficult to interpret whether this data suggests that hpl-2 and unc-3 work additively. The hpl-1 
unc-3 data was again variable like the data from hpl-1 single mutants. This experiment was 
performed two independent times, with >20 worms each. In one of these experiments, hpl-1 unc-
3 is not significantly different from unc-3, whereas in the second experiment, hpl-1 unc-3 shows 











Figure 4-9: HP1 homologs hpl-1 and hpl-2 are required for restricting the fate of 
cholinergic MNs 
CHE-1hs was induced at L4. The data cumulatively represents 4 independent heat-shock experiments (A) 
and 2 independent heat-shock experiments (B). Every dot represents an individual worm.  A) Both hpl-1 
and hpl-2 mutants have significantly more gcy-5prom::gfp expressing cholinergic MNs compared to 
wildtype and hpl-2; hpl-1 double mutants show a stronger phenotype than either single mutant.  hpl-2; 
hpl-1 mutants also have significantly more gcy-5prom::gfp cells than unc-3; however, the significance of 
this difference is difficult to access. B) hpl-2; unc-3 worms have significantly more gcy-5prom::gfp cells 
compared to wildtype, whereas hpl-1 unc-3  worms do not. The average difference is ~5 cells and may be 
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biologically significant. As hpl-1 and hpl-2 seem redundant, an analysis of hpl-2; hpl-1 unc-3 is necessary 
to determine the genetic interaction between unc-3 and these factors. The student t-test is used, *=p<.01, 
**=p<.001, ***= p<.0001, n.s.= p>.01. 
 
suggests that hpl-1 and hpl-2 work in an additive manner with unc-3. An hpl-2; hpl-1 unc-3 
mutant is currently being analyzed and may clarify the genetic interaction. 
 
Ongoing work: analysis of MET-2, HPL-1, and HPL-2 protein expression 
 Published HPL-1::GFP and HPL-2::GFP fusion proteins localize as foci on DNA and 
seem to be expressed broadly, but not ubiquitously in all cell types (Couteau et al., 2002; Schott 
et al., 2006). The published MET-2::MCHERRY fusion protein shows ubiquitous cytoplasmic 
expression, which is confounding as it functions as a nuclear histone methyltransferase (Towbin 
et al., 2012). In order to better understand the mechanism of action of unc-3 in relation to met-2, 
hpl-1, and hpl-2, we wanted to analyze the expression of these chromatin proteins in wildtype 
and unc-3 MNs. We hypothesized that if unc-3 in indeed playing a role in modulating H3K9me3 
levels it might do so in two ways: by directly or indirectly targeting the localization of these 
proteins on chromatin, or by contributing to maintaining the expression levels of met-2. The later 
scenario seems unlikely, as met-2 is a ubiquitously expressed gene and the known function of 
unc-3 is primarily to activate fate-specific genes; however, using TargetOrtho to predict potential 
unc-3 binding sites, we identified a conserved unc-3 motif upstream of the met-2 TSS, making 
this a possibility (Glenwinkel et al., 2014). To perform these experiments with the best possible 
reagents, we used CRISPR engineering (Dickinson et al., 2015) to add an mKate2 fluorescent 
protein tag into the loci of these genes (Figure 4-10). In the case of hpl-1 and hpl-2, we used the 
tagging strategy described in Schott et al., 2006, where the fluorescent protein is inserted into 
each protein (Schott et al., 2006). For met-2, we used an N-terminal tag with a small protein 
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HPL-1::MKATE2 HPL-2::MKATE2 MET-2::MKATE2
bridge, as an N-terminally tagged met-2 was shown to rescue H3K9me3 in met-2 mutants 
(Towbin et al., 2012).  In these CRISPR alleles, the expression patterns of all three tagged 
proteins seem ubiquitous. Additionally, all three proteins are found inside the nucleus. While this 
was the case for previous hpl-1/2 reagents, a rescuing MET-2::MCHERRY fusion  protein was 
thought to localize in the cytoplasm. Our MET-2::MKATE2 seems to localize in foci to 
chromatin, which is more congruent with the function of met-2 as a histone methyltransferase. 
We therefore think that this is the correct localization pattern. Additionally, MET-2::mKATE2 
worms develop normally at high temperatures as opposed to met-2 mutants which show some 
degree of sterility and larval arrest, suggesting that the fusion protein is functional.  
 The localization patterns of these proteins on the gcy-5 LacO arrays will be determined in 
wildtype, and unc-3 mutants. Additionally, the levels of expression in wildtype, and unc-3 MNs 
will also be quantified. This analysis may provide some insight into the mechanistic relationship 










Figure 4-10: HPL-1, HPL-2, and MET-2 are broadly expressed and localize to the nucleus 
HPL-2 and MET-2 are expressed in the germline, HPL-1 is not. MET-2 seems to be expressed at lower 




Individual cell types are defined by their fate-specific transcriptional programs and their 
fate-specific chromatin landscapes. While the processes that direct the acquisition of fate-specific 
transcriptomes have been under investigation for many decades, we are only beginning to 
understand the mechanisms that guide fate-specific chromatin organization. Here we provide 
evidence that in C. elegans neurons, fate-specifying TFs, or terminal selectors, play a role in 
coordinating the acquisition of fate-specific heterochromatin. We find that genes that are 
inaccessible for transcriptional activation in differentiated neurons become accessible in certain 
terminal selector mutants. The molecular nature of this change in accessibility is not fully 
understood, but we provide evidence to suggest that it may result from a change in the 
distribution of H3K9me3.  
 
Some, but not all, terminal selector genes act to restrict cell fate 
 We find that five of seven terminal selectors tested in our CHE-1hs assay are required to 
make genes of other fates inaccessible to trans-acting factors, i.e. to restrict cell fate. The TFs 
that function in this manner are the COE-TF unc-3, the homeodomain-TFs lin-11, ttx-1, ceh-14, 
and ETS factor ets-5. The two terminal selectors that did not share this function in our assay are 
the homeodomain-TFs, unc-30 and unc-42. The neuron types specified by these two groups of 
TFs do not have any functional or developmental differences that might explain this discrepancy. 
Neurons specified by the TFs that show a phenotype include the cholinergic MNs (specified by 
unc-3), a glutamatergic interneuron (DVC, specified by ceh-14) and two glutamatergic sensory 
neurons (ASG and AFD, specified by lin-11 and ttx-1 respectively). The neurons that did not 
show the phenotype are GABAergic MNs and ASH, a glutamatergic sensory neuron. All of these 
neurons, with the exception of subsets of GABAergic and cholinergic MNs are embryonically 
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born. Additionally, the neurons that did not show a phenotype are regionally located close to 
some neurons that do show a phenotype, suggesting that regional cues are unlikely to play a role. 
Moreover, no patterns in lineal relationships between ASE, the neurons specified by CHE-1, and 
those neurons that do or do not show a phenotype are evident.  
Considering the TFs themselves, it does not seem to be the case that all of the TFs that do 
or do not show a phenotype contain a unique structural domain that might explain their function. 
All terminal selector TFs are defined by their requirement for the activation and maintenance of 
a broad category of functionally unrelated terminal-identity genes (Deneris and Hobert, 2014; 
Hobert, 2011). Although all the TFs tested here have been shown to be required for the activation 
of diverse fate-specific genes, the breadth of their activity has not been equally dissected. For 
unc-3, for instance, over 40 target genes have been experimentally tested, while for the others 
only a handful have been (Kratsios et al., 2012; Serrano-Saiz et al., 2013). This discrepancy 
makes it difficult to understand the characteristics that make a TF perform this function. We 
simply hypothesize that the fates of GABAergic MNs and ASH sensory neurons are restricted by 
unidentified TFs that act as co-terminal selectors with unc-30 and unc-42.  
A similar function is also seen for the mouse TF Pax5, which is required for the 
differentiation of B lymphocytes. As discussed in the Introduction, differentiated B lymphocytes 
are refractory to the activity of the Yamanaka TFs; however, Pax5 mutant B lymphocytes can be 
reprogrammed into iPSCs by the activity of the same TFs (Hanna et al., 2008). This suggests that 
the activity of TFs in coordinating fate specification with the restriction of developmental 
plasticity is conserved in other systems.  
An additional question that will be interesting to address is the temporal requirement of a 
terminal selector in maintaining a restricted cell fate. Terminal selectors could, for instance, set 
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up fate-specific heterochromatin during differentiation, the maintenance of which could then be 
either dependent or independent of the TF. In the context of our CHE-1hs assay, this experiment 
became possible to perform only recently after the development of the auxin dependent 
degradation system (Zhang et al., 2015a). Using this technique, we have CRISPR engineered an 
mNeonGreen::AID degron tagged allele of UNC-3 protein, which can be rapidly degraded when 
worms are moved to auxin containing plates. In ongoing experiments, we will remove UNC-
3::MNEONGREEN::AID at the L4 stage and then active CHE-1hs. This will tell us whether unc-
3 is continuously required to maintain che-1 targets in an inaccessible state. 
 
The state of a neuron in the absence of its terminal selector 
 In the absence of Pax5, B cells have been shown to have certain characteristics of 
multipotent hematopoietic progenitor cells (Nutt et al., 1999). However, a progenitor-like state in 
not evident in neurons of terminal selector mutants. For instance, cnd-1, a homolog of bHLH 
protein NeuroD, which is expressed transiently during the progenitor-like state in cholinergic 
MNs, is turned off normally in an unc-3 mutant (Hallam et al., 2000; Kratsios et al., 2012). 
Additionally, activation of pan-neuronal gene expression, which happens after the terminal 
division, at the same time as the activation of fate-specific identity genes, also occurs normally in 
terminal selector mutants (Stefanakis et al., 2015). Moreover, mutant neurons of most terminal 
selectors tested in this assay do not show a complete loss of terminal identity. In lin-11 mutants, 
for instance, expression of various terminal fate genes is reduced or found in a fewer percent of 
cells, but most tested markers are not completely eliminated (Sarafi-Reinach et al., 2001b). 
Similarly, in ttx-1 mutant ASG neurons, the expression of the glutamate transporter is off in only 
~20% of neurons, while in a ceh-14; ttx-1 double mutant it is off or dim in ~80% of neurons 
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(Serrano-Saiz et al., 2013). However, the gcy-5fosmid::gfp locus is accessible in both in the ttx-1 
single and ttx-1; ceh-14 double mutants.  Therefore, it seems to be the case that while 
differentiation progresses to a similar temporal extent in wildtype and terminal selector mutant 
neurons, the terminal selector is required to trigger cell fate restriction.  
An analysis of the transcriptomes of terminal selector(+) and terminal selector(-) neurons 
could provide much deeper insight into this question. Specific nuclei from whole worms can be 
purified with the use a of a biotinylated protein localized at the nuclear lamina (Steiner et al., 
2012). Dylan Rahe, another graduate student, is currently optimizing this technique in our lab. I 
have build a strain that labels a subset of cholinergic MNs with the biotinylated tag and Dylan is 
in the process of generating samples of unc-3(+), unc-3(-),  unc-3(+) CHE-1hs(+), and unc-3(-) 
CHE-1hs(+)  MNs for RNA-seq. We intend to use this data to gain a better understanding of the 
nature of unc-3(-) MNs. Additionally, an analysis of unc-3 mutant cells after CHE-1hs induction 
will aid in the understanding of the categories of genes that CHE-1 can activate in this cellular 
context which will be important for reasons discussed in the following section. 
   
Terminal selectors trigger a decrease in the accessibility of unexpressed genes 
 The ability of CHE-1 to activate target genes in terminal selector mutants but not in 
wildtype worms could either result from a gain of accessibility in target genes or from the change 
in expression of a transcriptional co-regulator. We favor the accessibility hypothesis for a few 
reasons. First, CHE-1 is sufficient to activate expression of the gcy-54XASE::gfp reporter in adult 
somatic cells, suggesting that the protein itself is active and there is not a scarcity of generic 
transcriptional machinery in wildtype neurons. Second, when CHE-1 is expressed continuously 
using pan-neuronal promoters, it retains the ability to activate target gene expression throughout 
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the life of the worm. If it were the case that a terminal selector protein was activating a repressor 
of CHE-1 or repressing a co-activator, the CHE-1 expressed from these promoters would only be 
able to activate target gene expression for a short while and then its activity would be repressed, 
and reporters of its target genes would get turned off. Instead CHE-1 continues to activate target 
genes throughout the life of the worm. Third, removal of proteins that are known to form 
repressive chromatin phenocopy the terminal selector mutants in this assay. All of this evidence 
suggests that the inability of CHE-1 to activate target genes in wildtype L4/adult worms is 
caused by an inability to access its target sites. Additionally, the fact that CHE-1hs can only 
activate target genes in ~30% of cells in every terminal selector mutant suggests a complex 
interaction between activating and repressive factors is at play. This seems more reminiscent of 
the interactions between TFs and a complex chromatin environment, rather than a binary 
presence or absence of a transcriptional co-regulator. 
It will be important to understand in greater detail the extent to which CHE-1hs can 
activate target genes in terminal selector mutants. In unc-3 mutants, activation of 5 
independently integrated markers is observed, suggesting that unc-3 affects multiple genomic 
loci. An analysis of the unc-3(-) CHE-1hs(+) transcriptomes will provide further understanding of 
the breath of terminal selector activity in regulating the accessibility of unexpressed genes. 
 
The distribution of silencing histone modifications in differentiated MNs may require both 
unc-3 dependent and independent pathways 
 The removal of both an H3K27 methyltransferase, mes-2, and an H3K9 
methyltransferase, met-2, results in the gcy-5prom::gfp locus becoming more accessible to CHE-1. 
We find a strong enrichment of H3K27me3 on the gcy-5 LacO array, which remains unchanged 
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in an unc-3 mutant. In contrast, while the overall enrichment of H3K9me3 on this array is lower 
than H3K27me3 in wildtype worms, it decreases even further in an unc-3 mutant. This suggests 
that unc-3 mediates H3K9 methylation at this locus, while H3K27 methylation is unc-3 
independent. In congruence with this, on average only 2 extra cholinergic MN shows gcy-5 
induction by CHE-1hs in met-2; unc-3 vs. unc-3 single mutants. The lack of an additive effect 
supports the hypothesis that the phenotype seen in unc-3 mutants is mediated in part by met-2 
and H3K9me3. A similar analysis for mes-2; unc-3 double mutant may help to clarify whether 
they act in separate pathways. 
 set-25, which is also required for H3K9me3 in embryos (Towbin et al., 2012), seems 
dispensable in our assay. The expression pattern of set-25 is unknown in larvae, so it is possible 
that set-25 is either not expressed in the MNs or that there is another methyltransferase that acts 
redundantly with set-25. This possibility is corroborated by another study in which the repression 
of a TF is shown to be met-2 dependent but set-25 independent in the cholinergic VC neurons of 
L4 larvae (Zheng et al., 2013).  
Interestingly, while met-2 and mes-2 mutants show a strong reduction of H3K9me3 and 
H3K27me3 respectively in embryos, based on immunofluorescence analysis, they retain 
superficially normal levels of H3K9me3 and H3K27me3 in L4 and adult somatic tissues (Bender 
et al., 2004 and pers. comm. with Susan Strome for H3K27me3, our preliminary analysis for 
H3K9me3). This may suggest that these proteins are required to set up correct patterns early in 
neuronal specification. Alternatively, these mutants may affect the correct distribution, but not 
overall levels, of histone modifications in adult somatic tissues, which would not be evident by 
immunofluorescence. A closer analysis of the distribution of these marks in the corresponding 
mutants would illuminate the mechanisms underlying their role in fate restriction in MNs.   
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The role of H3K27me3 in silencing developmentally regulated genes has been well 
studied. Our previous finding that the loss of H3K27me3 in the germline allows for the TF 
dependent activation of somatic genes and the results here showing a role for H3K27me3 in 
restricting the fate of cholinergic MNs underscores the importance of this mark in defining a 
fate-specific chromatin signature. However, in this work we did not arrive at any conclusions 
about how this mark is deposited at the correct loci. 
H3K9me3 has been reported to function in the silencing of fate-specific genes in a few 
cases (reviewed in Becker et al., 2015). Here we show that met-2, an H3K9 methyltransferase 
and the homologs of HP1, an H3K9me3 reader, function to keep fate-specific genes in an 
inaccessible state. It is interesting that the loss of either met-2 or mes-2 makes gcy-5prom::gfp 
more accessible for activation. This may suggest that the presence of the two marks together is 
required to keep the chromatin in a inaccessible form, and that the removal or reduction of either 
makes the chromatin more dynamic, such that CHE-1 can now access target genes. It would be 
interesting to determine if there is any inter-regulation between these marks, i.e. whether the 
state of H3K27me3 is affected in met-2 mutants and vice versa.  
 The role of met-2 and mes-2 in silencing the gcy-5 locus is being further validated with 
ongoing experiments using the single copy hsprom::che-1 transgene and smFISH for gcy-5. These 
experiments will be valuable, as it is possible that the multi-copy gcy-5prom::gfp and gcy-5 LacO 
arrays used in these experiments are being regulated as repetitive DNA, and do not reflect the 
state of the genomic gcy-5 locus. A few lines of evidence suggest that this might not be the case. 
First, the multi-copy hsprom::che-1 array is expressed in a wild type germline, where repetitive 
DNA is kept silenced (Kelly et al., 1997). Second, repetitive DNA, including repetitive LacO 
arrays show strong enrichment H3K9me3 and hpl-2 (Garrigues et al., 2014; Meister et al., 
! 130!
2010b). The gcy-5 LacO array however, shows greater colocalization with H3K27me3 than 
H3K9me3, and a preliminary look at the HPL-2::mKATE2 fusion protein does not indicate a 
great enrichment of this protein on the gcy-5 LacO array.  
 Overall, these results suggest that chromatin-modifying enzymes are required for the 
formation of fate-specific heterochromatin, and that some of them may be directed by unc-3 
activity. 
 
Possible mechanism of action of unc-3 
 If it is true that one of the downstream effecters of unc-3 is the met-2 dependent H3K9 
methylation, this raises the question of how the absence of unc-3 causes a reduction of H3K9me3 
at specific loci.  
One possible scenario would be that unc-3 is required for the maintenance of met-2 
expression. Therefore in the absence of unc-3, there would be a reduction in met-2 dependent 
H3K9me3 deposition. The expression levels of MET-2::MKATE2 in unc-3 mutants and 
wildtype neurons will be tested soon to see if this is the case.  
Alternatively, unc-3 could bind chromatin-modifying complexes and direct them to 
specific loci that have to be silenced. The presence of unc-3 in a complex with a H3K27 
demethylase jmjd-3.1 has been reported (Zuryn et al., 2014), suggesting that unc-3 can bind 
chromatin modifying complexes. However, in that case, unc-3 is thought to direct jmjd-3.1 to 
genes where it is already known to bind as an activator. Whether unc-3 can direct repressive 
chromatin complexes to genes that have to remain silenced is not known. This kind of activity 
would suggest that unc-3 and other terminal selectors would bind a large proportion of the 
genome, as much of it is silenced in differentiated cells. This possibility would have to be tested 
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by performing TF ChIPs in specific cell types.  
Thirdly, one could hypothesize that unc-3 is responsible for activating the expression of 
genes that act as general repressors, like the Groucho family proteins, and aid in the recruitment 
of chromatin modifying complexes to genes that need to remain silent. Our analysis of the 
transcriptomes of wildtype and unc-3 mutant MNs may provide candidates for such repressors.  
Lastly, the decrease of H3K9me3 from specific loci in unc-3 mutants could simply result 
from the titration of this mark over the whole genome. Since unc-3 is responsible for activating a 
large number of genes, it is possible that in unc-3 mutants, the lack of active transcription and a 
resultant reduction in histone modifications associated with active transcription leads to the 
spread of H3K9me3 and a concomitant reduction of it from other loci. This would imply that 
unc-3 is not directly responsible in ensuring the correct deposition of H3K9me3, and rather 
suggest that the decrease of H3K9me3 at specific loci is a secondary affect of the overall 
reduction in transcription. There is evidence of interdependence between H3K9me3 and the 
H3K4me3 mark associated with active transcription (Greer et al., 2014). It is possible that if 
levels of H3K4m3e are reduced, H3K9me3 gets titrated. However, the fact that we did not 
observe a reduction in H3K27me3 at the gcy-5LacO loci suggests that this mechanism might not 
be at play, as it is known that in the absence of H3K36me3 marks associated with transcribed 
chromatin, H3K27me3 mark gets titrated over the genome (Gaydos et al., 2012). Although, it is 
also quite possible that our LacO assay is not sensitive enough to detect subtle changes in 
H3K27me3 levels, so this data does not dismantle this hypothesis. To test if such a titration 
model is in play, CHE-1hs will be induced in H3K36me3 and H3K4me3 methyltransferase 
mutants. If these mutants phenocopy unc-3, mes-2, and met-2, a titration model could explain the 
observed phenotype. 
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In conclusion, the work in this chapter shows that fate specifying TFs can co-ordinate the 
activation of fate-specific genes with the chromatin dependent silencing of unexpressed genes, 
thus providing a cell with a restricted identity. These results add to the growing body of work 
that together implicate the function of fate-specifying TFs in every aspect of fate acquisition, 
maintenance, and restriction. These TFs function to activate and maintain transcription of fate-
specific genes, to remove repressive chromatin and facilitate the formation of active chromatin at 
actively transcribed genes, and to ensure the deposition of silent chromatin on genes that do not 
need to be activated.  
 
MATERIALS AND METHODS 
Strains and transgenes 
All strains were maintained using standard procedures, unless otherwise noted. For heat-shock 
experiments strains were grown at 15°C, heat-shocked at either 37°C or 32°C for 30min, and left 
overnight at 20°C. Experiments in figures 4-4, 4-5, 4-8, and 4-9 were performed with 32°C heat-
shocks, the rest of the heat-shocks were done at 37°C. Marker expression was scored around 
24hours after heat-shock. 
The following strains and transgenes were used (Strains in bold were created by me): 
Mutant alleles: unc-3(e151), unc-3(n3413), ceh-14(ch3), lin-11(n389), unc-30(e191), unc-
42(e419), ets-5(tm1734), ttx-1(p797), met-2(ok2307), set-25(n5021), hpl-1(tm1489), hpl-
2(n4317), unc-55(e402), unc-4(e120), mab-9(gk396730) 
SS186:  (mes-2(bn11) unc-4(e120)/mnC1 dpy-10(e128) unc-52(e444)II)  
Transgenic strains: 
OH9846: otIs305 [hsp16-2prom::che-1::2xFLAG; rol-6(d)]; ntIs1 [gcy-5::gfp; lin-15(+)]  
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OH13139: otIs587 [gcy-5fosmid::sl2::1xnlsgfp; ttx-3prom::mcherry] 
OH13102: otIs586 [gcy-6fosmid::sl2::1xnlsgfp; ttx-3prom::mcherry] 
OH13140: otIs588 [gcy-5fosmid::sl2::1xnlsmcherry; ttx-3prom::gfp] 
OH13984: ot835 (gcy-5::sl2::1xnls::mNeonGreen) CRISPR engineered into the genome  
OH14049: otIs629 [gcy-7prom::tagrfp; ttx-3prom::gfp] 
OH13099: otIs583 [gcy-5prom306bp4XASE::gfp; ttx-3prom::mcherry] 
OH8882: otEx3909 [ceh-36fosmid::yfp] 
OH10689: otis355 [rab-3prom::nlstagrfp]  
OH11157: otIs393 [ift-20prom::nlstagrfp; pha-1] 
OtTi6: hsp16-41prom::che-1::2xFLAG (miniMos single copy insertion)  
OH10598: otis348 [unc-47prom::mchopti; pha-1] 
OH11124: otis388 [eat-4fosmid::yfp::h2b] 
OH13988: ot837(UNC-3::MNEONGREEN::AID) protein tag CRISPR engineered into the 
genome 
OH14021: ot841 (HPL-1::MKATE2) protein tag CRISPR engineered into the genome 
OH14220: ot860 (HPL-2::MKATE2) protein tag CRISPR engineered into the genome 
OH14221: ot861 (MET-2::MKATE2) protein tag CRISPR engineered into the genome 
GW396: gwIs39 [baf-1prom::gfp::lacI; vit-5prom::gfp] 
OH12738: otIs545 [gcy-5prom::rfp; LacO repeats] 
OH13330: otIs593 [let-858prom::gfp::LacI; ttx-3prom::mcherry] 
OH11744: otis445 [ace-2prom::rfp; LacO repeats] 
CRISPR alleles 
CRISPR engineering was performed exactly as described in (Dickinson et al., 2015). 
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For unc-3, mNeonGreen::AID tag was inserted into the C-terminus of the protein just before the 
stop codon. 
For hpl-1, mKate2 was inserted into the protein after the 12th amino acid. This tag was based on 
a published hpl-1 protein fusion (Couteau et al., 2002). 
For hpl-2, mKate2 was inserted into the protein after the 96th amino acid. This tag was based on 
a published hpl-1 protein fusion (Couteau et al., 2002). There are two isoforms of hpl-2, both are 
tagged in this allele. 
For met-2, mKate2 was added to the C-terminus of the protein followed by a small protein 
bridge. The start codon of met-2 was kept intact. 
LacO arrays 
To create the gcy-5 LacO arrays, 10ng/ul of PCR products containing gcy-5prom::rfp were 
injected with 2ng/ul of LacO repeats acquired by digesting out the10 kb Sph1/Kpn1 fragment 
from lacO multimeric plasmid pSV2-dhfr- 8.23, and 100ng/ul of digested bacterial genomic 
DNA were injected into GW396 young adult hermaprodites. Extrachromosomal arrays that 
formed nuclear LACI::GFP spots were chosen for integration with gamma irradiation. Integrants 
that showed nuclear spots were then chosen. 
The ace-2 LacO arrays were similarly build. The injection mix contained: 10ng/ul of ace-
2prom::rfp PCR, 2ng/ul of LacO repeats, 2ng/ul of elt-2::nlsdsred, and 86ng/ul of digested 
bacterial genomic DNA. Extrachromosomal and integrates lines were chosen as with gcy-5. 
 
DiI/O filling 
The amphid sensory neurons of worms can uptake fluorescent dyes (Shaham, 2006). DiI labeling 
was performed by washing worms into 1mL of M9 butter containing 1:500 dilution of DiI or 
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DiO. Worms were left to incubate with the dye for 1 hour at room termperature, washed 3 times 
with M9 and placed on NGM plates with E. coli for >1hr to recover before imaging. 
 
Antibody staining 
 A freeze crack antibody staining protocol on whole worms was used (Duerr, 2006). 
Worms were washed, suspended in 0.025% glutaraldehyde and spread out in between two frost-
resistant glass slides. These slides were frozen on dry ice and cracked open to break the cuticle of 
the animals. Acetone/methanol fixation was used for most antibodies to prevent gonad extrusion. 
Freeze cracked worms were incubated for 5 min each in ice cold acetone and methanol. The 
worms were then washed off the slides in 1X PBS, blocked and stained. Blocking was done in 1x 
PBS with 0.2% gelatin and 0.25% Triton for 30 min at room temperature. Antibodies were 
diluted in 1x PBS containing 0.1% gelatin and 0.25% Triton. Primary antibody was left on 
overnight at 4°C and secondary antibody was applied for 3 hours at room temperature. After 
washing off the secondary antibody, worms were incubated with DAPI for 15 minutes, washed 
again and mounted on glass slides. Primary antibodies used were: H3K27me3 (Millipore, 1:500), 
H3K9me3 (abcam, 1:500 dilution), and GFP (Invitrogen, 1:1000 dilution). All secondary 
antibodies were Alexa Flour dyes used at 1:1000 dilution 
 
Microscopy 






CHAPTER 5: Discussion and Future Perspectives 
 The work in this thesis was aimed at better understanding the molecules and mechanisms 
that ensure the restriction of cell fates in differentiated cells. Years of study have shown that the 
process of differentiation is correlated with changes in chromatin organization. The chromatin of 
pluripotent cells is characterized by a lack of compact heterochromatin and a rapid turnover of 
nucleosome proteins. Differentiated cells, on the other hand, acquire domains of compact 
heterochromatin and more stable nucleosomes (Efroni et al., 2008; Meshorer et al., 2006; Park et 
al., 2004; Zhu et al., 2013). The formation of silent and accessible chromatin in differentiated 
cells also corresponds to their cell-type-specific transcriptional programs; transcribed and non-
transcribed genes are enriched for distinct histone modifications and chromatin bound enzymes 
(Ernst and Kellis, 2010; Filion et al., 2010). These findings have highlighted the complex 
regulation that underlies the specification of diverse cell types. Thus far, very little is understood 
about the factors that contribute to the restricted chromatin state of a differentiated cell. For 
instance, the functional relevance of many histone-modifying enzymes enriched at silent 
chromatin domains remains unknown. And, how the correct deposition of chromatin 
modifications is coordinated with the activation of fate-specific transcriptional programs is also 
not well understood.   
 In this work, we have used the overexpression of a fate specifying TF, che-1, to better 
understand processes that control the formation of inaccessible chromatin in differentiated cells. 
We find that the ability of ectopically expressed CHE-1hs to activate its target genes is inversely 
correlated to the differentiation state of the host cell (Chapter 2). Early in development, CHE-1hs 
activates its target genes in a wide variety of cell types, whereas later in development it can only 
do so in a smaller number of cells. This suggested that CHE-1 could not access and activate 
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target genes once differentiated cells have acquired a cell-type-specific chromatin landscape. By 
performing an RNAi screen against chromatin factors, we found that the correct distribution of 
PRC2 dependent H3K27me3 is required for maintaining a germline specific closed chromatin 
state (Chapter 3). The knockdown of PRC2 components, or the H3K36 methyltransferase, mes-4, 
which indirectly specifies H3K27me3 domains, allows CHE-1 and two other somatic TFs to 
access and activate numerous target genes. The incorrect distribution of H3K27me3, therefore, 
results in loss of fate restriction in these cells.  
Using a candidate approach, we also found that neuronal terminal selector TFs are 
required to restrict the fates of the cells that they differentiate (Chapter 4). In five of seven 
terminal selector mutants tested, we found that CHE-1hs has an increased ability to access its 
target genes. We further found that one of these TFs, unc-3, may be performing this function by 
ensuring the correct deposition of H3K9me3 in cholinergic MNs. Further analysis of the 
cholinergic MNs showed that PRC2 is also required for the restriction of cell fate, but unlike 
H3K9me3, the regulation of H3K27me3 may not be mediated through unc-3. Experiments to 
better understand the function of unc-3 in relation with the H3K9 and K3K27 methyltransferases 
are ongoing. Here, I discuss the relevance of our results in the context of what is known and 
propose experiments to address open questions. 
 
TF activity in overexpression assays 
The finding that the overexpression of certain TFs leads to cell fate conversions in 
differentiated cells (Graf and Enver, 2009), and the ability of Sox2, Oct4, Klf4, and c-Myc to 
convert differentiated cells into induced pluripotent cells (Takahashi and Yamanaka, 2006) has 
lead to an increased interest in using TFs to create medically relevant cell types (Hochedlinger 
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and Jaenisch, 2015). In light of this, it is important to understand the properties that allow a TF to 
convert the fate of its host cell.  
Current literature and the data in this thesis suggests that the activity of an ectopically 
expressed TF depends both upon the context provided by the host cell and properties inherent to 
the TF itself.  When overexpressed in differentiated cells, the Zn-finger TF, che-1, can only 
access its target genes in a few cells. However, a reduction or misregulation of H3K27me3 and 
H3K9me3 in certain cell types makes target genes accessible for activation again. This finding 
tells us that the TF CHE-1 cannot access target promoters if they carry either of these histone 
modifications, suggesting that during normal development CHE-1 only activates genes lacking 
such repressive marks.  
The binding properties of other TFs in relation to histone modifications have been 
examined in detail in some in vitro fate conversion assays. For example, during the conversion of 
fibroblasts to iPSCs, TFs Sox2, Oct4, and Klf4 can bind targets enriched for H3K27me3, but 
cannot efficiently bind targets enriched for H3K9me3 (Soufi et al., 2012). In contrast, during the 
reprogramming of fibroblasts into neurons, the TF Ascl1 preferentially binds targets that contain 
H3K9me3, H3K4me3, and H3K27ac, but not H3K27me3 (Wapinski et al., 2013). These 
examples indicate that the affinity of TFs to target sites is dictated in part by the chromatin 
signature. An increased understanding of the chromatin signatures preferred by different kinds of 
TFs can aid in efficient pairing of TFs and host cell types that should be used for fate 
conversions. 
In the context of our assay, further understanding of the properties that allow CHE-1 to 
bind target genes can be studied by comparing the small number of adult neurons that are still 
responsive to CHE-1 with the rest of the somatic cells that are not. For instance, when CHE-1hs  
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is induced during L4 and adult stages, it can access its target genes in some neurons like the RIS 
and the CEPs. Using the gcy-5 LacO array, one could stain for various histone modifications and 
determine which marks are differentially enriched on gcy-5 LacO in cells like the RIS, in which 
che-1 can continuously activate gcy-5, compared to other cells in which che-1 cannot activate 
gcy-5. 
   
H3K27me3 is required for the restriction of differentiated cell fates 
 H3K27me3 is found enriched on developmentally regulated genes when they are not 
being robustly transcribed. As transcriptional profiles change during the development of 
individual cells, so do the patterns of H3K27me3 (Boyer et al., 2006; Filion et al., 2010; Ho et 
al., 2014; Oktaba et al., 2008). This mark is therefore dynamically regulated and represses 
different categories of genes at different stages of development (Conerly et al., 2011). Previous 
studies have shown that the loss of PRC2 in ESCs results in the loss of pluripotency, and that the 
loss of PRC2 makes the reprogramming of fibroblasts into iPSCs less efficient (Boyer et al., 
2006; Onder and Daley, 2012), suggesting a crucial role for PRC2 in creating and maintaining a 
pluripotent state in ESCs and iPSCs. Additionally, in Drosophila, the loss of H3K27me3 in 
developing imaginal discs results in the derepression of polycomb targets for which 
transactivating TFs are present and repressors are absent (Oktaba et al., 2008). Our work shows 
that PRC2 is also required to maintain the repressed state of unexpressed genes in terminally 
differentiated cells. The reduction or misregulation of H3K27me3 makes silenced loci in germ 
cells and differentiated motor neurons more accessible for transcriptional activation, providing 
functional evidence that the presence of this histone modification in differentiated cells is 
required to keep unexpressed genes in a inaccessible state.  
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 An interesting aspect of H3K27me3-mediated repression is that it can be overcome by 
specific TFs and in specific cellular contexts. For example, during in vitro ESC differentiation to 
neurons, H3K27me3 removal from Hox clusters is mediated by the binding of the retinoic acid 
receptor and the TF Cdx2. This suggests that in ESCs, the presence of H3K27me3 does not make 
target loci inaccessible to these TFs (Mazzoni et al., 2014). Similarly, during Drosophila 
development, Polycomb repression can be overcome in certain cellular contexts by signaling 
factors like Wg and Dpp, but not in all cellular contexts (Oktaba et al., 2008). It will be 
interesting to understand all of the factors that dictate these differences in the sufficiency of 
H3K27me3 to make a locus inaccessible. These factors may include the presence of other 
histone modifications, differences in the strength of the cis-regulatory enhancers, or the presence 
of different combinations of trans-activating TFs. The experiments to test these hypotheses are 
perhaps best done in in vitro systems, where cells in which TFs overcome H3K27me3 repression 
and those in which TFs do not overcome H3K27me3 repression can be isolated and profiled.     
 
H3K9me3 is required for the restriction of differentiated cell fates 
 The repressive function of H3K9me3 is primarily studied at repetitive chromatin. 
However, genome-wide profiling studies show that H3K9me3 domains are also enriched at some 
gene rich locations and a repressive role for H3K9me3 has been observed at a few 
developmentally regulated loci (Allan et al., 2012; Ho et al., 2014; Liu et al., 2015b; Zheng et al., 
2013). Here we provide further evidence that H3K9me3 can regulate the silencing of genes in a 
cell-type-specific manner. While the overexpression of che-1 in L4 worms does not result in the 
activation of a transgenic gcy-5 reporter in many cell types, we find that the removal of an H3K9 
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methyltransferase, met-2, relieves this repression and makes the gcy-5 reporter accessible for 
transcription in cholinergic MNs.  
However, this experiment only provides evidence of H3K9me3’s repressive activity at a 
single genomic site. In the future, our experimental paradigm can be used to further dissect the 
breadth of H3K9me3 repressive activity and compare it to that of H3K27me3. For instance, 
CHE-1hs can be activated at various developmental stages in mutants of H3K27 and H3K9 
methyltransferases and its ability to activate a wide variety of target genes can be tested. Would 
the loss of both these marks result in the activation of the same target genes in the same cells? If 
both H3K27me3 and H3K9me3 levels are reduced, would this increase the efficiency of 
activation by CHE-1hs? These experiments could provide a better understanding of the repressive 
roles played by H3K9me3, and its interactions with H3K27me3. 
The study of chromatin during differentiation in C. elegans can also be greatly aided by 
the identification of methyltransferases that act in somatic cells during larval and adult stages. 
While met-2 and set-25 are required for the deposition of all H3K9me3 in embryos and early 
larvae, there is evidence to suggest that other factors are also required in the adult somatic tissues 
(Greer et al., 2014; Zheng et al., 2013). Similarly, whereas the worm homolog of the PRC2 
complex is required for H3K27 methylation in the germline and all embryonic cells, additional 
and unidentified histone methyltransferases deposit H3K27me3 in older larval and adult somatic 
tissues. An in depth protein expression (using fluorescently tagged CRISPR engineered alleles) 
and mutant analysis of all the SET domain containing proteins in C. elegans would provide 




Fate-specifying TFs mediate cell fate restriction  
 In this thesis we also report the requirement of fate-specifying TFs in mediating cell fate 
restriction. We found that in mutants of several neuronal fate-specifying TFs, CHE-1hs has an 
increased ability to access and activate its target genes in the affected cell types. This result 
provides evidence that the activity of fate-specifying TFs is necessary not only for the activation 
of a fate-specific transcriptional program, but also for the induction of fate-specific silent 
chromatin. Thus far, only a small number of loci have been tested for accessibility by CHE-1 in 
TF mutants. To better understand the function of these TFs at the genomic level, we are currently 
performing further analysis of unc-3, which is required for specifying cholinergic MNs. Our 
experimental approach is to isolate wildtype and unc-3 mutant cholinergic MNs with and without 
the induction of CHE-1hs and compare the transcriptional profiles of these cells by RNA-seq. 
This data will: 1) provide an understanding of the state of a cell in the absence of its terminal 
selector, 2) provide a greater overview of all the genes that become accessible for activation by 
CHE-1hs , and 3) point to possible mechanisms by which unc-3 regulates the restriction of cell 
fate.  
 Additionally, in this work we also provide preliminary evidence that the unc-3 dependent 
restriction of the MN cell fate may be mediated by the correct distribution of H3K9me3. This 
result is currently being validated and further experiments are being performed to understand the 
molecular relationship between unc-3 activity and H3K9me3 deposition. The results so far 
suggest an exciting model where unc-3-mediated deposition of H3K9me3 and unc-3 independent 




Further study of the role of TFs in regulating chromatin accessibility 
 Many fate specifying TFs are known to be essential for activating and maintaining fate-
specific transcriptional programs (Hobert, 2011). There is also some evidence that TFs are 
important for the organization of fate-specific active chromatin domains (Iwafuchi-Doi and 
Zaret, 2014; Natoli, 2010; Zaret and Mango, 2016). Furthermore, here we provide evidence that 
certain fate-specifying TFs also play a role in ensuring that genes that are not required for a 
particular fate remain in an inaccessible state after differentiation. While the function of TFs in 
activating target genes has been very well studied, our understanding of the overall functions of 
fate specifying TFs in chromatin organization is still rudimentary. A better understanding of 
these processes can be achieved by performing genomic analysis of specific neuron types. For 
example, the role of unc-3 in formatting the chromatin of cholinergic MNs could be assessed by 
isolating cholinergic MNs from wildtype and unc-3 mutant animals at various stages of 
development and extending the RNA-seq analysis discussed above to multiple stages. 
Additionally, ATAC-seq could be performed on these neurons to acquire open-chromatin 
profiles at various developmental stages (Buenrostro et al., 2013). The differences in chromatin 
accessibility in wildtype vs. unc-3 differentiated neurons would provide clues about the roles that 
unc-3 play in changing chromatin accessibility. Additionally, profiles of histone modifications 
associated with silent and active chromatin could also enhance this analysis. The worm provides 
an ideal organism for such analysis as numerous fate-specifying TFs have been identified, and 
based on this study, many of them play a role in chromatin organization. Additionally, the 
process of development is faster in worms suggesting fewer differentiation steps that would be 
easier to delineate. Furthermore, since many classes of terminal selector mutant neurons do not 
seem to adopt alternative fates or undergo cell death, a better comparison between wildtype and 
! 144!
TF mutant neurons can be acquired. Improvements in sequencing techniques and in INTACT, 
that technique used to isolate specific nuclei from organisms (Deal and Henikoff, 2011; Mo et 
al., 2015; Steiner et al., 2012), can make these experiments possible in the near future. 
 
In the context of development, why is the restriction of cell fate necessary? 
 The restricted state of a differentiated cell is evident under conditions in which 
developing cells are challenged by artificial experimental approaches. Such challenges include 
TF overexpression, cell fusion, and nuclear transplant experiments. However, a normally 
developing cell is not faced with any of these challenges, so why does the restriction of a cell 
fate occur? The following is a discussion of known and hypothetical functions that repressive 
chromatin domains can perform to specify and maintain cell fates during development. 
  The evolution of large genomes and the presence of numerous TFs that recognize similar 
binding sites make it essential that additional mechanisms for binding specificity be utilized. The 
organization of chromatin into domains with specific histone modifications is one mechanism 
that increases TF specificity. For example, the TF FoxA binds different sites in primary breast 
and prostrate tumor cell lines. This differential binding is not explained by a difference in the 
underlying DNA motif, which is the same in both cell types, but by the presence of specific 
histone modifications at enhancers. The binding of FoxA is directed by the presence of a 
H3K4me(+) and H3K9me3(–) chromatin signature, which differ in the two cell lines (Lupien et 
al., 2008). In this way, the presence of heterochromatin can diversify the functions of the same or 
similar TFs (Conerly et al., 2011).  
That the formation of heterochromatin results in increased specificity of TF binding is 
also compatible with preliminary data in our lab showing that expression levels of TFs decrease 
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as worms age. This has been observed so far for UNC-3 and CHE-1 proteins using fluorescently 
tagged, CRISPR-engineered alleles (analysis of UNC-3 performed by John Kerk, work on CHE-
1 done by Dylan Rahe). While there may not be a causal relationship between fate restriction and 
a reduction in TF levels, these mechanisms together can contribute to the robustness of fate 
maintenance. For example, high levels of UNC-3 protein expression might be required early in 
the differentiation of the cholinergic MNs because their cell fates are not yet restricted and both 
MN-specific and non-specific UNC-3 binding motifs are accessible for UNC-3 binding. In this 
scenario, initiation of the correct transcriptional program in a cell requires complex regulation, as 
additional co-factors would also be required to ensure that only the MN-specific UNC-3 bound 
targets get transcribed. However, once a fate-specific expression pattern is established, the 
sequestration of unexpressed genes into heterochromatin would increase specificity of UNC-3 
activity. At this point, low levels of TF would suffice to bind and activate transcription of the 
remaining accessible targets.  Low levels of UNC-3, and heterochromatin at non fate-specific 
genes would then persist through the life of the cell. These mechanisms would contribute to the 
maintenance of a stable fate by decreasing the probability of activating genes that carry TF-
binding motifs but are not required for the MN fate.  This hypothesis is yet to be tested, but 
proposes a potential role for cell fate restriction in fate maintenance.   
Similarly, the sequestration of unexpressed genes into silent chromatin also protects a cell 
from accidental transcription of unwanted genes in response to fluctuations in extracellular 
stimuli (Voss and Hager, 2014). Accumulating evidence suggests that the packaging of 
unexpressed genes into inaccessible chromatin is necessary for the maintenance of a normal cell 
fate. For instance, tumorous cells show misregulation of genes associated with pluripotency, and 
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cancerous tissues have been found to harbor polycomb mutations (Ben-Porath et al., 2008; Piunti 
and Pasini, 2011). Thereby, the restriction of fate is necessary to maintain homeostasis. 
 To conclude, understanding the processes that ensure cell fate restriction not only 
increases our understanding of developmental processes, but can also aid in understanding the 
mechanisms that go wrong when cells lose their terminal identities, as in the case of cancer. The 
production of differentiated cells from iPSCs also requires a thorough understanding of the 
processes that not only specify a cell fate, but also ensure their restriction. If such cells are to be 
used for studying disease mechanisms and for replacement therapies, they must reflect both the 
transcriptional and chromatin state of the cells they imitate. The work in my thesis adds to our 
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APPENDIX A: A clarification of the definition of differentiation 
 
In this thesis, as in common usage, the term differentiation refers to the process that cells 
undergo to acquire a specific terminal fate. By a differentiated cell, I mean a cell that has 
acquired its terminal function. For instance, a neuronal cell is differentiated when it expresses the 
proteins that it needs to make the correct synapses, and to receive and send signals that make it 
functional as that specific neuron. I also sometimes refer to this state as a terminally 
differentiated state- by this I simply mean a post-mitotic cell that, after its last division, has 
activated a battery of terminal identity genes that give it a unique fate and function. Of course, it 
is often the case that terminally differentiated cells continue to undergo transcriptional changes 
in response to external cues. By our criteria, these changes do not contribute to the process of 
differentiation, but rather take place in an already differentiated cell. 
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APPENDIX B: An alternative hypothesis to the accessibility hypothesis favored in  
Chapters 2-5 
 
In this work (Chapters 2-4), loss of cellular plasticity is defined as the inability of an 
ectopically expressed TF to activate its target genes. In our experimental paradigm, the 
ubiquitous ectopic expression of Zn-finger TF CHE-1in undifferentiated cells leads to a broad 
activation of CHE-1 target genes where as the ectopic expression of CHE-1 in differentiated cells 
does not, showing that cellular plasticity is lost as cells differentiate. The decreasing ability of 
CHE-1 to activate its target genes in differentiating cells can be explained by two hypotheses: 
A) As cells differentiate the chromatin is organized such that genes that are required for a 
specific cell’s identity and function are left in an accessible state while genes that are not 
required become inaccessible. This hypothesis would predict that while in undifferentiated cells 
CHE-1 can bind its motif in target genes and activate transcription, in undifferentiated cells it 
cannot bind its motif on target genes, because of the presence of a refractory or closed chromatin 
conformation. According to this hypothesis, a loss of plasticity results from other-fate genes 
becoming inaccessible in a cell that has acquired a specific fate. This hypothesis is expanded 
upon in Chapters 3, 4. 
B) Alternatively, it is possible that as cells differentiate, different transcriptional co-
regulators such as co-activators or repressors modulate the activity of CHE-1. This would 
suggest that CHE-1 can potentially bind its motif in target genes at all times but requires the 
presence or absence of other factors to activate transcription. If this were the case, in 
undifferentiated cells, the presence of co-activators and/or the absence of repressors would allow 
CHE-1 to activate target genes, where as in differentiated cells, a lack of co-activators and/or a 
gain of repressors stops CHE-1 from activating its target genes. Our data with the gcy-54XASE::gfp 
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in Figure 2-6 suggests that the protein CHE-1 is active as a TF at all developmental stages, 
therefore the regulation of target gene transcription must be at the cis-regulatory level, i.e., these 
other factors would bind to CHE-1target genes and modulate its transcriptional activity.  
This hypothesis is difficult to prove or disprove as the identity of potential co-regulators 
is unknown and numerous such proteins might be playing a role. In addition to the results 
presented in Chapters 2-4, we have performed an unbiased genetic screen to look for proteins, 
which when knocked down, allow CHE-1 to activate gcy-5prom::gfp in differentiated cells. If 
single repressors were non-redundantly involved in stopping CHE-1 from activating target genes 
in differentiated cells, these should have been uncovered in the screen. However we did not find 
any such proteins, suggesting that if this were the mechanism of regulation, multiple factors 
would be involved. In Chapter 3 we find that the knock-down of the C. elegans PRC2 complex 
allows CHE-1 (and two other TFs) to activate target genes in germ cells. It is possible in this 
case that the loss of these proteins leads to a derepression of co-activators or repression of 
repressors that would could explain the phenotype. In Chapter 4, we find that the loss of neuronal 
terminal selector TFs, H3K9 methylases, and PRC2 allows CHE-1 to activate target genes in 
adult neuronal cells. Here too, it is possible that the loss of all of these factors leads to an 
appropriate regulation of transcriptional co-factors that explain this phenotype. However, it is 
difficult to determine what these factors might be. Different co-regulators may also be 
misregulated in the various mutant conditions tested. 
The first hypothesis is preferred in this thesis as it is more parsimonious. Nonetheless, the 
data presented are congruent with either hypothesis, and it is difficult to definitively distinguish 
between the two. It is also possible that a mechanism that combines both hypotheses is at play. 
